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8
  C
H
A
PT
ER
 1
   
9
I
n an interview for a Dutch newspaper, Chalmers stressed the need for more
research that provides answers to clinically relevant questions (NRC, 28th
October, 2006). Indeed, there are many examples of research projects whose
findings appear to have little relevance to clinical practice. Although a
cost-effectiveness study demonstrated that ventilation tubes have limited value in the
treatment of otitis media for most children without complaints (Hartman et al.,
2001), these results hardly affected the clinical practices of otolaryngologists (van der
Wilt et al., 2004). Based on two studies demonstrating a decrease in the number of
diagnostic tests, perioperative complications, and treatment costs (Langmeijer et al.,
1996; Rutten et al., 1995), the Health Council advised all hospitals to implement an
outpatient anaesthesiological assessment (Gezondheidsraad, 1997). Despite these
findings and recommendations, anaesthesiologists in one hospital considered the
implementation of such outpatient assessments to be of little benefit. They felt that
their existing pre-operative anaesthesiological practices were sufficient, and saw no
need to change them. Possible savings in the number of diagnostic tests and costs
were limited (Hartman & van der Wilt, 1999). 
These examples illustrate a problem that has been frequently discussed in
Health Technology Assessment (HTA). Although much evidence has become
available, this information is often not applied to health policy or clinical practice.
This thesis addresses the problem of the limited impact of HTA research on health
policy and clinical practice and investigates the ways by which we can improve the
usability of research for health policy and clinical practices. 
Health Technology Assessment and use
Recent years, there is a rapid growth in the number of HTA studies being performed
(Banta, 2003; Draborg et al., 2005). HTA is a type of policy research that aims to
provide information concerning medical technologies in order to support health care
decision making. Ideally, such assessments not only evaluate the effectiveness of the
intervention but also take into account its potential economic, social, cultural, legal,
ethical, and/or organisational consequences (Raad voor Gezondheidsonderzoek,
1998). 
HTA can be considered a specialised field of Technology Assessment. The
Office of Technology Assessment (OTA) was established in the 1970s to assess rapidly
developing technologies. The reports from the OTA included comprehensive policy
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research on the social consequences of the short and long term use of technological
innovations and presented an example of a new analytical tool to direct policy
making (Banta, 2003; Lehoux & Blume, 2000). Although HTA can be considered a
specialised form of Technology Assessment, its assessments are generally less
extensive. In practice, these studies emphasise the efficiency of interventions, while
corresponding ethical and organisational implications are only superficially addressed
(Banta, 2003; Berg et al., 2004; Lehoux & Blume, 2000; Reuzel & van der Wilt,
2000).
In the Netherlands, HTAs are usually cost-effectiveness analysis, undertaken by
universities or university hospitals. Furthermore, extensive reviews on the state of
affairs concerning medical subjects are provided by the Health Council. Until 2000,
the national HTA programme, ‘Developmental Medicine’ (ontwikkelings-
geneeskunde) was under the auspices of the Netherlands Sickness Funds Council (the
current Health Care Insurance Board) (Raad voor Gezondheidsonderzoek, 2004;
Berg et al., 2004). The Dutch Ministry of Health established this fund in order to
enable the evaluation of the costs and effects of new, innovative clinical interventions.
Presently, a great deal of research on the efficacy of interventions is subsidised by the
‘Health Care Efficiency Research Programme’ from the Netherlands Organisation for
Health Research and Development (ZON-MW). Research may be commissioned
directly by the Ministry of Health, the Health Care Insurance Board, or clinical
practitioners. The information provided by the HTA is used by both policy makers (at
the Ministry of Health or organisations such as the Health Care Insurance Board)
and professionals in the field (physicians and hospital administrators). Professionals
may apply the HTA results directly to their area of speciality or they may be
influenced indirectly through subsequent policy measures. 
Although, in many cases, HTAs appear to affect health care decisions, their
actual contribution has been frequently debated (Drummond et al., 1997;
Drummond & Weatherly 2000; Duthie et al., 1999; Graf van der Schulenburg,
2000; Oliver et al., 2004; Williams & Bryan, 2007). Policy decisions concerning the
introduction of (new) technologies in health care are not always based on the results
of HTA studies (van den Heuvel et al., 1997; Berg et al., 2004), cost-considerations,
are rarely incorporated in clinical guidelines (Berg et al., 2004; Niessen et al., 2007),
and behavioural changes as the result of a HTA occur infrequently (Raad voor
Gezondheidsonderzoek, 1998).
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Currently, two solutions that seek to increase the applicability of research are being
instituted, namely the standardisation of research methods and the active
implementation of research findings in clinical practice. Standardising the research
methodology is expected to increase the credibility of the results and thereby their
utility. Actively promoting the use of evidence and developing guidelines for
summarising the evidence seek to overcome the passive dissemination of new
evidence, thereby decreasing the gap between the available information and its use in
clinical practice (Bero et al., 1998; Grol et al., 1998; Haines & Donald, 1998; Haynes
& Haines, 1998;, Grol & Grimshaw, 2003; Grol & Wensing, 2004; Gagnon et al.,
2006).
Limited usability of HTA 
The abovementioned approaches may improve the utilisation of HTAs to some
extent. However, there may be an alternative solution to increase the degree to which
research-based findings are used in decision making. This solution is based on the
‘argumentative approach’ developed by the policy sciences. A possible explanation for
the limited impact of HTAs is that they do not sufficiently answer the questions
deemed important by their potential users, namely policy makers and health care
professionals. These users are likely to see the problems different than the problems
identified by the researchers. Interventions that are judged as a solution from one
perspective might be irrelevant from another perspective.
Theoretical framework: the argumentative approach in policy analysis 
Also within policy sciences, the relevance of policy and the need for adequate
implementation of that policy has been discussed. The development and
implementation of a policy is shaped by the interactions between all actors involved
(stakeholders). Stakeholders are actors directly involved in the decision making
process and actors who are, or might be, affected by any action taken by an
organisation or group. (Derthick, 1972; Mazmanian & Sabatier, 1983; Pressman &
Wildavsky, 1973). As Elmore (1985) has argued, this implies that policy design should
iterate between forward mapping, translating the social problem into a policy
problem and then generating policies to deal with the problem, and backward
mapping, analysing ex-ante the extent to which implementers and target groups will
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likely respond to these policies in ways that help resolve the social problem prior to
implementing the policy. 
The theory of argumentative policy analysis provides a possible explanation for
the failed implementation of policy measures. The basic idea of the argumentative
approach is that actors’ behaviours can be explained by different views on a problem
and the argumentation behind these views (Fischer & Forrester, 1993; Yanow, 1996;
Grin & van de Graaf, 1996a; Hoppe & Peterse, 1998). Central to the argumentative
approach (Fischer & Forester, 1993; Fischer, 1999; Fischer, 2003), is the notion that
action is driven by processes of problem setting (Schön, 1983) in which actors iterate
between forward mapping and backward mapping in order to define problems and
solutions that correspond with each other and the actors' normative and empirical
backgrounds. The way in which a problem is defined depends on the assumptions
the actors have about the situation and their beliefs regarding what is considered
good practice (normative values). Based on these insights, authors from the
argumentative approach emphasised the importance of considering these differences
in problem definitions and the underlying arguments during policy development.
In reaction to the problems that arise during the implementation of policy
programs, much attention has been paid to the evaluations of implemented
interventions. Evaluation is usually restricted to assessing whether a specific
programme or intervention has, or has not, fulfilled the programme objectives. The
problem is that the outcome of an evaluation depends heavily on the criteria used to
evaluate it (Fischer, 1999). Disputes between actors on the meaning of a specific
intervention frequently can be explained by their disagreements with respect to which
criteria actors consider relevant for assessing the success or failure of an intervention. 
The evaluation of cochlear implants provides a concrete example of the
consequences of divergent assumptions. A cochlear implant (CI) is a small electronic
device that can help a person who is profoundly deaf perceive sound. The implant
consists of an external portion that is placed behind the ear and a second portion that
is surgically implanted under the skin. The stated objective behind implementing CI
was to allow deaf children to hear. To measure the effectiveness of the implants, most
evaluations included the perception and production of speech as an outcome
measure. Based on the results of an evaluation performed in the Netherlands
(Severens et al., 1997), the Ministry of Health was advised to include this technology
in the health package. However, the ministry could not reach a decision when
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confronted with protests from the deaf community. For many deaf people, the ability
to perceive sound through technology was an insufficient reason to adopt the new
technology. Apparently, the evaluation did not provide sufficient evidence that could
be used by all the stakeholders to make decisions regarding cochlear implants.
According to Fischer (1999), the main problem is that such evaluations fail to
take into account the underlying assumptions and normative values which influence
the evaluation of specific interventions. Frequently, the assessment is limited to
simply evaluating whether the objectives of the programme are met. It is a mistake,
however, to assume that a single analyst can objectively identify which specific
objectives should be met. This requires an analysis about the scope and purpose of
public policy. When is a programme successful? When is an intervention worthwhile?
Framework for a full evaluation
Fischer (1999) presented a framework for including empirical and normative concerns
in evaluation and termed this the ‘logic of practical deliberation’. A full evaluation
should not only include an assessment of the situational context of the intervention
but also an assessment of the more general assumptions and normative values. An
evaluation of the situational context, also called a first order evaluation, includes both
the measurement of outcomes and the identification of relevant criteria for
determining success. An evaluation of the more general assumptions includes an
assessment of the underlying assumptions and normative values of the stakeholders.
This is termed a second order evaluation. A summary of these four levels is presented
in Figure 1.1 and will be explained in more detail below. 
The first level of evaluation measures whether an intervention meets the
defined outcome measures (verification of program outcomes). For example, the
evaluation of CI consisted of measuring the perception and production of speech in
children who had received a CI. Most evaluations take place at this level. If there is no
consensus on the relevance of an intervention, Fischer proposes that the evaluation
should move to the next level, namely validation. Evaluation at this level deals with
identifying relevant criteria. During this phase, one should assess whether outcome
measures are relevant and valid in the given situation. Which outcome measures are
relevant depends on how the problem is defined and the purpose of the
improvement. 
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Figure 1.1 Four levels of a full evaluation (Fischer
1999)
Returning to the problem of CI, some years later, Reuzel (2004) performed an
interactive analysis on the use of CI for deaf children. In this analysis, he aimed to
identify criteria for success and acceptability. He organised an interactive discussion
among stakeholders in order to discuss the problems and relevant criteria for success.
In the case of CI, possible stakeholders included physicians, parents, counsellors, and
deaf children. The interactive analysis indicated that some stakeholders considered
the effect of CI on the social and emotional well-being of children implanted with the
device more relevant than the potential perception of sound. The problems were
defined differently by the advocates and opponents of CI. As a result, the choice with
respect to outcome measures was not obvious. Evidently, each actor’s preference with
respect to the outcome measure was dependent on that actor’s definition of the
problem and the various actors had divergent problem definitions. It is important to
note that a problem is frequently defined as the gap between the actual situation and
the desired situation. Both the actual and desired situation might be viewed
differently by different stakeholders.
If there is dissension regarding the nature of the problem, the evaluation
should shift to the next level, which involves an assessment of the actors’ underlying
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theoretical and normative assumptions. This is termed vindication. People can have
assumptions on the mechanisms behind intervention (theoretical assumptions) and
on how these interventions are effective in meeting the goals of the society
(normative assumptions). People working in different disciplines will frame the
situation or a problem differently (Rein & Schön, 1993, p. 147). Whether someone
considers a state of affairs to be evidence supporting a hypothesis depends on his or
her background beliefs and assumptions (Longino 1990, p. 43). These considerations
are no longer limited to the interventions. What we see then is that the evaluation
moves towards the broader social context in which the evaluation takes place. This is
then a second order evaluation. 
With respect to the problem of CI, differences in the perception of the problem
between the opponents and advocates of its use were likely the result of the differing
assumptions concerning deafness itself. Deafness can be seen as a pathological
disorder which prevents people from fully participating in society. In this context,
spoken language is considered necessary for individuals to adequately function in
society. Children with hearing deficits should thus receive a CI so they can learn how
to communicate orally so that they can communicate and function within the larger
community. However, others regard deafness as the distinct linguistic and cultural
aspect of a group of people. They considered the acquisition of sign language
necessary for the individual’s social and emotional development. Sign language is
considered by these actors to be someone’s natural language. Furthermore, they
would contend that the introduction of CI could have consequences for the future of
the deaf community (for example, the financing of certain facilities).
If it is not possible for the concerned parties to reach agreement on which
assumptions are legitimate, the evaluation must move to the fourth and final level. At
this level, the normative values that are held by the participants (social choice) are
examined, since it is believed that these normative values strongly affect which
theoretical assumptions are considered relevant and how the problem is defined. The
relevance of the underlying assumptions is not determined through empirical
evidence but rather by an examination of the values and beliefs held by the
participants (Longino 1990, p.57).
Considering the case of CI, at least two different normative positions could be
identified among the participants. The first is the medical perspective which seeks to,
firstly, eradicate what they see as a disability and, secondly, integrate deaf people into
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Figure 1.2 The four layers of someone’s interpretive frame
(Grin et al., 1997)
hearing society. However, many people within the deaf community, value
maintaining the deaf community as a distinct community with its own language and
culture. These people hold the second normative perspective. In the interactive
evaluation, the existence of these conflicting values were presented (Reuzel, 2004)
and criteria that were considered relevant for both normative values were identified.
In conclusion, in many cases the criteria used to evaluate the outcome of an
intervention are inadequate. Consequently, it may be desirable to examine the issues
surrounding the intervention more comprehensively. Since the underlying beliefs
that determine which criteria are relevant can differ between actors, an analyst should
consider carefully how the actors in a given situation define the problem and which
outcome measures are relevant. When there is no agreement between the parties on
the definition of the problem, the underlying beliefs and values influencing their
perception of the problem should be considered.
Interpretive frames
Grin et al. (Grin & van de Graaf, 1996b; Grin et al., 1997) developed an instrument
to reconstruct someone’s problem definition and the underlying argumentation. This
instrument draws on the four-phase model for evaluation proposed by Fischer (1999).
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The idea is to reconstruct (for example, during an interview) how interventions are
judged, which criteria are considered relevant and the way in which the problem is
defined the theoretical and normative assumptions that shaped them, and someone’s
preferences (Figure 1.2). These four layers of evaluation together constitute an actor’s
‘interpretive frame’. In Table 1.1, the interpretive frames of the two viewpoints that
manifested in the CI case are summarised. 
Careful analysis of perspectives in terms of interpretive frames helps to
determine what is agreed and disagreed upon. When the interpretive frames of the
actors are found to be divergent with respect to problem definitions and normative
assumptions, there is a lack of congruence between interpretive frames. According to
Hisschemöller (1993), the kind of research needed to solve a problem depends on the
kind of problem one has to deal with. If actors agree on the problem definition and
which norms are at stake, the problem is well structured (Table 1.2) and can be solved
using standardised (quantitative) methods. However, if actors disagree on the nature
of the problem, what information is required to evaluate an intervention and which
normative values are at stake, the problem is ill-structured. If the problem is ill-
structured, conventional research methods might lead to the over-simplification of
the problem. As a result, the wrong problem may be solved, or the problem may be
only partially solved. Addressing the wrong problem occurs frequently when there is
no acknowledgement of the diverging perspectives the actors have towards the
situation (Dunn, 2004; Hisschemöller, 1993). Clearly, when a problem is ill-
structured, alternative methods are necessary to structure the problem.
  Table 1.1. Interpretive frames concerning CI, based on Reuzel 2004
medical perspective member of the deaf society
judgement solution CI is a valuable instrument CI is only a moderately valuable aid 
problem definition Communication between deaf people
and hearing people is difficult.
With CI, deaf people should face high
expectations, because child with CI will
be hard of hearing
theoretical assumption Deafness is a disability.
Offering spoken language is needed
for rapid development of the child’s
orientation to spoken language.
Oral language relevant for functioning
in society; communication improves
someone’s well being. 
Offering sign language needed for the
child’s social and emotional
development. 
Sign language is someone’s natural
language.
normative value Integrate deaf people in the community Maintaining a deaf community with its
own language and culture
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      Table 1.2. Types of policy problems according to Hiscchemöller (1993)
Agreement on needed information
yes no
Agreement on
which norms
are at stake
yes well structured
 problem
moderately structured problem
no moderately structured problem ill structured 
problem
Ignoring differences in problem definitions in HTA
Returning to the problem outlined at the beginning of this chapter regarding the
limited impact of HTA, we contend that if an HTA has only a limited impact on
policy and practice, it is possibly the result of the assumption that there is agreement
between all stakeholders on the criteria for evaluation. HTA is usually restricted to the
level of verification, assessing whether an intervention meets the predefined criteria.
However, HTA might not adequately take into account the possible difficulties that
result from divergent problem definitions resulting from differing assumptions and
values. In the case of CI for children, the initial study was restricted to evaluating the
cost-effectiveness of the procedure. This provided insufficient information to support
health policy decisions made by the Ministry of Health. The evaluation in which the
role of underlying assumptions and normative values were acknowledged provided
additional information that was more relevant to the different actors involved. The
evaluation on CI was successful because it resulted in a number of clear policy
recommendations supported by all participants (Reuzel, 2004).
Critics might emphasise that the example provided by CI does not fully
correspond to mainstream HTA research. In mainstream HTA, the issues seem less
complex. Indeed, CI was a case in which the intervention was strongly debated from
the beginning. Nevertheless, the hypothesis is that it is imperative to consider the
stakeholders’ perspectives, even when dealing with technologies that initially appear
to be less controversial. In many cases, the actors involved may define the problem
differently based on differences in education or profession. Different ways of framing
a disease result in different strategies for resolution and different views on what
research is considered to be relevant (van der Wilt, 1995) At the same time, the
  C
H
A
PT
ER
 1
   
19
cooperation of these actors is required to successfully implement the intervention.
The direction and goals of health care policy has shifted towards policy making as a
process of co-production. A functioning health care system is seen as the joint
responsibility of all the relevant parties, including hospitals, health care professionals,
consumers, health care insurers, and the government (Hurst, 1991; Okma, 2001).)
The implementation of policy measures may only be effective if implementers and
target populations consider the proposed policy measure to be meaningful (Grin &
van de Graaf, 1996a). The latter implies that the proposed policy 1) must make sense
in light of their perception of the problem and 2) does not violate their normative
values.
In conclusion, HTA evaluates interventions in order to support policy making.
Current HTA methods are adequate for solving well-structured problems. However,
when stakeholders interpret findings and situations differently, problems are likely to
be ill-structured. HTA currently does not adequately assess the underlying theoretical
assumptions and normative values of the policy makers and stakeholders that lead to
diverging views of the problems and research. If this is true, more emphasis should be
put on the possible differences in problem definitions and the underlying arguments
of actors involved for improving the usability of HTA. Instead of exerting the greatest
effort towards the implementation of research results after the completion of a trial,
the relevance of the research to both policy making and clinical practice should be
stressed before initiating the research.
This kind of ‘problem oriented approach’ in HTA resembles, to some extent,
the new view of Technology Assessment presented by Smits & Leyten (1991). They
argued that more attention should be placed on the definitions of the problem as
viewed by the actors involved. In accordance with Lehoux & Blume (2000), this
approach might also elaborate on the need to include a socio-political aspect in HTAs.
By assessing the needs and beliefs of the actors involved, an HTA can provides an
opportunity to include issues that go beyond the mere effectiveness and cost of an
intervention. The interactive nature of the approach may provide an opportunity to
include interests and perspectives in HTA. This problem-based approach to increasing
the applicability of HTA to decision making also coincides with the Health Council’s
directive to emphasise the optimisation of patient care rather than focussing on the
implementation of evidence (Gezondheidsraad, 2000).
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In this thesis, I will further explore the hypothesis that it is imperative to consider the
stakeholders’ perspectives, even when dealing with technologies that initially appear
to be less controversial.  If this is true, it is necessary to perform an extensive process
of problem structuring in which the stakeholders' perspectives in HTA are taken into
account. The main questions to be answered are:
1 In cases where HTA research or the implementation of subsequent policy
measures failed, were the research findings or policy measures congruent
with the views of all actors involved? 
a Which actors were involved (policy makers, researchers, policy’s target
populations), how did they define the problem, and which theoretical
assumptions and normative values were held by them?
b To what extent are research findings or subsequent policy measures
congruent with the views of actors involved (fit actors’ problem
definitions and not conflict with their normative values)?
2 How does involving the policy’s target population’s influence the design of
policy research? Does their participation result in research findings or
subsequent policy measures that are congruent with the views of all actors
involved? 
3 What are the outcomes of an interactive process of problem structuring in
policy research, whereby the problem definitions, underlying assumptions,
and norms are analyzed and discussed? How does this impact the
interventions themselves, the criteria for success, and the research questions
considered relevant?
Outline of this thesis 
Reconstructing interpretive frames
The methodology of reconstructing actors’ interpretive frames will be used for
describing and reconstructing the actors’ problem definitions and underlying
arguments (Grin & van de Graaf, 1996b; Grin et al, 1997). Reconstructed interpretive
frames will be used to assess 1) the type of problem (well, moderately, or ill
structured) and 2) whether interventions are congruent with the interpretive frames
of actors involved. 
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In Chapter 2, the methodology of reconstructing interpretive frames is discussed in
more detail. Firstly, relevant validity criteria are discussed. Secondly, the results of an
analysis of the inter-observer variability of reconstructing the interpretive frames are
presented. Research questions are: Is reconstructing interpretive frames a reliable
method to assess problem definitions, underlying theoretical assumptions and
normative values? Is reconstructing interpretive frames a reliable method to assess the
cooperation of actors on predefined solutions?
Retrospective analyses of failed research or subsequent policy measures
In Chapters 3, 4, and 5, case studies are presented in which research projects failed.
Failed research includes those situations in which 1) research results are considered
irrelevant by policy makers or the commissioner, or 2) the implementation of
subsequent policy measures failed. Failure of subsequent policy measures is
considered relevant, because HTA can be regarded as a kind of policy development.
The case studies consisted of research projects that were commissioned by the
Department of Policy Analysis of Medicines (PAM) of the Dutch Health Insurance
Board, an advisory board for the Ministry of Health. Within the Board, PAM
contributes to identifying developments that may jeopardise optimal medical care,
analysing the nature and size of such threats, and ensuring that additional research
that may provide a basis for resolution through policy is conducted
(Ziekenfondsraad, 1998).
In Chapter 3, a case study on the drug mebeverine for patients with the
irritable bowel syndrome is presented. Prior to this project, measures to exclude the
drug from the health package had failed. Actors involved (policy analysts, researchers,
and policy’s target populations) disagreed whether the drug fulfilled the criteria to
qualify for reimbursement. Research was expected to provide the lacking knowledge.
The results of a preliminary study, however, were considered not useful by its
commissioner. No further research was commissioned and no policy measures were
implemented. Questions are: can differences be found between researchers and
potential users, policy makers and professionals in the field in the definition of the
problem and which norms are at stake? Are research results congruent with
interpretive frames of actors involved? 
Chapter 4 describes a case study in which the implementation of policy
measures based on research results failed. The subject was the implementation of a
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national protocol for prescribing lamotrigine, an antiepileptic drug. The
recommendations in this guideline were based on the available evidence from clinical
trials at that time. An inquiry had shown that this guideline was hardly used in
clinical practice. In this chapter, the theory of argumentative policy analysis is used to
explain the proceedings of the project. Question is whether the policy measure was
congruent with interpretive frames of policy maker and members of the target
population.
In Chapter 5, a project in which target populations were invited to participate
in policy development is described. Two workshops were arranged which aimed to
advice on policy measures to improve the efficient use of the drug interferon-beta for
patients with Multiple Sclerosis. Research question to be answered is, does
participation of target populations in policy development result in policy measures
that are considered as solutions to problems they perceive and do not conflict with
their normative values?
Monitoring case studies in which lessons are incorporated
Based on the findings in the abovementioned cases, changes were made in the
processes of commissioning research by the Health Care Insurance Board. Aim was
to take into account stakeholders’ perspectives and prevent a shift in problem
definition. In chapter 6 and 7, two case studies are presented in which these lessons
were incorporated. 
The first case study (Chapter 6) deals with the project on new analgesics, the
cox-2 selective inhibitors. In this study, researchers were asked to provide 1)
information on target populations perspectives and 2) evidence on the value of
specific interventions in one project. We monitored the process of policy analysis
conducted by PAM staff, the European tender for proposals, and the PAM appraisal of
the research proposals that were submitted. Research question is, is the new approach
to commissioning research successful in terms of increasing the cooperation of
researchers and the relevance of the results? 
The second case (Chapter 7) deals with the efficient use of two, novel drugs
for patients with pulmonary hypertension. The PAM staff asked researchers to make
an inventory of problems and judgements of solutions according to the policy’s target
populations. The PAM staff decided to commission the project on perceived problems
separately from a research project aimed at obtaining specific information needed for
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policy making. Furthermore, it allowed them to commission the projects via a
non-European tender. This provided flexibility in the organisation of the tendering
process and allowed for meetings between the commissioner and researchers.
Research questions are: Did research proposals correspond with the problems as
perceived by both those who commissioned the study and the stakeholders in the
field? Were the research results translated into the implementation of concrete policy
measures?
Interactive process of problem structuring
Finally, a promising methodology for problem structuring is the methodology of
Interactive Technology Assessment, which is based on the methodology for fourth
generation evaluation developed by Guba and Lincoln (1989). In Chapter 8, a case
study is presented in which an interactive methodology is used for structuring
problems. The case study dealt with acute hospital care for patients who attempted
suicide by intoxication. This study aims to compare the outcome of an interactive
approach for problem structuring with the outcome from a conventional approach.
Research questions is: What problem definition emerges from a fourth generation
approach to problem structuring, as compared to the problem definition as presented
by the person who first put it on the agenda?
In Chapter 9, the findings from the case studies results will be summarised and
conclusions will be drawn on the need for a problem based approach in HTA. 
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2
Validity and reliability of qualitative data-analysis:
inter-observer agreement in reconstructing
interpretive frames
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M
any authors have discussed criteria for assessing the quality of qualitative
studies. However, relatively few authors present the results of employing
criteria for validity of qualitative studies. We investigated the quality of
reconstructing interpretive frames, a method for analysing interview transcripts. Aim
of this method is to describe a person’s perspective, distinguishing between perceived
problem definitions, proposed solutions, empirical background theories, and
normative preferences. Based on this description one should be able to estimate this
person’s cooperation on implementing specific changes in his or her practice. In this
article, we assessed the inter-observer reliability of this analytical method as an
indicator of its rigor. Six analysts reconstructed interpretive frames on the basis of
verbatim transcripts of three interviews. As to the issues identified and the question
which problems should be prioritized, the analysts only moderately agreed. However,
as to the estimates of the respondents’ cooperation on proposed solutions, the
analysts showed remarkable unanimity. 
M Moret, RPB Reuzel, van der Wilt GJ, J Grin. Validity and reliability of qualitative
data-analysis: reconstructing interpretative frames. Field Methods 2007; 19(1):24-39
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M
ost articles and books on the "quality" ("validity", "credibility", or "rigor")
of qualitative research deal with the question how to assess the quality of a
study that has been performed. Rarely, however, the results of employing
these criteria are published (Barker, 2003; Clavarino et al., 1995). Moreover, there is
discussion as to which criteria should be used to assess the "quality" of a qualitative
study. Commonly, the discussion centers on the concept of truth and the question
whether truth is (a) universal or local, and (b) determinable. According to many
authors, criteria used for quantitative research are also applicable in qualitative
research, which is to say that validity and reliability are meaningful concepts in
qualitative research. 
Discussing validity is not only important for estimating the trustworthiness of
research findings, but also for scrutinizing the aims and scope of the methods used.
In this sense, discussing validity is an instrument for improving methodology.
Validity is context-bound, however (Yanow, 2000). That is, it depends on the
aims of a method and the context in which this method is employed. For example, it
is well known that (western) methods for assessing health related quality-of-life are
not valid in many African countries (Mkoka et al., 2003.) 
Furthermore, it is important to acknowledge that qualitative research and
quantitative research do not exclude each other. It is more useful to view both as
approaches, which in practice may involve the employment of several different
methods for data collection and analysis, some qualitative, some quantitative. Each
method features its own definition of reliability. If a question is quantitative in
nature, it is perfectly appropriate to use quantitative approaches, even when the
subject of study is a qualitative analytical method.
In this paper, we address a method for analysing qualitative data, i.e. the
reconstruction of interpretive frames. This analytical method is used within the
context of so-called ‘fourth generation’ approaches to evaluation. It allows for
eliciting stakeholders’ views, in order to estimate the likelihood that these
stakeholders co-operate on a set of proposed solutions, or policy interventions. Our
aim is (1) to explain how validity and reliability are defined in the context in which
the method is employed, (2) explain why validity and reliability are important in this
context, and (3) to demonstrate how reliability can be assessed. 
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Validity in fourth generation approaches
Unlike researchers who are quantitatively oriented, many ‘qualitative researchers’
would claim that they are not interested in the truth. Rather they would inquire into
a respondent’s version of the truth. Still, qualitative research aims at knowledge. That
is, qualitative research is still defined as a scientific endeavour that is successful if in
the end it produces knowledge that is broadly accepted, even if truth is considered a
local concept. It is at this point, that so-called ‘fourth generation’ approaches to
qualitative research mark a difference. According to these approaches knowledge
should not be considered as an end-point of inquiry. Instead, action (e.g. policy
recommendations) should. To be sure, knowledge is important as a sound basis for
action. Consequently, knowledge claims should be meticulously scrutinized, but they
primarily serve deliberation processes, which should culminate in action, or change.
This has important consequences for the concept of validity involved.
Guba and Lincoln (1989), inventors and two advocates of the fourth
generation evaluation approach, view evaluation as a procedure ‘in which a
combination is made of responsive focusing (using the claims, concerns and issues of
stakeholders as the organizing elements) and a constructivist methodology (which
aims to develop consensus among stakeholders who earlier held different or
conflicting constructions).’ (p. 71) Central in their methodology is the hermeneutic
dialectic process. It consists of one or more rounds of open-ended interviews with
stakeholders. It starts with an interview with a first respondent to determine his or
her construction of the investigated phenomenon. Next, the researcher interviews a
second respondent to determine his or her construction. Furthermore, the researcher
confronts the second respondent with claims, concerns, and issues raised in the
interview with the first respondent. The interviewer then makes a shared
construction based on these two interviews. Then a third respondent is interviewed,
etc. Ideally, this process proceeds until no new information is added. In the view of
Guba and Lincoln, the aim is to reach consensus.
Obviously, 'traditional' criteria (internal validity, external validity, and
reliability) are not useful in this approach. Reproducibility is considered irrelevant,
because in qualitative research the researcher is commonly interested in practices that
are strongly bound to a specific context (including time and place). Similarly, the
fourth generation researcher would not aim at generalisability. On the contrary,
fourth generation evaluation should produce change in order to provide solutions for
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problems conceived in a specific context. Thus, in fourth generation evaluation,
reliability of interviews looses in significance, for if evaluation aims at action, rather
than knowledge, then reliability in the sense of being researcher independent and
yielding the same results upon repeated measurements is not only futile, but even
undesirable. It is therefore that Guba and Lincoln prefer to use ‘dependability’
instead.
However, Guba and Lincoln have derived their criteria from the aims of
fourth generation evaluation as a whole. The question remains whether these criteria
apply to methods, e.g. methods for analyzing interviews, used within the process.
Could concepts of validity and reliability be meaningful there? One could argue that
if the analyst has difficulties with interpreting an interview, several interviews should
be scheduled to adjust the interpretation until analyst and respondent agree to an
interpretation that covers the respondent’s version of the truth. However, we would
argue that in fourth generation evaluation it is unwise to exclusively rely on the
self-correcting mechanism of the hermeneutic process, if only for reasons of
efficiency. Constraints on time and money call for an analytic tool that makes it
possible to interpret someone's ideas in a sound way. It is at this level, then, that we
do believe that reliability remains important.
     
Reconstructing interpretive frames 
Reconstructing interpretive frames is one such method for analyzing interviews. The
term ‘interpretive frame’ is used by Grin and van de Graaf (1996b; based on a
synthesis of Schön, 1983, and Fischer, 1980) to refer to a quadruple set of elements
that determine a respondent’s view: context-specific problem definitions, solutions,
empirical and ethical background theories, and normative preferences. Grin and van
de Graaf argue that the ‘second order notions’ of background theories and normative
preferences span the space within which problems are defined, and solutions sought.
This adds some precision to understanding the process initiated in fourth generation
evaluation. Careful analysis of interviews in terms of interpretive frames helps ‘at the
level of knowledge’ sorting out what is agreed and disagreed upon, and thus helps
preparing subsequent interviews. But reconstructing interpretive frames is even more
useful for designing widely endorsed solutions to problems encountered, and
estimating the likelihood that participants agree to these solutions. The idea is that
cooperation on the implementation of policy measures depends on whether
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stakeholders consider these policy measures meaningful from their own interpretive
frame. A measure is considered meaningful by a particular stakeholder, if it solves his
or her problems and does not violate his or her background theories and normative
preferences. Thus, in designing policy measures it is relevant to identify actors
involved and their interpretive frames. Clearly, the method fits in Guba and
Lincoln’s fourth generation approach, which similarly aims at agreement over policy
measures.
Until now, little has been published on the validity and reliability of this
method or comparable methods (Grin et al., 1997). To assess the inter-observer
reliability of the method, we aimed at answering the following research questions: 
1. To what extent do different analysts agree on (a) issues identified and (b) the
most important problem definitions for each respondent?
2. To what extent do different analysts agree as to whether respondents would
cooperate on a set of proposed solutions?
Methods 
We used the transcripts of three interviews from a fourth generation evaluation of
cochlear implantation (CI) in deaf children (Reuzel, 2004). A cochlear implant, or
‘bionic ear’, is a device that provides a hearing sensation to profoundly deaf people.
Sounds from the environment are transduced by a microphone, processed by a
so-called ‘speech processor’, and then transferred to the acoustic nerve through
electrodes. Surgery is required to implant the receiver coil and connect the electrodes.
Through extensive rehabilitation, recipients can learn to interpret the auditory input
they receive. Although the technology is effective in most individuals, the technology
has raised considerable controversy for its development, implementation, and
evaluation have been primarily based on a medical perspective on deafness as a
handicap to be eradicated. Seen from this perspective, cochlear implantation helps to
ensure that deaf subjects are integrated into the ‘hearing society’ as much as possible.
However, advocates of cochlear implantation, who have been responsible for the
development and evaluation of the technology, have largely neglected Deaf concerns
about the sustainability of Deaf culture and the social and emotional development of
deaf children. These concerns are associated with an alternative view on deafness
referring ‘to socio-cultural characteristics of those hearing-impaired persons who
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consider themselves to belong to a special (Deaf) community’ (Tellings, 1995: 21).
The perspective on deafness as a handicap is thought of as a threat to this
community. Furthermore, deaf children would be in danger of experiencing social
and emotional pressures, due to discrimination and high expectations, the effects of
which could be serious and lasting. 
A fourth generation evaluation was undertaken (Reuzel, 2004) to identify the
conditions under which implementation of CI might be effective and acceptable.
Moreover, it was felt that the evaluation perhaps could restore the severely
deteriorated mutual trust between advocates and opponents of CI. This fourth
generation evaluation was, in fact, a response to the claim of many opponents that
not only CI, but also the health technology assessment studies undertaken to support
policy decisions on it, were dominated by a conventional medical rationality. The
project involved of a series of open-ended interviews with 51 different stakeholders.
Among the most important issues that came up was communication, particularly the
question whether a deaf child wearing a cochlear implant should be raised and
educated using oral language, Sign language, or a combination of both. It is this issue
that we have emphasized in assessing the validity of reconstructing interpretive
frames.
Reconstructing interpretive frames
Using the verbatim interview transcripts, six analysts employed within our
department have reconstructed the interpretive frames of three respondents. One of
them (Reuzel) was the interviewer. The other analysts were familiar with evaluation
studies in health care, but inexperienced in reconstructing interpretive frames, and
only superficially acquainted with the CI problematic. They followed a short training
(three half days, by Grin) on the theory of reconstructing interpretive frames.
Moreover, they were provided with a protocol with references to Miles and
Huberman (1994) on the coding of texts, and Grin et al. (1997) on the method of
reconstructing interpretive frames.
Next, all analysts independently analyzed the interview transcripts, coding for
the issues encountered and the four elements of the interpretive frame. As to the
coding of issues, no agreements had been made beforehand. After analyzing the first
transcript, the results were discussed between the analysts and John Grin. After
analyzing the second and third transcripts, the analysts filled out a questionnaire,
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prompting them to note the three most relevant problems for each respondent and
predict the cooperation of each respondent on a set of predefined solutions. Answer
categories included 'yes', 'no', or 'indeterminate'. 
Three solutions were based on the problem of exposition to oral language in schools
for the deaf or hard of hearing usually being insufficient for optimal use of CI: 
1. Children with CI should attend mainstream schools as soon as possible, 
2. Ambulatory services should be increased. 
3. Regional expertise centers in which schools for the deaf, schools for the hard of
hearing, and mainstream schools co-operate are necessary. 
Two solutions referred to the fact that communication between hearing and deaf
persons is commonly problematic, particularly in the first years of life:
1. Simultaneously offering sign language and oral language is necessary to enable
early communication with deaf children. 
2. Parents of deaf children should learn sign language in order to better
communicate with their children.
We also noted what arguments for or against cooperation the analysts ascribed to the
respondents and to which elements of the respondents’ interpretive frames these
arguments referred. Finally, in order to further interpret inter-analyst similarities and
differences, we discussed the results during two 2-hour sessions.
Analysis
We compared the reconstructions of the analysts as to the following items: 
1. The issues identified in the first interview
2. The three most important problems for each respondent 
3. A prediction of the cooperation of each respondent on the five proposed
solutions. 
A qualitative description was given of the agreement on issues identified and the lists
of three most important problems. 
In order to assess the degree of agreement between analysts about the
respondents’ cooperation on proposed solutions, reliability coefficients were
calculated. A quantitative calculation is possible because the number of outcomes is
limited (three options) and have an order in ranking. One reliability coefficient was
calculated for each respondent. The calculation method has been described in detail
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by Streiner and Norman (1991), and is based on the analysis of variance. The overall
variability in answers could be attributed to three sources of variability: variability
attributable to the analysts, variability attributable to the interventions, and residual
variability. 
We replaced the answers (yes, indeterminate, no) by numeric values. We
valued a 'yes, the respondent will cooperate' as '1', 'indeterminate' as '0', and 'no' as
'-1'. We assumed that 1) an 'indeterminate' is situated between a 'yes' and a 'no'; and
2) the difference in scores between 'yes' and 'indeterminate' is equal to the difference
in scores between 'indeterminate' and 'no'. On these assumptions, the outcome is
independent from the selected values.
The overall variability is based on deviations between the observed values and
the average value of all observations (= expected value). The variability attributable to
analysts is based on the deviation between the average value for each analysts and the
average value of all observations. The variability attributable to interventions is based
on the deviation between the average value for each intervention and the average
value of all observations.
To calculate the reliability coefficient, the variability attributable to the
interventions is divided by the overall variability (variability attributable to the
analysts, variability attributable to the interventions, and residual variability). The
reliability is expressed as a number between 0 and 1, 0 indicating ‘no reliability’ and 1
indicating ‘perfect reliability’. If all analysts agree, the variability attributable to the
analysts is low and the coefficient is high. 
Results
Five analysts reconstructed the interpretive frames for the interview with respondent
A (R, W, G, M, & J). Four analysts reconstructed interpretive frames on the basis of
interview transcripts pertaining to respondents B and C (R, W, G, & M). Five
analysts completed the questionnaire for respondents A and B (R, W, G, M, & H).
Four analysts completed the questionnaire for respondent C (R, W, G, & M).
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Table 2.1. Relevant issues in the interview with respondent A, identified by the 4 analysts
identified issues R W J M
language x x x x
education x x x x
counseling of the child x x x x
indication for CI x x x x
education / counseling of parents x x x
funding x x
identity x
pressure of work (counselor) x
role (counselor) x x
social well being / communication x
equipment x x
discussion around CI x
use of protocol x
CI in general x x
Identified issues
The analysts identified the following issues: language, education, counseling of the
child, and eligibility criteria for CI (Table 2.1). The coding differed between analysts
as to the measure of detail. For example, issues that were coded as "CI in general" by
two researchers were identified by the other analysts as issues concerning the role of
the counselor, social well-being, and identity. Not surprisingly, the analyst who had
held the interviews (R) made the most detailed list of issues. Moreover, the analysts
appeared to attach different meanings to concepts such as communication.
Most important problems 
As to interview A, all analysts identified the problem that 'language input is generally
insufficient for deaf children' (Table 2.2). The lists for interview B and C, however,
were more diverse (Tables 2.3 & 2.4). Regarding interview B, three out of five analysts
mentioned the problem of gearing language input to the capabilities of individual
deaf persons. The problem that oral language alone is insufficient for a healthy social
emotional development was also mentioned frequently. On the basis of interview C,
two out of four analysts identified the problem that the medical perspective is
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dominant in information for parents. Two analysts mentioned that deafness is more
than not hearing, and that the social emotional development of deaf children is at
stake. All other problem definitions were mentioned by one analyst only.
Table 2.2. Three most important problem definitions for respondent A according to the five analysts
R W G M H
language input is generally insufficient for deaf children x x x x x
information on deafness and CI is not objective x
value of CI for an individual is difficult to assess x
conditions for integration in regular education x
indication: who decides who are qualified for CI x x
children cannot use CI directly x
CI not available for everyone due to too less financial sources x
education should be geared to one another x
* CI =Cochlear Implants
Table 2.3. Three most important problem definitions for respondent B according to the five analysts
R W G M H
Gearing language input with possibilities of individual children; an individual
approach in education is preferable 
x x x
Oral language is insufficient for social emotional development x x x
Insufficient nuance in information/ expectations of parents x
It is not clear what is the best way to communicate x
Unclear how to obtain the maximum with right mix van bi-lingualism? x
Deaf people do not respect parents choice for CI* x
At schools no agreement on using oral language, sign language or both x
Regular education whereas deaf education seems more suitable x
* CI =Cochlear Implants
Expected co-operation on proposed solutions
Analysts were asked to consider 15 (=3x5) combinations of a respondent and proposed
solution. In eight combinations, all analysts agreed about the likelihood that the
respondent would cooperate on the proposed solution (Table 2.5). In one situation
analysts fully disagreed. In the remaining six situations, some small differences were
found. Most differences were found in the predicted cooperation of respondent A.
The calculated reliability ratio was 0.73. The analysts disagreed on the cooperation on
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the last three solutions. All analysts referred to respondent's background theories, but
interpreted these differently. Some analysts indicated that information was missing.
Apparently, the respondent's opinion was nuanced. 
Table 2.4. Three most important problem definitions for respondent C according to the four analysts
R W G M
Adequate information is necessary; medical perspective in information dominant x x
Deafness is more than not hearing; culture and identity; acceptance of deafness by
hearing people and deaf 
x x
(Uncertainty on) social emotional development of children x x
Deaf have language deficiency x
Self image of deaf is indistinct x
Deaf always push oneself to he limit x
Consequences of CI* are indistinct x
People think that input of sign language suffice x
Fewer differences were found in the predicted cooperation of respondent B and C.
For both respondents, reliability ratios were 0.98. In most situations the analysts
agreed and mentioned similar arguments, referring to respondent’s background
theories. Furthermore, the answer 'indeterminate' was given less often. In three
situations, some analysts answered that the issue that the proposed solution referred
to was not addressed in the interview, whereas others based their judgments on
background theories. Finally, all analysts agreed that co-operation on the fourth
solution was to be expected of all respondents.
Discussion
In this article, we presented the results of the reconstruction of interpretive frames by
six analysts. We found that the analysts only moderately agreed on issues identified
and the most important problems for the respondents. Texts coded as 'CI in general’
by some analysts were coded in greater detail by others, the analyst who had held the
interviews achieving the greatest detail. From the discussion between the team
members, it became clear that the identification of issues depends on prior
knowledge from the analyst. For example, the analyst who held the interviews
probably recognized issues that had been dealt with in other interviews. Another
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possible explanation is that this analyst was more experienced in reconstructing
interpretive frames.
Table 2.5. Estimated cooperation of the three respondents on five proposed solutions by analyst *
respondent A respondent B respondent C
R W G M H R W G M H R W G M
1. Children with CI** should
participate in regular education as
soon as possible.
+ + + + + - - - - -
- ? - -
2. The capacity of ambulatory
counselors should be increased to
optimize the input of oral language at
school and at home.
+ ? + + + ? ? + ? + - ? - ?
3. Regional expertise centers in
which schools for the deaf, schools
for the hard of hearing, and regular
schools co-operate are necessary.
? - ? ? ? - - - - - ? ? ? ?
4. Offering sign language besides
oral language is necessary to
facilitate communication with the
child.
+ + ? ? ? + + + + + + + + +
5. Parents should learn sign
language so that they can better
communicate with their children.
+ ? ? - - + + + + + + + + +
* '+' = yes, it is likely that the respondent will cooperate on the proposed solution according to the analyst, '-' = no, the respondent will
not cooperate according to the analyst, and '?' indicates that the analyst could not ascertain whether the respondent would cooperate. 
** CI =Cochlear Implants
Other authors found a high agreement in coding of text between analysts (Clavarino
et al., 1995). Ryan (1999) also reported on a comparison between multiple coders.
However, the aim of this analysis was not to assess the validity or reliability of the
coding method. The author argued that comparison of multiple analysts could also
be used to identify core and peripheral issues from a text. He emphasized text
fragments that are coded by several analysts. An explanation for the high agreement
claimed on the basis of these studies might be that agreements regarding the codes to
be used had been made before analysis. In our study, we only agreed that two kinds
of codes should be used: one concerning the four elements of the interpretive frame
and one concerning the issues discussed in the interview. No agreements were made
on the coding of these issues. 
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Agreement on cooperation
Although it is not always appropriate to use quantitative measures in qualitative
research, we consider quantitative measures appropriate in our analysis. For instance,
results from qualitative research need not always be replicable, in case of which
quantification is inappropriate. However, we asked to what extent analysts agree on
the likelihood that a respondent is willing to co-operate on a set of proposed
solutions, which involves a quantitative question. We found that the agreement
between the analysts as to the estimated cooperation of actors B and C on the
proposed solutions was fairly high. Streiner and Norman consider a score of 0.75 as a
minimal requirement for a useful instrument (Streiner & Norman, 1991). 
Analysts moderately agreed on the co-operation of respondent A. In the
calculation of reliability coefficients, we have accounted for three sources of
variability: variability attributable to the analysts, variability due to differences
between the proposed policy measures, and residual variability. The extent of
agreement found with respect to respondent A may result from differences between
the analysts or from residual variability. In our data, the low agreement resulted from
a relatively high residual variability (data not shown). Inadequate interviewing may
affect the reliability assessments of expected co-operation on policy measures. Poor
interviewing (on the part of either the interviewer or the respondent) could leave a
respondent’s view unclear or obscure, as a result of which analysts interpret it
differently and the residual variability increases. The limited experiences of the
analysts could also provide an explanation for the relatively high residual variability,
in case of which the relatively high levels of agreement found for respondents B and
C indicate a learning effect. Finally, in the questionnaire, solutions were introduced
by a short description of a problem to provide the analysts with some context.
Sometimes an analyst remarked that the problem appeared not to be acknowledged
by the respondent. This might also affect the analyst’s prediction. It might be better
to present solutions alone. 
It is difficult to tell which explanation accounts for the extent of agreement
found. However, in any case, our calculation of the extent of agreement indicates that
there is a problem concerning validity and reliability. Similarly, a high degree of
agreement may be interpreted as an indicator of good reliability. 
Mostly, when analysts estimated a respondent’s cooperation, they referred to
similar arguments, which often derive from the respondent’s background theories.
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Sometimes, analysts would be cautious and answer that an issue was not addressed in
the interview, while others would not hesitate to predict cooperation on the basis of
the respondent’s background theories. As we noted, the theoretical idea is that
cooperation is likely if 1) the intervention is conceived of as a solution to his or her
problems, and 2) the solution does not conflict with second order notions.
Apparently, it was not always easy to unambiguously assess whether a solution that is
not explicitly discussed will conflict with someone's second order notions. Here
again, our discussions indicated that the amount of prior knowledge could explain
much of the inter-analyst variation.
Limitations our study and steps for further inquiry
A limitation of our study was that we restricted our analysis to interview transcripts.
In fact, reconstructing interpretive frames involves both interviewing and analysing
the interviews. It is plausible to think that if all analysts had been involved in data
collection, we would have found more agreement. It would be interesting to compare
outcomes of the whole process of interviewing and reconstructing interpretive frames.
However, this is more complicated to arrange in practice. 
Furthermore, we assessed the agreement between analysts in their estimates of
respondents’ co-operation on a set of proposed solutions. Even when all analysts
agree on the cooperation of a respondent, the question remains whether the actor will
actually cooperate. A high agreement between different analysts is not enough to
establish the validity of the interpretation of data. It is possible that all analysts were
wrong about the interpretation. Moreover, in reality, it is possible that the
respondent changes his or her perspective. Guba and Lincoln acknowledge changes
in the perspectives of the respondents as one of the hallmarks of quality. In fourth
generation evaluation, the results of the data-analyses do not mark the end stage of a
research project, but are submitted to the respondents in a continuous process. The
next step would be to monitor whether the respondents indeed co-operate on the
proposed solutions when these are implemented.
Conclusion
The method of reconstructing interpretive frames from verbatim transcribed
interviews seems reliable to assess the cooperation of respondents on proposed
solutions. Thus, the method is useful for identifying widely endorsed policy
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interventions. Nevertheless, in some situations it might be difficult to assess
cooperation on issues that were not discussed in the interview. The method is less
reliable when it comes to identifying relevant issues raised by the respondents and the
most important problem definitions, at least with analysts not involved in data
collection. When more than one analyst cooperates in one project, it might be
advisable to make agreements on the coding of issues. In particular, a shared
understanding of the problematic and an associate coding system might significantly
improve reliability.
41
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Health Technology Assessment and ill-structured
problems: a case study concerning the drug
mebeverine
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T
he practical significance of Health Technology Assessment (HTA) in policy
decisions or clinical practice has been challenged. Possibly, problem
definitions underlying HTA do not concur sufficiently with the problem
definitions held by policy makers or clinicians. We performed an in-depth case study
on mebeverine, a drug prescribed to patients with irritable bowel syndrome to
explore this hypothesis.
Methods: Theoretical framework was provided by the theory of argumentative policy
analysis. We analysed documents and held semi-structured interviews to collect data.
We reconstructed interpretive frames to analyse actors’ argumentation.
Results: The funding and usage problems relating to mebeverine were ill-structured.
Actors disagreed on the information needed and the norms at stake. As a result, the
problem definition shifted and the resulting problem definitions failed to correspond
with the problems perceived by the target populations. 
Conclusions: To ensure that future studies on health care problems are useful, it is
imperative that policy makers take the problem definitions of potential users into
account. 
M Moret-Hartman, GJ van der Wilt, J Grin. Health Technology Assessment and ill
structured problems: a case study concerning the drug mebeverine. International Journal
of Technology Assessment in Health Care 2007; 23(3):316-23
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H
ealth Technology Assessment (HTA) generally aims to support health care
policy-making. (Banta, 2003) However, the actual contribution of HTA to
the policy making process has been questioned. (van den Heuvel et al., 1997;
Rosen & Gabbay, 1999) It is possible that HTA provides its users (policy makers) with
insufficient insights on the considerations and life worlds of the target populations
that will be affected by potential policy measures. Such insights are needed because,
in health care, policy has shifted from central regulation to an approach based on
target populations. The focus is currently placed on influencing the doings and
dealings of patients, physicians, and other target populations (Chernichovsky, 1995;
Frankish et al., 2002; Hurst, 1991; Malcolm, 1989; Okma, 2001; Schieber, 1995).
Policy problems can be formulated differently by the actors involved because
information that surrounds these problems can be interpreted differently (Dunn,
2004). 
Literature on argumentative policy analysis (Fischer & Forester, 1993; Hoppe
& Peterse, 1998; van de Graaf & Grin, 1999) contends that in order to acquire the
cooperation of target populations (crucial for effective policies), the perspectives of
the target population must be taken into account during the development of policy.
For instance, with respect to policies aimed at promoting sustainable development,
target populations co-operate if, and only if, they consider the proposed policy
measures to be meaningful. A measure is considered meaningful when it corresponds
with theirs problem definition and does not conflict with their background theories
or preferences (Grin & van de Graaf, 1996a; van de Graaf & Grin, 1999).
Consequently, policy research should take the problem definitions of its users and
target populations and the meaning they attribute to potential policy measures into
account. 
We examined a case of policy research on mebeverine, a drug frequently
prescribed to patients with irritable bowel syndrome (IBS). Patients with IBS suffer
from diarrhoea, constipation or spasms of the gastrointestinal tract for which no
structural or biochemical cause can be found. The drug is thought to affect smooth
muscle cells in the colon and is thus expected to relax the muscles and thereby
decrease spasms (Connell, 1965; Greenwood & Mandel, 1992; Poynard et al., 1994).
Although the drug is frequently prescribed, there is discussion regarding its
effectiveness. (Klein, 1988) The uncertainty about the effectiveness of mebeverine has
also been a relevant issue in Dutch reimbursement decisions. In particular,
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mebeverine seemed to be a drug that could easily be removed from the public health
care package. After failed policy, new research was proposed to inform future policy
measurements on this subject. Unfortunately, the commissioner considered the
outcome of a preliminary study not useful for further policy measures. As a result, no
further policy measures were taken.
The aim of the present study was to explore the extent to which the failures in
policy and subsequent policy research may have resulted from incompatible problem
definitions among various stakeholders. The research questions were: 
• How did the process of policy analysis and subsequent research proceed? Who
were involved and how did they define the problem? 
• Did the study incorporate problems perceived by target populations
(physicians and patients) with respect to policy measures? 
Methods
The theoretical framework employed in this study was argumentative policy analysis.
This theory contends that successful implementation of policy requires the
cooperation of the target populations. Target populations are: actors who are likely to
experience the consequences of the intended policy and actors whose cooperation
may be necessary for successful implementation. Cooperation from these target
populations is more likely if they consider the proposed measures meaningful. This
means that they expect the measures to provide a solution to problems they perceive. 
We used the method of reconstructing interpretive frames to analyse target
populations’ argumentation (Grin et al., 1997). One’s interpretive frame is comprised
of problem definitions and judgement of possible solutions but also the empirical and
normative background theories that shape them (Grin & van de Graaf, 1996b;
Schön, 1983).
We analysed documents and held semi-structured interviews to collect data.
Firstly, we analysed the process of policy analysis and the subsequent research project
retrospectively. Data were obtained from the file on this project in the archive of the
Heath Care Insurance Board. The file contained letters, reports from the Board,
internal memos on this subject, research proposals and a research report. Secondly,
semi-structured interviews were held to reconstruct actors’ perspectives. Interviews
were held with policy makers, researchers, physicians, and patients. We prepared for
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interviews by conducting a detailed analysis of the existing literature on mebeverine
and irritable bowel syndrome. In the interviews, the questions focussed on perceived
problems and reasons for actions or decisions. The actors involved in the project (two
policy makers from the Health Care Insurance Board (HCIB) and two researchers)
and a policy maker from the Ministry of Health were asked provide reasons for the
specific choices that were made during the process of policy analysis. Members of
target populations (two general practitioners, one gastroenterologist, and two
patients, who were founders of the IBS patient association) were asked about their use
of mebeverine, their reasons for using this treatment, alternative treatment strategies,
ideas about IBS, and perceived problems relating to the care for IBS patients. 
Interviews were transcribed verbatim and coded. Four layers of one’s
interpretive frame and relevant subjects were distinguished. The interview transcripts
and a conceptual version of the report were sent to respondents for comment
(respondent validation). 
Results
In this section, we, firstly, describe the proceedings of the policy analysis. A summary
of the problem definitions and possible solutions at several time intervals is also
provided in Table 3.1 Secondly, we compare policy makers’ perspectives with the
perspectives of target populations.     
Reconstruction of policy analysis proceedings 
In 1996, drugs in the Dutch public health care package were screened on the basis of
the need for and effectiveness in order to develop a high quality and affordable health
care package. The Ministry of Health asked the Sickness Funds Council (currently
called the Health Care Insurance Board) for advice on several drugs, including
mebeverine. The Ministry did not consider mebeverine to be very effective. Other
interventions, such as a dietary advice and reassurance, were considered more
efficient.  In response to the Ministry’s request for advice on the reimbursement of
drugs, the Sickness Funds Council developed a decision model (Ziekenfondsraad,
1995). The criteria for assessment included the efficacy, effectiveness, therapeutic
value, and efficiency of the drug in question (Table 3.2). 
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Table 3.1.Problem definitions and proposed solutions 
problem definition solution
Advice Sickness Funds Council
(September 1995)
Effectiveness of mebeverine is
disappointing
Strict administration of the protocol should
lead to exclusion from the health care
package; however, because of symptoms
and lack of alternatives, it should be
reimbursed until further notice. 
Ministry of health (December 1995) mebeverine has little therapeutic value;
other interventions more efficient
mebeverine should be excluded from
reimbursement
Policy document PAM* (March 1999) Mebeverine is reimbursed, however, still
questions on its efficacy or effectiveness
Research on the effectiveness of
mebeverine
Letter covering the PAM policy
document (March 1999)
The industry made the court pass a
sentence on the efficacy of mebeverine.
However, efficacy does not lead to
effectiveness automatically
Question on the effectiveness of
mebeverine still needs to be answered
Policy document PAM (April 1999) Unlikely that trial results will be useful to
remover mebeverine from health care
package. 
Aim should be to act on prescribing
patterns. Research on therapeutic value of
mebeverine. 
Proposal researchers (June 1999) - Preliminary study on the feasibility of a trial
on the therapeutic value of mebeverine
Final report researchers (November
1999)
Evidence on IBS treatment is lacking A trial on the efficacy of mebeverine and
fibres is feasible
Policy document PAM (January 2001) European tender of placebo-controlled trial
on effect of mebeverine
Comment advisory committee PAM
(January 2001)
Previous studies on the effectiveness of
mebeverine were methodologically flawed
Impossible to prove effectiveness
mebeverine in trial
Report Health Care Insurance Board
(February 2002)
No randomised controlled trial on the
effectiveness or therapeutic value of
mebeverine 
* PAM = department of Policy Analysis of Medicines
With respect to mebeverine, the Council concluded: a) that the efficacy of the drug
was assessed when mebeverine was initially registered b) that convincing evidence on
the drug’s effectiveness was lacking; and c) that its therapeutic value is limited.
Despite the apparent limitations, the Council recommended that the Ministry
continue to reimburse mebeverine since the Council deemed it advisable to have at
least some form of medicinal treatment and, of various alternatives, mebeverine was
considered to have least amount of side effects (Ziekenfondsraad, 1995). The Ministry
of Health rejected the advice provided and excluded the drug from the public health
care package. This decision was challenged both by the medical profession and by the
industry and the matter was taken to court. The court concluded that both the
Ministry of Health and the industry acknowledged the lack of clear evidence on
effectiveness but differ in the opinion whether mebeverine fulfilled the criteria for
reimbursement. 
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Table 3.2.Reimbursement criteria (Ziekenfondsraad 1995)
Criterion Description 
efficacy Its pharmacological action results in a therapeutic effect in clinical research (therapeutic potential)
effectiveness Its use in clinical practice results in the aimed goal of the treatment 
therapeutic value The sum of its relevant characteristics (effectiveness, toxicity, user-friendliness, etc.) qualifying for its
position relative to alternative therapeutic interventions
efficiency A medicine is effective and the balance between therapeutic value and costs is favourable in
comparison to other treatments
The court decided that mebeverine should be reimbursed because the interest in its
continued use and funding far outweighed the Ministry’s justification for
withdrawing the drug from the health care package. Following this, the Ministry
sought new means to substantiate their claim that mebeverine be removed from the
health care package and thus proposed a new study that could hopefully generate
evidence on the drug’s lack of effectiveness
In 1999, this matter was adopted by the department of Department of Policy
Analysis on Medicines (PAM) at the HCIB (Ziekenfondsraad, 1998). PAM employees
performed a policy analysis and wrote a short proposal for the requested trial that was
presented in a meeting with the PAM advisory committee. The committee, which
consisted of various experts from the field, concluded that a placebo-controlled trial
on the effectiveness of mebeverine might not be able to provide the relevant
information needed for policy making. Because the Ministry of Health considered
dietary advice more efficient, they contended that dietary advice should be included
in the study. PAM employees then proposed to commission a trial on the therapeutic
value of mebeverine compared to dietary advice. However, PAM employees were
uncertain about the feasibility of such a trial. In June 1999, they proposed a
preliminary study on the feasibility of a clinical trial on the therapeutic value of
mebeverine in relation to dietary advice. This preliminary study aimed to assess the
possibility of standardising dietary advice, determine which outcome measures could
be considered clinically relevant and how many patients should be included. 
In May 2000, researchers from two departments of general practitioners at
university hospitals were commissioned to perform the requested preliminary study.
The final report was presented in November 2000. According to the researchers, the
major problem was the lack of evidence on the efficacy of any interventions for IBS
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patients. Evidence from valid controlled trials was needed in order to develop a
evidence-based guideline. Aim of their study was to assess determine the feasibility of
the study. Their study included: the identification of an optimal outcome measure;
the standardisation of dietary advice; and some specific IBS related problems, such as
the inclusion of the relevant spectrum of patients and the identification of subgroups.
To get an impression of the effectiveness of usual care, researchers reviewed the
literature on dietary advice, held interviews with general practitioners, and conducted
an inquiry with patients. To identify objective outcome measures, they reviewed
literature and consulted both general practitioners and internal medicine specialists.
They determined that the primary outcome measure should be a global assessment of
patient judgement. Additionally, changes in symptoms of patients should be
measured. The researchers concluded that standardisation of dietary advice would be
difficult and discussed which design would be most feasible by referring to criteria for
an adequate trial with IBS patients (Klein, 1988). In the end, a trial on the efficacy of
mebeverine versus fibres and a placebo was proposed.
Although some questions remained unanswered, PAM employees proposed that
a trial on mebeverine be commissioned. Despite this, the advisory committee
decided, in January 2001, not to commission another trial on the effectiveness of
mebeverine. They contended that the preliminary study failed to reveal a) the
methodological problems of previous trials on mebeverine; and b) how these
problems could be prevented in subsequent trials. As a result, they considered the
feasibility of a methodologically sound trial on the effectiveness of mebeverine to be
low due to potential placebo effects and other methodological problems (College
voor Zorgverzekeringen, 2002). 
Perspectives of policy makers, researchers, and target populations
As a part of the present study, interviews were held with relevant actors in order to
reconstruct their perspectives. A summary is presented in Table 3.3.
According to an employee at the Ministry of Health, mebeverine should be
removed from the health care package because of the lack of evidence on its
effectiveness. The Ministry considered alternative interventions, such as dietary
advice, to be more efficient. At that time, the Ministry was struggling with increasing
costs of drugs and wanted to ensure that ineffective medicines did not impact the
medical expenses carried by the community. They claimed that decreasing the cost of
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drugs was necessary to prevent other problems in health care like waiting lists. They
also claimed that the decision model was useful for deciding which interventions
should be reimbursed and which interventions should not. 
PAM employees considered an additional placebo-controlled trial on the
effectiveness of mebeverine to be useless: "[...] [A]fter a study on the effectiveness, we
still might be unable to remove mebeverine from the public health package [...]
[Alternatively,] you can try to affect prescription patterns by giving advice. Then,
[interventions like] dietary advice and advice on a health regime become important".
In order to change prescribing patterns, a different kind of information was
needed and it was apparent that interventions other that drugs could be relevant. A
social scientific approach in research was considered most appropriate. However,
given that the pharmacy department at the HCIB is mainly involved in clinical trials,
it was unlikely that they would accept a social scientific approach. Consequently,
PAM proposed a study on the therapeutic value of mebeverine in comparison to other
IBS treatments. Therapeutic value is also a criterion for drug reimbursement of drugs
and PAM employees expected that a study on this aspect could provide useful
information on prescribing patterns.
According to the researchers, the main problem was a lack of knowledge to
support clinical practice. According to the researchers, the first step in the assessment
of a drug is to define its efficacy. The effectiveness and therapeutic value of
mebeverine could only be deemed relevant in subsequent phases. The researchers
contended that dietary advice is very difficult to assess but that, if a diet is effective,
this is because of an increased fibre intake. Additionally, they claimed that, before the
effectiveness of dietary advice can be assessed, knowledge of whether or not fibres
actually help was needed; "[...] evaluating dietary interventions is complicated. It is
easier to add only a bag of fibres [...] and it is easier to standardise [...]". Researchers
assumed that they would get the opportunity to perform the proposed trial.
Physicians acknowledged that mebeverine may not always help patients with
IBS and that a placebo effect may be present. Nevertheless, they claimed to prescribe
mebeverine because other effective treatments are lacking and because, in some
patients, mebeverine appears to be successful. "Mebeverine is easy in use and it is not
harmful [...] it is the only therapy that can be given."
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Table 3.3.Reconstructed interpretive frames of actors involved
Actor Judgement of  solution Problem definition Background theories Normative
values
Ministry of
health
No evidence on
effectiveness mebeverine
exclude mebeverine from
health package.
increasing medicines
costs 
Decreasing costs of medicines is
necessary to prevent other
problems (waiting lists).
Decision model adequate for
reimbursement decisions 
Only
effective
medicines at
the expense
of the
community
Affordable
health care
PAM* staff Affect prescribing
practice 
A study on the
effectiveness might be
useless; Preferable,
research on the
therapeutic value of
mebeverine as compared
to a dietary advice.
Unlikely that mebeverine
can be excluded from the
package.
For good policy, it is important to
know what is important to
physicians and patients;
A more social scientific approach
might experience resistance,
because internal traditions
Research
that is
relevant and
useful for
policy
making
Researchers Research on the efficacy
of mebeverine compared
to fibres is feasible
Evidence on the efficacy
of interventions  for IBS
patients is lacking; 
Previous studies are
methodologically flawed
Standardising diet is complicated 
If there’s something in diet that is
beneficial then these are fibres. 
Valid research provides relevant
information
Research
that is valid
and feasible;
General
practitioner 1
mebeverine is adequate,
it might be effective in
some patients;
sometimes because the
placebo effect
more attention should be
paid to psychiatric or
mental causes by GPs
and internal medicine
Some IBS patients visit
physicians frequently; 
no effective treatment
strategies available; 
counselling and
reassurance take a lot of
time. Compliance of
dietary advice is low
Aetiology of IBS is unknown; 
Frequently, patients are anxious
for severe illness (malignancies) 
A good
relationship
with the
patient
General
practitioner 2
Sometimes medicines
used from discomfit.
Preferably, advice on
healthy lifestyle & healthy
food; 
Information flyers from
the patients association; 
Some IBS patients consult
general practitioner
frequently
Not always possible to
use other interventions
besides medicines; 
Patients have pain and wonder
what the cause might be,
including serious diseases; 
Some people are not acquainted
with functioning of their own body;
Complaints can result from
unhealthy lifestyle
Inform and
reassure
patients
Gastro-entero
logist
mebeverine is a sop; its
effect is limited; 
reassurance is difficult
and can take a lot of
time; 
a solution should be to
manage the anxiety; 
behaviour therapy is
labour intensive
(expensive);
During consultations,
time is lacking; 
patients do have
complaints but we don't
have a solution for them
Patients sometime expect that a
drug is prescribed; 
IBS is related to anxiety
Several subgroups of IBS patients
To spend
time
meaningful
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Patient
(patients'
association)
The patients association
offers possibilities to talk
to volunteers with IBS;
Psychological care might
be useful for listening;
mebeverine might be
effective in some type of
spasms
Physician don't have
enough time for talking
and reassuring; 
Sometimes a physician
has tried mebeverine in
patients without success,
the next patient won't
receive it; 
current research does not
take into account
subtypes of spasms;
IBS can be due to general
increased irritability 
Diet or stress can lead to
complaints;
Mechanism IBS is related to
brain-gut-axis
Currently, to much emphasis on
scientific evidence, to less
attention to patients experiences;
Recognition
of
complaints
and disease
* PAM = department of Policy Analysis of Medicines
IBS patients visit general practitioners frequently but the treatment options are
limited. Additionally, patient compliance with alternative interventions, such as
dietary advice, is usually low. Thus, the effectiveness of these interventions is variable.
According to some general practitioners, IBS is primarily caused by anxiety and not
just a physiological abnormality of the colon. However, many patients are not open
to psychological explanations of their illness. The presumption of physicians was that
patients who receive mebeverine feel that they are taken seriously and will, as a result,
visit the physician less frequently. A diagnosis and a prescription for a medicine are
important for patients as they contribute to a sense of legitimacy and a feeling of
recognition. The general practitioner aims to maintain a good relationship with
patients and thus prescribes mebeverine. In the words of a gastroenterologist: "I am
convinced that if you talk to a patient for a long time, that patient can be helped and will
need no medicines. However, that time is lacking." 
Patients with IBS mentioned that general practitioners only have a limited
understanding of their complaints. For them, recognition of their complaints and
being acknowledged is most important. Patients need to accept the existence of their
complaints. Therefore, talking about their complaints is important. The patients'
association established an IBS helpline that is maintained by volunteers who also have
IBS. These volunteer workers can be contacted for answers to questions, advice, or
just to tell one's story. According to the patient representatives, mebeverine, is
effective in some patients.
   
52
Discussion
In this case on mebeverine, there was a lack of agreement on the kind of information
that needed to be obtained. There was disagreement on which intervention should be
included (diet or fibres) and on which outcome measures were most relevant (a
decrease in symptoms, patient satisfaction, or number of consultations). Differences
were found with respect to the criteria used to appraise the mebeverine situation. For
physicians, establishing and maintaining a good relationship with patients was most
important. They consider mebeverine to be helpful in the absence of other
interventions. For the Ministry of Health, the increasing cost of drugs was important.
It established criteria by which reimbursement decisions should be made and claimed
that mebeverine should be excluded due to the lack of evidence needed to fulfil these
criteria. In accordance with Hisschemöller’s work, we contend that the problem was
‘ill-structured’: actors disagreed on the information needed and the norms at stake
(Hisschemöller, 1993). Unfortunately, researchers and policy makers did not
acknowledge that the problem was ill-structured. As a result, the problem definition
shifted during the research project and the subsequent studies endeavoured to answer
the wrong question. 
The results from the preliminary study did not answer the HCIB’s questions. It
is important to note that the process of policy analysis can be seen as a series of
successive rounds, each with its own problem definition: from initial indication to
research problem; from research problem to research questions; from research
questions to the provision of recommendations for policy. In every round, another
actor was involved who redefined the problem, based on his or her interpretive frame
and the contexts in which he or she worked. The end result is that the findings of the
project were hardly useful for policy making. Similar problems have also been found
in different settings (Hoppe & Grin, 2000). 
The proposed research did also not correspond with the problems perceived by
physicians and patients. Physicians did not prescribe mebeverine because they were
convinced of its effectiveness. In fact, some physicians acknowledged a relatively high
placebo effect in some patients. Physicians claimed to prescribe mebeverine for the
following reasons: a) no other treatment strategies were available; b) too little time for
counselling was available; and c) reassurance and acknowledgement of the patient was
important. With this in mind, we can assume that the results of a trial indicating that
mebeverine has limited effectiveness would not change physicians’ current
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prescribing practice. Excluding mebeverine from the health package could even limit
their treatment options. 
The error that was made in this case was that the policy maker failed to analyse
the problem from the perspective of the target populations. A trial on mebeverine’s
effectiveness may have provided a solution to the Ministry’s problem and, quite
possibly, the evidence would have been sufficient to exclude mebeverine from the
health package. However, it would not have solved the physicians’ and patients’
problems. To dissolve ill-structured problems, adequate problem structuring is
essential (Hisschemöller, 1993). It is advisable to identify a policy’s target populations
and involve them during the developmental stages. The objective of involving these
groups at an early policy development stage is to assess the degree to which policy
implementation is dependent on their cooperation and to also estimate whether the
requisite cooperation will be obtained. Obviously, in doing this, policy makers run
the risk of that policy making will become the prisoner of its target populations.
However, when analyses reveal that the requisite cooperation may not be obtained,
policy makers can make a choice to apply additional measures so that the requisite
cooperation is obtained (Grin & van de Graaf, 1996a). 
To solve the health care problem of treating IBS patients, it may be important
to acknowledge differences and variances between patients. Although physicians
preferred to maintain the option by which they could prescribe mebeverine, it is
questionable whether this drug provides the most optimal care for all patients. It is
possible that the ambiguity of previous trials can be explained by an implicit
assumption that patients groups are homogenous. The physicians we interviewed
indicated that what can be considered the most effective treatment is different for
different patients. Several theories on the underlying mechanisms of IBS exist. Some
contend that complaints are due to physical abnormalities in the colon. Others claim
that IBS is a physical expression of psychological factors, such as anxiety. At the same
time, advocates for visceral hypersensitivity, for a neurotransmitter imbalance and for
infection and inflammation exist (Horwitz & Fischer, 2001). Despite the varying
theories, the previous studies on mebeverine were based on only one mechanism,
namely the physical activity in the colon. Obviously, if a case is caused by
psychological factors, the use of mebeverine will not eliminate the underlying cause.
Patient education and/or behavioural therapy are then considered more appropriate
(van Dulmen, 1996; van der Horst, 1997). Further, it is possible that the total IBS
patient population is comprised of various subgroups. Unfortunately, professionals
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have not come to any agreements on the criteria necessary to distinguish between
sub-populations (Camelleri, 1999; Janssen et al., 1998; Ragnarsson & Bodemar, 1999;
Wahnschaffe et al., 2001). In the absence of convincing evidence on specific therapies
for identifiable subgroups of patients, physicians are likely required on to identify the
best treatment for each patient individually. Evidently, this is the current practice of
most physicians. It would, however, be advantageous to standardize this process as
standardization can prevent a significant amount of bias. For example, n-of-1-trials
can provide objective evidence that an individual patient is truly benefiting from a
particular treatment rather than from the non-specific effects of treatment (Sackett et
al., 1991). This approach appears to be promising despite its current lack of
application in HTA studies. Additionally, as new drugs for IBS become available
(Camelleri, 1999; Farthing, 1998), an approach whereby we identify the best
treatment on an individual patient basis becomes important. These new drugs are not
as inexpensive or harmless as mebeverine (Charatan, 2000) and it is likely that not all
patients will benefit from their use. These suggestions correspond with the problems
communicated by the physicians and are thus likely to be more successful. Further,
our suggestions may stimulate increases in mebeverine use among those patients who
are most likely to benefit while decreasing unnecessary prescriptions.
Our study has, like all studies, certain limitations. The first is that only a small
number of respondents were interviewed. Although the study aimed to provide
insight on the heterogeneity of the stakeholders’ perspectives, given the small sample
size, it is impossible to draw definitive conclusions on the views of all physicians or all
patients. We cannot precisely gauge the generalizability of our findings. As a result,
the recommendations provided with respect to the use of mebeverine among IBS
patients are tentative.
      
Conclusion
The analysis of this case indicated that the health care problem was ill-structured
which was not acknowledged by the stakeholders involved. As a result, the problem
definition shifted and the resulting problem definitions failed to correspond with the
problems perceived by the target populations. An argumentative approach in HTAs
can help us to identify problems, to uncover the argumentation that underlies these
problems, and to develop possible solutions. This, in turn, can not only make HTAs
more relevant to decision-makers but also increase the effectiveness of future policy
actions.
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Policy implications
Policy makers should be more acutely aware of the possibility that problems may be
defined quite differently by different stakeholders. Problem definitions critically
determine the range of solutions that is taken into account. Hence, overlooking
incongruencies in problem definition may lead to one-sided, partisan HTAs, with
outcomes that are considered valid and relevant by only part of the target population.
This, in turn, may severely hamper evidence-based policy making and resolution of
the problem. We recommend that policy makers require a cogent analysis of the
problem from a variety of perspectives, resulting in evidence of sufficient congruence
in problem definition among stakeholders to ensure wider support for HTA outcomes
and HTA-based policy decisions. 
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4
Non-compliance on the part of the professional
community with a national treatment protocol: an
argumentative policy analysis
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I
n 1997, the National Health Insurance Board of the Netherlands introduced a
guideline for the use of a new anti-epileptic drug, Lamotrigine. The goal was to
limit the use of this relatively expensive drug to patients with difficult-to-treat
epilepsy. A survey had shown that only a minority of neurologists were familiar with
the guideline, and even fewer applied it in practice. In the present study, interviews
were held with stakeholders to obtain a better understanding of why this policy
measure failed. The results indicate that the problem definitions of policy maker and
practising neurologists differed widely, and that the policy measure was conflicting
with certain professional beliefs. In such cases, the theory of argumentative policy
predicts that policy is unlikely to succeed, unless policy makers take actions to ensure
a greater congruence in interpretive frames between them and their target population.
M Moret-Hartman, PD Knoester, YA Hekster, GJ van der Wilt. Non-compliance on the
part of the professional community with a national guideline: An argumentative policy
analysis. Health Policy 2006;78:353-9 
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T
he intractable problems associated with the implementation of public policy
are well known (Lindblom, 1992; Netherlands Court of Audit, 2003; Trouiller
et al., 2002). On the basis of an analysis of the nature and causes of these
problems, policy scientists have argued that policy should be conceived as an instance
of co-production between policy makers and the target audience (Fischer & Forester,
1993; Majone, 1989). A key feature of this argumentative policy theory is the
recognition that different stakeholders may define policy problems quite differently,
leading to different and sometimes opposing appreciations of proposed solutions.
Differences in problem definition may, in turn, be related to differences in
background theories and preferred ways of social organisation. Such ensembles are
usually referred to as appreciative system or interpretive frame (Schön, 1983; Schön &
Rein, 1994). In this concept of policy, it is crucially important to identify the target
audience (Whose co-operation is necessary to make this policy successful?) and to
identify their interpretive frames (How do they define the problem and how does this
relate to other elements of their appreciative system?). Argumentative policy theory
predicts that when there is evidence of insufficient congruence in problem definition
between policy makers and target audience, implementation is likely to fail. In order
to succeed, policy should also be directed towards achieving better congruence in
problem definition. In other words, it should also be aimed at inducing a process of
social learning. This may require adjustment on the part of policy makers, target
audience, or both, and may entail reconsideration of policy options, evaluation
criteria, or underlying assumptions and preferences (Grin & van de Graaf, 1998).
In this paper, we present the results of an argumentative policy analysis of a
specific health care policy, enacted by the National Health Care Insurance Board
(HCIB) in The Netherlands. This board is an advisory body to the Ministry of Health
on coverage issues. In 1997 it issued a protocol for the use of a novel anti-epileptic
drug, Lamotrigine in which the use of lamotrigine was restricted to difficult-to-treat
patients. For reimbursement, Lamotrigine needs to be prescribed in accordance with
the protocol. This initiative was taken since the costs of the new drug were
substantially higher than those of conventional drugs, while there was no clear
evidence that it had stronger anti-epileptic effect. The gist of the protocol was that
the novel drug should be prescribed only to patients who show insufficient response
or unacceptable side effects to (combinations of) conventional drugs. The protocol
was issued to prevent that Lamotrigine would substitute conventional anti-epileptic
drugs on a wide scale, with cost control as a major motive. The protocol was
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distributed among all registered neurologists in The Netherlands. From a survey
among neurologists, we found that the policy measure had been largely ineffective:
only a minority (22%) of respondents knew the protocol, and an even smaller
proportion endorsed its content and put it into practice (Tuinder et al., 2004). The
aim of this paper was to identify the contents of the interpretive frames of policy
maker and members of the target population. On the basis of this material, we
discuss whether more congruence in interpretive frames should have been sought,
and how this might have been used for successful policy making.
Methods
The method of reconstructing interpretive frames was used to elicit problem
definitions, possible solutions, background theories, and preferences. (Grin et al.,
1997) Data were collected by anonymous semi-structured interviews with a
representative of the policy making institute and with members of the target audience
(seven prescribing neurologists engaged in the treatment of patients with epilepsy).
One neurologist was employed in a teaching hospital, one was employed in both a
teaching and a general hospital, three neurologists were employed in a general
hospital, and two neurologists were employed in a tertiary centre, specialized in
treatment for patients with epilepsy. Two neurologists were also involved in the
development of a broader guideline on the clinical management of patients with
epilepsy, to be issued by the Dutch Society of Neurology. 
In the interviews, questions focused on perceived problems and reasons for
actions or decisions concerning care for patients with epilepsy. All interviews were
taped, summarized, and coded, making distinction between four layers of interpretive
frames: appreciation of solutions, definition of problems, background theories, and
normative preferences. Respondent validation was conducted by sending a summary
and interpretation of each interview to the respondent for correction. After
validation, all respondents received an overview of results from all other interviews. 
A summary is constructed of the key problem definitions, possible solutions,
background theories, and preferences according to (1) the policy maker, (2) general
neurologists working in a general or teaching hospital, and (3) epilepsy specialists
working in a tertiary centre. Triangulation was conducted by checking findings from
interviews in literature and documents. 
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Results
The reconstructed interpretive frames of the respondents are presented in Table 4.1. 
Policy maker
To the policymaker, the protocol was a means to prevent neurologists from
prescribing Lamotrigine in patients for whom a similar seizure control could be
achieved with conventional anti-epileptic drugs, at a lesser cost. The problem stems
from a fixed health care budget on the one hand, and the continuous development of
novel health technologies on the other hand, for which funding is sought. Also, the
problem is anticipated because more generally, physicians are held to be inclined to
prescribe novel drugs to an extent that may not be supported by scientific evidence,
so encouraged by manufacturers. A crucial aspect of the policy maker’s background
theory was the notion that the majority of patients with epilepsy can be adequately
treated with conventional drugs. An important aspect of the policy maker’s
appreciative system was that an efficient use of public resources justifies restrictions
on professional autonomy.
Neurologists
None of the respondents was aware that prescription of Lamotrigine should be in
accordance with the HCIB protocol in order to obtain reimbursement from health
insurance companies. As a key problem, neurologists reported to find, for the
individual patient, the optimal (combination of) anti-epileptic drugs, and to find this
optimal drug regimen as quickly as possible, without imposing undue harm. To
them, there are two aspects that determine optimality: seizure control and side
effects. The optimum may vary between patients, as patients respond differently to
drugs, and because they value seizure control and the various side effects differently.
Moreover, the optimum may not be stable over time: side effects may become
apparent only after a prolonged period of time, acceptance of side effects or seizures
may change, or drug effectiveness may decrease or may be affected by concurrent
events such as pregnancy. This is the major challenge for the clinician, and anything
that helps to achieve this objective will be welcomed. A protocol restricting the use of
a novel anti-epileptic drug on the basis of its costs is not one of them.
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Table 4.1. Interpretive frames of PAM staff and researchers
Actor Proposed solution Problem definition Background theories Normative values
Policy
maker
Guideline is
appropriate
instrument to define
reimbursement
conditions for a new
drug
How to control costs
when novel, expensive
technologies continue
to be developed?
Health care professionals
easily adopt novel
technologies
Conventional AEDs are
sufficient for the majority
of patients with epilepsy
Don’t spend public money on
services that perform
marginally better at
substantially higher costs 
Neurologist
general
hospital
Guideline does not
address problem of
my practice
Little ‘hands-on’
experience with
Lamotrigine
Lamotrigine difficult in
use
New drugs are not
always better than
existing ones
Most patients can be
treated successfully with
conventional AEDs
Relation between volume
and quality of care
Safety
Patients with refractory
epilepsy should be treated in
specialised centres
Neurologist
teaching
hospital
- Little attention to
long-term toxicity
Patients differ in their
valuation of seizure
control and side effects
Patients’ quality of life
Trials should be
conducted that have
greater relevance to
daily practice
Evidence from trials not
applicable to clinical
practice
Knowledge on research
methodology
Health care should be
evidence based 
Guideline development is a
professional responsibility
Guidelines should be regularly
updated
Epilepsy
specialist
Therapeutic
repertoire should not
be unduly restricted
Selecting best therapy
for each patient
individually (search
carefully by trial and
error)
conventional AEDs are
far from optimal
(toxicity)
incomplete seizure
control incurs
considerable costs to the
patient and to society at
large
Safety
Professional autonomy
Acting in the best interest of
the individual patient
Don’t stop searching for better
treatment modalities
Costs were not an issue, or, more accurately, costs were defined differently. To the
neurologists, costs are incurred as long as no seizure control is achieved, without
acceptable side effects. Here, costs are defined more broadly, in terms of
unpredictability, interference with daily life, and costs of self-inflicted harm (resulting
from seizures), to the patient and his family. Although not quantified, they are
considered to outweigh the costs of drug treatment.
Apart from this commonality, there were certain differences between
neurologists working in general hospitals, teaching hospitals, or specialised centres.
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General Neurologists 
Interestingly, the novelty of the anti-epileptic drug Lamotrigine was mentioned as a
major problem by neurologists working in a general hospital. Inevitably, because of
its novelty, relatively little is known, especially about the safety profile of the drug.
Although trials have been published in the literature, the medical profession has had
little opportunity to obtain experiential knowledge. This was considered particularly
relevant, since earlier drugs that had been introduced on the basis of trial results, had
turned out to be inferior to then available drugs in terms of safety and effectiveness.
“Some drugs promised to be very good, however, they appeared to have many side effects,
which holds for vigabatrin, or were not as effective as promised, for example gabapentin”
(respondent N2, interview)
Respondents also considered Lamotrigine as relatively difficult in its daily use,
since its dosage needs to be gradually increased in order to prevent rash. Generally
speaking, neurologists thought that Lamotrigine was not more effective than
conventional drugs. They also emphasized that in general hospitals, patients with
uncomplicated epilepsy are treated. Generally speaking, they found no need to treat
these patients with novel drugs, nor a justification to do so, in view of the limited
knowledge of these drugs. Patients with more complicated epilepsy are referred to
tertiary centres, specialising in care for epilepsy. As such, respondents considered it
inappropriate to examine drug effects in this group of patients, and not part of their
professional responsibility. 
An additional problem was that evidence from trials does not always translate
easily into clinical practice. The purpose of trials is to support registration of a new
drug on the basis of its efficacy and safety. Because of differences in study
populations and patients seen in daily practice, the generalisability of trial findings
may be limited. According to this respondent, the HCIB should support the conduct
of trials in a natural setting, to assist the professional community in finding the value
of new drugs in daily practice. 
With respect to costs, a respondent pointed out the arbitrariness of health care
policy. Why should the use of Lamotrigine be restricted on efficiency grounds, while
many treatments are covered that have never been assessed for their efficiency?
Clearly, to this respondent, consistency in health care policy was an important
element of his appreciative system.
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Epilepsy specialists
In patients with more complex types of epilepsy, finding the best treatment is a
process of trial and error: ‘Predominantly, you follow the textbooks, but sometimes you
try medicines or combinations of them as presented on conferences. Sometimes it is an
improvement, sometimes not.’ (respondent N5, interview)
Respondents considered the toxicity profile of Lamotrigine an advantage, as
well as its lower potential for interaction with other drugs. Furthermore, they had
observed a positive psychotropic effect of Lamotrigine, which was sometimes an
additional reason for its prescription. 
An objection of these neurologists to the protocol of the national Health
insurance Board was that it was too static. ‘New anti-epileptic drugs are missing, the
protocol is not updated [à] opportunities for evaluation of the treatment protocol should be
incorporated.’ (respondent N4, interview)
Discussion
This study showed that policy makers failed to acknowledge how the target
population defined problems or what argumentation gave direction to their
prescription practices. The guideline might have seemed a solution for the problems
of policy makers: to keep the prescription of lamotrigine low to control costs of
anti-epileptic drugs. However, target populations did not cooperate and thereby
policy failed. 
Interviews with a limited number of neurologists allowed for the
reconstruction of part of their interpretive frames that are relevant to the issue of the
usage of novel anti-epileptic drugs. This resulted in information that is important to
the policy maker in a variety of ways: Firstly, the target population appeared to be
heterogeneous. Neurologists working in general hospitals differed from neurologists
working in teaching hospitals or specialised centres in a way that should be taken into
account when devising policy measures. Secondly, these general neurologists
appeared cautious in prescribing new drugs. Little ground appeared to exist to
assume that all neurologists would start prescribing the new anti-epileptic drug on a
wide scale. Thirdly, other problems are experienced by neurologists in their treatment
of patients with epilepsy. The HCIB might assist in resolving these problems, thereby
realizing their own policy objectives: optimization of quality and efficiency of health
care. 
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1 A naturalistic trial is a trial in a natural setting
2 A multiple cross-over trial within one patient. The patient receives one period intervention A and another
period intervention B. The sequence of treatment is randomised.
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The gist of the protocol, issued by the HCIB was: try to achieve seizure control,
without incurring serious side effects, using (combinations of) conventional
anti-epileptic drugs. The rationale for this recommendation was cost control.
Interestingly, the recommended strategy is common practice among general
neurologists interviewed in this study. The rationale, however, is different: they
consider the novel drug not particularly easy to use, and, more importantly, they
have learned in the past that novel drugs, although approved by national agencies,
need not always be better than existing ones. Neurologists considered conventional
drugs such as valproate safe and effective, although recently the toxicity of these drugs
has been discussed (Kaplan, 2004). Part of their professional ethics prohibits
neurologists experimenting with new drugs when the annual number of patients seen
in their practice is too small. This may be especially true of patients with epilepsy,
where achieving seizure control without incurring side effects is notoriously difficult. 
For neurologists working in teaching hospitals or specialised centres, however,
the protocol was largely irrelevant. They only treat patients with refractory epilepsy;
attempts to achieve seizure control with conventional drugs have already been made
and unsuccessful. The type of problems that are experienced in their management of
patients with epilepsy are related to the unpredictability of responses of individual
patients to various treatments. The challenge, then, is to find the optimal treatment
for each individual patient as quickly as possible. Data from published trials are
relevant to this purpose, but to a limited extent: study populations may, and often
do, differ from patients seen in daily practice, and treatment protocols may be
atypical (Black, 1996). It would be helpful, therefore, to conduct more naturalistic
studies1 (Tunis, 2003) and to conduct N of 1 trials2 (Sackett et al., 1991). Also, the
setting up of central registries where unexpected events can be reported when treating
patients with anti-epileptic drugs would help to identify possible side-effects at an
earliest possible time, since trials have not always been found to constitute a reliable
source for this type of information (Derry et al., 2001).
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Alternative solutions
Although current prescription practice resembled the recommended strategy, in the
guideline from the Dutch Society of Neurology, Lamotrigine was proposed as a drug
of first choice. Unfortunately, little evidence was given that supported this
recommendation. Neurologists' experiences appeared important in their judgment.
However, individual experiences on effectiveness and toxicity might be biased. As
long as evidence is lacking, a careful prescription and strict monitoring of patients is
needed. It would be justified to stipulate that novel drugs are used exclusively in
specialised centres. Furthermore, data on prescription and patients' outcomes should
be collected systematically. Subsequently, knowledge from these data can be used for
process of learning by neurologists on the value of lamotrigine or other drugs. 
Alternatively to guideline development, the HCIB might consider ways of
assisting or encouraging the professional community to enact such measures, e.g. by
co-funding naturalistic trials (that are unlikely to be funded by manufacturers) or by
covering the costs of setting up N of 1 trial facilities or central registries. 
If policy institutes help funding naturalistic trials and setting up research
facilities, it would not be unreasonable to demand that they are involved in deciding
whether novel drugs should continue to be used in specialised centres or may be
released for general usage.  
Limitations of study
The study has, of course, certain limitations. A small number of respondents were
interviewed. This might affect the generalizability of our results. Although the study
aimed to provide insight in the heterogeneity of stakeholders’ perspectives,
conclusions about the viewpoints of all neurologists or the completeness of possible
viewpoint on this subject cannot be drawn. It cannot be excluded that in other
general hospitals, neurologists do not refer patients who fail to respond to
conventional drugs to specialised centres. Also, there may be other areas where
physicians are more likely to adopt novel drugs. Policy makers should, therefore,
examine this aspect from case to case. 
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Conclusions
This case study supports the idea that it is important to establish how target
populations of policy measures experience problems and which solutions appear
sensible to them at an early stage of policy development. The investment that this
requires in terms of money and human resources is almost certainly modest as
compared to the costs of (repeated) health policy failures.
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5
Participatory workshops are not enough to prevent
policy implementation failures: an example of a
policy development process concerning the drug
interferon-beta for multiple sclerosis
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A
possible explanation for policy implementation failure is that the views of the
policy’s target groups are insufficiently taken into account during policy
development. It has been argued that involving these groups in an interactive
process of policy development could improve this. We analysed a project in which
several target populations participated in workshops aimed to optimise the utilisation
of an expensive novel drug (interferon-beta) for patients with Multiple Sclerosis. All
participants seemed to agree on the appropriateness of establishing a central registry
of Multiple Sclerosis patients and developing guidelines. Nevertheless, these policy
measures were not implemented. Possible explanations include 1) the subject no
longer had high priority when the costs appeared lower than expected, 2) the
organisers had paid insufficient attention to the perceived problems of parties
involved, and 3) changes within the socio-political context. The workshops in which
representatives of the policy’s target populations participated did not provide enough
interactivity to prevent policy implementation failure.
M Moret-Hartman, R Reuzel, J Grin, GJ van der Wilt. Participatory workshops are not
enough to prevent policy implementation failures: an example of a policy development
process concerning the drug interferon-beta for multiple sclerosis. Health Care Analysis
2008;16(2):161-75.
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T
here are numerous examples of health policy measures that have failed in their
implementation. A review from the Netherlands Court of Audit indicated that
no evidence of a full policy implementation can be found in previous audits
(Netherlands Court of Audit, 2003). For example, the applied measures for reducing
greenhouse gas emissions have not met predetermined targets, the legal rules for
maintaining food safety have not been able to prevent targeted risks, and policy
measures for cost control of medicines have not resulted in more structural cost
control (Netherlands Court of Audit, 1992). 
The theory of argumentative policy analysis offers a possible explanation for
such policy implementation failures (Fischer & Forester, 1993; Hoppe & Peterse,
1998). The basic idea of this theory is that actors’ behaviours can be explained by
different views on a problem and the argumentation behind these views. According
to the argumentative approach to policy analysis (Fischer, 1999; Fischer & Forester,
1993), action is driven by processes of problem setting (Schön, 1983) in which actors
define coherent sets of problems and solutions that correspond to these actors’
normative and empirical background theories. The way in which problems are
defined depends on the assumptions the actors make about the situation and their
beliefs regarding what is good practice (normative values). 
Combining these findings with those of classical implementation theory, Grin
and van de Graaf (1996a) have argued that a policy will only be effective if both
implementers and target populations consider the proposed policy measure
meaningful. (Target populations consist of persons who will experience the
consequences of  a policy when implemented.) This means that the proposed policy
should (a) make sense in the light of problems perceived by the target populations
and (b) be consistent with their normative and empirical background theories. 
However, the fact that policy problems and associated solutions tend to shift
over time, different actors with different background theories being involved
successively, renders this rather complicated. In other words, a policy measure is not
invented at a specific moment in time, but develops over time. Nevertheless, the
challenge is to identify policy measures that cohere with the views of all actors
involved.
If the argumentative policy theory is correct, then it is advisable to identify the
policy’s target populations and involve them in the process of policy development.
An interactive process of policy making could thus ensure that policy coheres with
and prevent that it diverges from the views of target groups.
   
72
The objective of this paper is to analyze a specific instance where target populations
were involved in the process of policy development. The policy institution in this
example was the Health Care Insurance Board in the Netherlands (HCIB). It is an
advisory board to the Ministry of Health, particularly with respect to coverage and
reimbursement issues. The Department of Policy Analysis of Medicines (PAM) is
responsible for identifying developments that may jeopardise optimal medical care,
analysing the nature and size of such threats and conducting further research that
may provide a basis for policy decisions. The annual work programme in which
topics are prioritised is submitted to the Ministry of Health for approval. 
The policy objective discussed in this paper was to promote the appropriate
use of a recently introduced drug for patients with multiple sclerosis. Multiple
Sclerosis (MS) is a neurodegenerative disease characterised by neurological
dysfunction. The drug interferon-beta (IFNß) appeared to be a promising treatment.
However, its costs were high (€ 12,000 per patient annually) and the evidence of its
long-term effectiveness was limited. Therefore, policy measures to guide the
prescription of this medicine were considered necessary. Representatives of
prescribing physicians (neurologists), health insurance companies, and patients were
invited to participate in two workshops. During these workshops, participants
discussed policy measures that could promote the appropriate use of the new drug.
Although two concrete policy measures had been proposed, these have never been
implemented.
In this paper we evaluated whether the theory of the argumentative policy
analysis could explain the proceedings in this case study. It offers a description of the
process of the policy development that included the two workshops, as well as  an
analysis of the views of policy makers and target populations in order to assess
whether the proposed policy measures fitted the perceived problems and underlying
background theories. 
 
Methods
Relevant documents were analysed and semi-structured interviews were held with the
various stakeholders. These documents included correspondence, reports from the
Board, internal memos on this subject, a report from Health Council on IFNß,
reports from meetings, research proposals, and research reports. Interviews were held
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with three HCIB employees, two employees from the Ministry of Health, the
organisers of the workshops, two neurologists, a patient, and a medical advisor from a
health insurance company. Participants of the workshops were contacted and
interviewed to reconstruct the proceedings of the workshops. MS patients were
contacted via a Dutch MS patient organisation. Representatives of target populations
were interviewed to assess their problem definitions and underlying argumentation. 
Interviews were transcribed verbatim. A summary from the interview and a
concept report were sent to respondents for verification and literature was used to
check the findings from interviews or documents. In line with the theory of
argumentative policy analysis, we used the method of reconstructing interpretive
frames to analyse target populations’ argumentation (Grin & van de Graaf, 1996b,
1997; Moret et al., 2007). The idea is to reconstruct (1) how problems are defined, (2)
how solutions or policy measures are judged, (3) what theoretical and normative
assumptions shaped them, and (4) what normative preferences underlie this all.
Together, these four ‘layers’ of evaluation entail an individual’s interpretive frame. 
      
Results
Proceedings of project
The content of the workshops was, to a large extent, determined by two reports
concerning IFNß. These had been issued by the HCIB and by the Health Council,
respectively. In July, 1995, the Ministry of Health asked both institutions to provide
advice regarding the introduction of IFNß on the Dutch market. The Ministry asked
for recommendations with respect to whether or not restrictions could be imposed on
the reimbursement of the drug. 
In May 1996, a committee from the Health Council reported to the Ministry
of Health (Gezondheidsraad, 1996). This committee was comprised of three
neurologists, a chemical technologist, and a HCIB staff member. It concluded that
IFNß could be a promising new drug, but also cautioned against unrealistic
expectations. Clinical trials had shown that IFNß could decrease the rate and severity
of exacerbations, but there was no evidence of IFNß preventing the onset of disability.
The Health Council emphasised that the drug should be prescribed only to patients
who meet eligibility criteria for the trials. These criteria were: a) clinically definite
Relapsing Remitting MS; b) at least two exacerbations in the two previous years; c)
mild to moderate disability; and d) age of 18 years or older. The Council also
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proposed the following policy measures: 1) develop a guideline for treatment of MS
patients with IFNß; 2) ensure that the drug is prescribed by neurologists who have
sufficient experience with the diagnosis and treatment of MS patients; 3) properly
instruct and guide MS patients; 4) conduct a systematic follow up of patients using
IFNß in order to evaluate side effects; 5) provide clear indications on which patients
should be treated with IFNß; 6) establish a national registry of MS patients in order to
conduct further research on the effectiveness of IFNß; and 7) conduct a re-appraisal
after a number of years. 
June 1996, the HCIB issued recommendations that corresponded partially with
the Health Council's report. The HCIB recommended that: a) patients fulfil the
criteria described in the Health Council’s report; b) a treatment protocol be
developed; c) health insurers approve reimbursement requests before starting
treatment; d) a prospective registration be established; and e) the use of IFNß be re-
assessed after three years (College voor Zorgverzekeringen, 1996). Restricting
prescription to a limited number of experienced neurologists was considered
impossible, because IFNß had already been included in health care package. 
In 1999, the PAM department started a project on IFNß. Initially, they
considered evaluating other, less expensive interventions that could be effective, but
are of no interest to the industry. Indications had been received from the field that a
much cheaper drug, namely methotrexate (used in oncology and rheumatoid
arthritis), could be as effective as IFNß. Furtheremore, PAM considered developing a
national database of MS patients. PAM later decided that conducting a clinical trial
was not its responsibility. PAM staff, in collaboration with neurologists,  decided to
initiate the development of a treatment protocol and a national registry of MS
patients. They proposed the organization of two workshops. 
Workshops 
In 2000, these workshops were organised by an external institute for policy research.
The first workshop aimed to provide an overview of the criteria that are used for
prescribing IFNß. This workshop was preceded by an inventory study among health
insurance companies into current reimbursement practices with respect to IFNß. This
inventory study was performed by a HCIB department. The results from the inventory
study on current reimbursement practices indicated that health insurance companies
did not assess reimbursement requests against medical content. Assessments were
limited to an administrative review of the completeness of data (College voor
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Zorgverzekeringen, 2000a). Nevertheless, health insurance companies considered the
pre-utilization approval effective, because it functioned as an administrative barrier.
The authors of this report recommended the following: a) assess whether a pre-
utilization approval by a central committee could improve the assessment of
reimbursement requests; b) develop a clear protocol and design application forms. 
Neurologists, medical advisors from health insurance companies, policy
makers, and a representative from a patient organisation participated in the
workshop. During the workshop, vignettes with patient descriptions were used to
discuss which patients should be treated with IFNß. The organisers concluded that
only a few problems were perceived with respect to criteria for IFNß use. Health
insurers questioned whether the situation was indeed problematic given the small size
of the patient population and IFNß’s status as an essential medicine. Neurologists
argued that problems arose incidentally. Most often, these problems were related to
reimbursement requests for continued use of IFNß. All participants agreed that
subjectivity in decisions on prescription should be minimised. The participants
claimed that clear distinctions should be made between the criteria for initializing
treatment and the criteria for continuing treatment. The development of a guideline
by neurologists was considered relevant. According to the participants, small
adjustments of the current criteria would be sufficient (B&A, 2000). 
The second workshop aimed to obtain advice on how existing databases could
be improved so that the effects of IFNß or other new drugs for MS patients could be
evaluated. In preparation for this workshop, a neurologist was asked to make an
inventory of available databases that contained data on IFNß users. This inventory
showed that data on MS patients were no longer being collected systematically in the
Netherlands (B&A, 2000). Former local databases were no longer up-to-date. The
participants in the workshops agreed that a national database could be relevant and
could serve the following goals: a) policy making (such as financial surveys, planning
health care capacity); b) research (effects of treatment; monitoring for side effects);
and c) clinical practice support for neurologists (reflection on clinical practice,
improvement of expertise). Participants agreed on the inclusion of general static data
in the database, such as demographic details, diagnosis (type MS), the criteria used to
make the diagnosis, and the initial treatment. Participants disagreed on the kinds of
dynamic data, such as treatment details and information on physical functioning. A
database including a broad range of data could be useful for research, but this was
considered expensive. A small database that includes static data only could be used as
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a sample frame for selecting potential participants in further studies. In their report,
the organisers concluded that additional research was needed to ascertain which
variables should be included in the database.
      
Proposed policy measures
Based on the organizers’ report, the HCIB proposed the following policy measures to
the Ministry of Health (College voor Zorgverzekeringen, 2000b):
• Have neurologists develop an evidence based guideline for the treatment of
patients with multiple sclerosis.
• Have reimbursement requests for IFNß appraised on medical grounds.
• Possibly, implement a central pre-utilisation approval by experts
(neurologists).
• Define clear criteria for (dis)continuing IFNß reimbursement
• Establish a national registry of MS patients. The database should enable
scientific research, the improvement of treatments, monitoring, and the
evaluation of efficiency and therapeutic value of new interventions.
In 2003, a medical advisor from a health insurance company mentioned that some
small changes had been made to the procedures established for judging
reimbursement requests (requests for continued use). A neurologist mentioned
working on a guideline for diagnosis and treatment of MS patients. According to a
PAM staff member, neither a central pre-utilisation approval nor a national database
to prospectively register patient data had been established.
Reconstructed interpretive frames
In June 2003, we conducted interviews to reconstruct interpretive frames of policy
makers and policy’s target populations. The actors’ views are summarised in Table 5.1
(IFNß guideline) and Table 5.2 (national database).
Ministry of Health
Initially, the Ministry contended that the long term effectiveness of the drug was not
established sufficiently, while the acquisition costs were high. Trials had shown that
IFNß decreased the number of exacerbations, but it was unknown whether IFNß
would prevent disability. 
-
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Table 5.1. Judgement of guideline or central pre-utilisation approval for IFN and underlying problem definitions
Actor Judgement of solution Problem definition Background theories Normative values
Ministry of
health 
(1996)
+ Clear criteria for
reimbursement
needed
IFN is an expensive
medicine 
uncertainty on meaning of
effects
Possibly inappropriate use
because high expectations
Only medicines of which evidence
of effectiveness is available at the
expense of the community
If no evidence on effectiveness,
use is inappropriate
efficiency
Ministry of
health
(2003)
- Central committee
not efficient; too
expensive 
Guideline should be
set up by neurologists
Actual costs were lower
than expected costs.
Health insurers did not
perceive problems 
Finances (also) influence the
Ministry’s agenda.
cost control
efficiency
Quality
improvement is
neurologists’ task
Health
care
insurance
board 
(also in
advice
Health
Council)
+ clear criteria for start
& discontinuation
needed; treatment
protocol should be
developed
Health insurance
companies judged
reimbursement requests
differently,
Expensive medicine; while
effectiveness uncertain; 
A large population of
potential users 
IFN belonged to new type of
medicines, of which impact was
unclear
Impact = does use lead to
savings elsewhere
Task: to assess
new medicines &
defined relative
position towards
alternative
interventions
Staff
member
departmen
t PAM
+ possibly, a central
pre-utilisation
approval 
a clear treatment
protocol should be
available
expected increase in use
IFN; 
health insurance companies
judged reimbursement
requests differently
Individual health insurer
lack expertise to judge
reimbursement requests
Situation IFN resembles situation
growth hormones, for which a
central pre-utilisation approval in
combination with central
registration was set up
Central pre-utilisation approval
improves efficient use of
medicines, prevents inappropriate
use
cost control;
efficiency 
equal
accessibility
Staff
member
departmen
t PAM
(2003)
- no central judging
committee
(expensive/ additional
value is limited)
no problem concerning
reimbursement requests
Situation concerning IFN
was relatively stable (only
discussion in case of new
medicines or extension of
indication)
Criteria for central pre-utilisation
approval:
- medicine is expensive
- inappropriate use expected
- decisions on treatment are
complex
efficiency
Medical
advisor of
health
insurance
company
+ / - guidelines 
needed for decisions
reimbursement
Central pre-utilisation
approval no longer
meaningful
unclear when IFN is (still)
meaningful
neurologists are prescribing
IFN;  
Pharmaceutical companies
benefit from extending criteria
Expensive drugs are financed
from public funds, on a solidarity
base ;For accessible health care,
fundamental choices should be
made ;No clear guideline on
acceptable outcome measures for
expensive medicines
Clear vision from
the ministry of
health on
pharmacy 
Physicians are
responsible for
guideline
development;
Neurologis
t
+ / - No IFN guideline
but MS guideline
(diagnosis &
treatment);
summarise available
evidence
In the past, differences in
reimbursement decisions
between health insurers 
If a medicine is available at the
market and health insurers
reimburse it, it should be possible
to prescribe the medicine.
be able to offer
something to
patients
   
Actor Judgement of solution Problem definition Background theories Normative values
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Patient + Guideline might be
useful
care differences between
hospitals (IFN not offered in
every hospital); Advises (on
lifestyle) are contradictory
No common knowledge on MS
Prognosis differs between
individuals
Follow own
experiences
The potential target population, namely patients with MS, is large and the
expectations of both patients and physicians may also have been high. As a result, the
risk that the drug could be used inaccurately was considered to be high.
Consequently, additional policy measures to control IFNß use in clinical practice were
requested.
According to employees from the Ministry of Health, the HCIB report (College
voor Zorgverzekeringen, 2000b) had revealed that only health insurers perceived few
problems with respect to judging reimbursement requests. The costs of a committee
for a central pre-utilisation approval were considered relatively high, while the costs
of the interferon-beta prescription were less than expected, namely € 18 million (in
1999) versus the € 90-180 million estimated by the Ministry. Therefore, both
interventions were considered to be no longer relevant.
PAM staff
According to the PAM staff, the main problem was that the use of IFNß was expected
to extend to other subgroups of patients. A central pre-utilisation approval in
combination with a national registry of MS patients could provide a solution. This
contention was made because the situation concerning IFNß resembled the situation
concerning other drugs for which a central pre-utilisation approval had already been
established. In that case, requests for reimbursement of drug use were judged by a
central committee of medical experts. For this purpose, a clear protocol including
criteria for IFNß use is needed. Simultaneously, patient data were recorded in a
national registry.
At the time that PAM staff started their project, it was undesirable to evaluate
why the proposed policy measures had not been implemented until then. Reason was
a change in the relationship between the HCIB and the Ministry of Health. In 1999,
the HCIB, an independent advisory board, was established as the successor to the
Sickness Funds, which was a politically involved advisory board comprised of actors
from the field.  
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Table 5.2: Perspectives towards a national registry of MS patients or IFN users
Actor Judgement of
solution
Problem definition Background theories Normative
values
Ministry
of health  
(1996)
+ Uncertainty on (meaning of)
effects
Only medicines of which evidence
of effectiveness is available at the
expense of the community
If no evidence on effectiveness,
use is inappropriate
efficiency
Ministry
of health
(2003)
-
Central committee
no longer efficient 
Expectations on costs and
problems did not come true.
Health insurers do not perceive
many problems (anymore)
Finances (also) determine the
Ministry’s agenda.
MS is complex disease; difficult to
measure effects, to know what
should registered
cost control
efficiency
Health
care
insurance
board 
(in Health
Council)
+
database for 1)
patient data, to take
samples for
research, or 2)
register all relevant
data for research
Insufficient evidence
concerning effectiveness of IFN
(disease progression)
Aim of national database: to
monitor use of IFN in practice
(which patients (indications),
volume, costs) and to evaluate
effectiveness INF
Task: to
assess new
medicines
PAM staff +
National database
linked to central
judging committee
discussion on effectiveness of
IFN;health insurance companies
judged reimbursement requests
differently, leading to difference
in health care
central pre-utilisation judgement
provides a minimal registration
efficiency 
PAM staff
(2003)
-
registration without
central judgement
committee difficult 
central committee no longer
relevant 
No problems perceived
A database can be a means in
policy research, not a goal
/objective
Efficiency
setting up
databases not
their task / 
responsibility
Medical
advisor of
health
insurance
company
+ 
prospective
database only way
to assess long term
effectiveness
database only useful
if clear which data
should be registered
Unclear when IFN is meaningful
Judgement of relative value as
compared to alternative
interventions not systematically
but in the neurologists head
no clear guideline on
acceptable outcome measures
for expensive medicines 
Expensive drugs are financed from
public funds
Pharmaceutical industry’s power is
underestimated 
For accessible health care,
fundamental choices should be
made.
What data should be registered is
a political question
clear vision
from the
ministry of
health on
pharmacy 
quality of care
Neurologi
st
+ / -
depends on aim and
who is responsible
aim of national database was
unclear
registration takes time
If a medicine is available on the
market and health insurers
reimbursement
If registration for policy evaluation,
Dutch government should pay and
initiate it
be able to offer
something to
patients
+/- 
Neurologists not
responsible for data
collection.
Possibly a role for
patients in data
collection
Aim behind database was
unclear
National coverage might be
difficult
MS neurologists have their own
“kingdoms”
Distrust among neurologists
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After completion of the project, the PAM staff considered the option of having
reimbursement requests judged by a central committee no longer meaningful. They
considered the implementation of policy measures difficult because the drug had
already been introduced several years earlier. Limiting or discontinuing the
reimbursement of IFNß would have been practically impossible. Furthermore, the
scale of problems relating to the prescription and/or reimbursement of IFNß and the
costs related to IFNß use turned out to be much smaller than expected. PAM
considered the initiation of a national MS patient registry without the central pre-
utilization judgment to be infeasible. 
Medical Advisor Health Insurance Company
According to a medical advisor from a health insurance company, the problem was
attributable to a lack of clarity on exactly what kind of patients benefit from IFNß.
IFNß is an expensive drug and the costs are either carried by the community (public
health insurance) or reimbursed on an individual basis (private health insurance).
Preferably, physicians should develop a guideline on the relative position of IFNß in
relation to alternative interventions. 
At the time of IFNß’s introduction, a central pre-utilisation approval could
have been relevant. However, time had passed and the prescription of IFNß had
become common practice. Unfortunately, new drugs are often introduced and
included in the health care package long before all medical specialists agree on criteria
for treatment. Professionals cannot develop guidelines quickly. In contrast, the time
that passes between a drug being introduced  into the market and its inclusion in the
health care package is regulated by law and, in most cases, quite short. As a
temporary solution, the drug could be included into the health care package under
certain conditions, such as the registration of patient data. 
Neurologist
A neurologist mentioned working on a guideline for diagnosing and treating MS
patients as part of an initiative from the Dutch Society for Neurology. A guideline
for diagnosis and treatment was considered relevant as it could support
evidence-based practice. As in other medical fields, knowledge and treatment options
have increased. The development of a guideline is a time-consuming endeavor as,
often, it has to be done alongside the professional’s usual activities. A central pre-
utilisation approval was no longer relevant. Prescribing IFNß was considered common
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practice, also in small general hospitals. Most neurologists were already familiar with
the indications for treatment. IFNß was proven to be effective in one type of MS that
is characterised by invalidating exacerbations (relapsing remitting MS) through
clinical trials that demonstrated IFNß’s ability to decrease the severity and frequency
of these exacerbations. A national database could still be useful. However, its purpose
must be clear. An appropriate goal could be to evaluate the long-term effectiveness of
IFNß. The neurologist questioned whether participants would have come to
agreement on specific recommendations, such as which data should be collected and
who should become the owner of the database. Most neurologists do have ‘their own
kingdoms’ and do not want to share these with others. 
Patient
The patient claimed that agreement among neurologists about MS treatment could be
useful. For him, the main problem was that MS care differs between hospitals. He
conveyed his experiences with receiving contradictory answers to questions from
numerous health professionals and the option of using IFNß had not been discussed
in the hospital where he was initially treated. For this patient, the exacerbations are
highly invalidating. Obviously, his preference is to lead a normal life, in so far as that
is possible. MS has a high impact on his life. 
Discussion
Although results from the workshops showed that all respondents agreed that
developing a guideline and a national database could be meaningful, these policy
measures have never been implemented. A number of factors can provide an
explanation for the proceedings in this project.
Firstly, the costs of IFNß appeared to be lower than expected. Perhaps the
information campaign on IFNß had had this effect (Coolen, 1997). It may also have
been that the calculation by the Ministry of Health, which differed from calculations
made by the Health Council and rested on the assumption that all MS patients are
treated with IFNß, were unrealistic. In any case, the subject of IFNß no longer had
high priority. From the point of view of policy makers, the expected high costs of
IFNß in combination with its uncertain effectiveness were the main problems behind
the proposed policy measures. Apparently, however, the problem of the high costs
had still higher priority than the limited knowledge on IFNß’s effectiveness. As a
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result, policy makers left it to the medical profession to implement policy measures.
Neurologists, however, considered cost-containment not their problem and not their
responsibility,
This also explains why the initial questions about the long-term effectiveness
remained unanswered, without this being perceived as a problem. The effectiveness
of IFNß and the possible role of the industry was an issue of international debate.
Clinical trials have shown that IFNß decreased the number and severity of
exacerbations in patients with relapsing-remitting MS (IFN MS Group, 1993; PRIMS,
1998). Probably, this is enough reason for neurologists to claim the right to prescribe
IFNß. That evidence of long-term effectiveness, in terms of preventing disability, and
safety was still limited (Rice, 2002) is not of great concern to them. Neither is the
possible influence of the industry on prescription practices through the financing of
clinical trials that had been discussed (de Haan & Vermeulen, 1999; Pieters, 1998;
Polman, 1999; Vermeulen & de Haan, 1999). Some authors have even challenged the
hypothesis of MS as an inflammatory auto-immune disease (Behan et al., 2002). A
national registry could have been relevant from this point of view. In the UK, the
Department of Health initially refused to reimburse IFNß use for reasons of costs
(Lie, 2004). In 2002, however, agreements were made with the industry concerning
the funding of IFNß. The Department of Health announced that it would reimburse
IFNß for MS patients who agreed to participate in a monitoring program on the
effectiveness of IFNß.
Secondly, the policy development process from the beginning centred around
two specific policy measures, whereas it could have started with a broader scope,
actors involved first eliciting the problems they perceive and adequately structuring
the problem. Now, the proposed measures appeared not to be the most optimal
solutions for the problems as perceived by neurologists, and therefore represented
right solutions to the wrong problems. This typically concerns what Hischemöller
and Dunn have coined an ‘error of the third kind’ (Hisschemöller, 1993; Dunn,
2004). We have found that on a first order level, all actors agreed that a national
guideline and a registration could be meaningful. But as it was, on a second order
level they disagreed as to what goals such policy measures should serve. For example,
neurologists considered a national guideline relevant, as long it was a broad guideline
on the diagnosis and treatment of MS in general. All actors agreed that a national
registry could be relevant, but defined different goals. Each goal came with different
variables to be included in the registry. 
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Thirdly, during the workshops, the proposed policy measures remained rather
vague and were not elaborated in detail. As a result, participants could easily consent
without violating their background theories and preferences. They had not felt the
urge to (re)consider these theories and preferences. This, however, was necessary, as is
clearly illustrated by the respondents who questioned whether participants would
have come to agreement on specific recommendations, such as which data should be
collected and who should become the owner of the registry. Such an agreement
requires that policy measures are made sufficiently substantive for every actor to
understand what are the consequences. Moreover, it requires that background
theories and normative preferences are elicited and scrutinized.
Fourthly, changes in the socio-political context affected policy development.
Opinions with respect to which kind of policy measures are the responsibility of the
HCIB had changed over time. The PAM staff considered conducting a clinical trial to
obtain relevant information that would not be provided by the industry.
Simultaneously, their position towards another Dutch institute involved with
subsidising clinical research changed. Putting out clinical trials was then no longer
their responsibility. Furthermore, the relationship between the HCIB and the Ministry
of Health changed over the course of this project. These changes strongly affected
ideas with respect to the Board’s responsibility on initiating a national registry of
patient data. 
On this basis we conclude that the workshops failed to meet the objectives set for
interactive processes in policy development, namely to prevent policy
implementation problems as a result of diverging views among target groups.
Moreover, we concede that they could not have met those objectives. From the case
of IFNß, we infer that an interactive process should meet the following criteria:
• The interaction should cover the whole process from problem structuring to
policy implementation, in order to be able to deal with problem shifts and
changes in the socio-political context. It is not enough to reduce interactivity
to workshops at one or two moments in time.
• Actors involved should resist the temptation to think that policy problems can
be understood at a first order level. That is, background theories and
normative preferences should be explicated in the problem definition phase.
Only if problem structuring is taken serious in this sense can one think of
developing solutions that could meet with the approval of all target groups.
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• Developing widely endorsed solutions requires that actors involved are willing
to learn from one another and adapt their views if necessary. A process of
interactive policy development should include room for such learning
processes (Guba & Lincoln, 1989; Reuzel, 2001; Reuzel, 2004; Yanow, 2000).
Grin and van de Graaf (1996a) have argued that learning is likely to occur only
if external events urge a revision of background theories and preferences, or if
repeated failures show actors that their background theories are not functional.
• Proposed policy measures should be sufficiently elaborated, as to enable target
groups to assess their consequences and constructively engage in the interactive
process. As the case of IFNß shows, actors involved are not willing to
reconsider their background theories and preferences, should proposed policy
measures not be sufficiently elaborated and actors involved not understand
what is at stake.
      
In sum, this study has shown that the organisation of workshops in which target
populations participate does not qualify as an appropriate process of interactive
policy development. From the beginning, emphasis had been put on a limited
number of interventions aimed to control the expected increase in treatment costs.
Although target populations participated in policy development, perceived problems
and which interventions could provide a solution had been discussed insufficiently.
For policy development to be successful, interactive methods are needed, in which
problem definitions and assumptions are explicated and discussed, providing an
opportunity for mutual learning between actors involved. 
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Importance of identifying interventions that are
congruent with perspectives of actors involved:
Lessons from a case study on new analgesics
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T
he Dutch Health Care Insurance Board, an advisory body to the Ministry of
Health commissions research to guide their policy recommendations.
However, the studies conducted did not always yield relevant information
which might result from differences in problem definitions held by the Board and by
target populations. To compensate for these problems, the Board made a number of
changes in their commissioning procedures. Researchers were asked to analyse
problems from the perspective of the policy maker and the policy's target
populations. We monitored and analysed this new approach when used in a
European tender that was issued for research proposals on a new type of analgesics,
selective cox-2 inhibitors (COXIBs). Main reasons for commissioning this research
were its frequent off label prescription and high costs. Our analysis showed that
researchers seemed to be reluctant to adopt the Board's problem definition,
questioning whether it would be shared by 'the field'. At the time of finishing the
study, however, one of the COXIBs was withdrawn from the market because of serious
side effects. The results of this case study emphasize that involving target populations
in policy research should not imply that target populations control the problem
definition and identification of solutions. The primary aim of involving target
populations is to identify solutions that are congruent with both the perspectives of
policy makers and policy’s target populations.
M Moret-Hartman, GJ van der Wilt, J Grin. Importance of identifying interventions
that are congruent with perspectives of actors involved: Lessons from a case study on new
analgesics (submitted) 
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A
s in most Western societies (Kamke, 1998; Hurst, 1991; Rodriguez, 1999), a
crucial challenge to Dutch health policy makers is to ensure that the quality of
and access to health care is maintained or improved while keeping costs within
acceptable limits. Striving for an optimal balance between quality, accessibility, and
efficiency requires new and innovative policy making strategies. In order to be
considered as legitimate and effective in bringing about the requisite re-orientation of
health care practices, it is crucial that policies are designed such that a sufficient level
of congruency is achieved in problem definition between policy makers and target
groups (Grin & van de Graaf, 1996a). This task is far from trivial. It involves a shift
from a supply-driven system to a system that seeks to optimally resolve health care
problems. It also demands a shift from a system dominated by medical rationality to
a system that is considerate of the wide variety of rationalities possessed by all parties,
including providers of care, recipients of care, and insurers (Grin, 2004).
One of the organisations charged with this task is the Dutch Health Care
Insurance Board (HCIB). Within the Board, the Department of Policy Analysis of
Medicines (PAM) responsible for identifying developments that may jeopardise
optimal medical care, analysing the nature and size of such threats, and ensuring that
additional research that may provide a basis for resolution through policy is
conducted. This department consists of both staff members employed by the Board
and an advisory committee consisting of external experts from the field. Annually,
PAM staff invites professionals, such as physicians, health insurers, and policy makers,
to list (potential) problems involving the use of medicines. Following this
consultation, PAM selects relevant topics which are then presented for approval to the
Ministry of Health. Once approval is provided, PAM staff investigates the problem in
zfurther detail and determines the kind of research needed to support policy making.
The department then commissions the research.
In 2000, PAM identified a number of shortcomings in its activities programme.
Research projects did not always generate clear answers to their questions. In
addition, policy measures based on research results appeared to have only limited
impact in practice. Consequently, PAM requested that we monitor and analyse their
programme and provide recommendations for improvements. The results of two case
studies suggested that when commissioning research, the problem definition guiding
the research repeatedly shifted over time. This shift could be largely explained by
differences in the interpretive frames of the various stakeholders (Moret-Hartman et
al., 2007). Based on these findings, the Board implemented a number of changes in
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the programme. Firstly, the Board decided that, when tendering research projects, it
would state its objectives and problem definition more explicitly. Secondly, the
Board asked researchers to take into account the problem definitions of policy’s target
populations. In this way, PAM aimed to involve researchers more closely in the
process of structuring the problem and developing policy options.
In this paper, we report on our experiences with this novel approach to
commissioning policy research. The case study provided here involves research that
was commissioned to develop policy to achieve an optimal introduction of a new
class of analgesics on the Dutch market. Research questions were: Was the new
approach to commissioning research successful in terms of increasing a) the
cooperation of researchers; b) the relevance of the results; and c) the effectiveness of
subsequent policy measures? 
         
Methods
Theoretical framework  
First and foremost, policy is considered as a matter of co-production. This means
that the development and implementation of policy is shaped by interactions
between implementers of policy, members of target groups, and policy makers
(Derthick, 1972; Mazmanian & Sabatier, 1983; Pressman & Wildavsky, 1973). As
Elmore (1985) has argued, this implies that policy design should iterate between
forward mapping (translating the social problem into a policy problem and then
generating policies to deal with the problem) and backward mapping (analysing
ex-ante the extent to which implementers and target groups will likely respond to
these policies in ways that help resolve the social problem). According to the
argumentative approach of policy analysis (Fischer, 1999; Fischer & Forester, 1993),
action is driven by processes of problem setting (Schön, 1983) in which actors iterate
between forward mapping and backward mapping in order to define problems and
solutions that correspond with each other and the actors’ normative and empirical
background theories. Combining these findings with those of classical
implementation theory, Grin and van de Graaf (1996a) have argued that a policy will
only be effective if implementers and target populations consider the proposed policy
measure meaningful. This means that the proposed policy should also make sense in
the light of problems perceived by the target populations and should be consistent
with their normative and empirical background theories. This implies that it may be
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that collects data on the use of drugs. (Farmaceutisch weekblad, 2001,136:49).
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crucial to policy making to analyse the interpretive frames of policy’s target
populations. 
         
Data collection and analysis  
We monitored the process of policy analysis conducted by PAM staff, the European
tender for proposals, and the PAM appraisal of the research proposals that were
submitted. Data were collected by document analysis of policy analytical documents
at various stages and of research proposals. Semi-structured interviews were held with
PAM staff and researchers who submitted proposals. We also attended PAM meetings.
Lastly, we examined the first draft of the research report. Employing triangulation
(Stake, 1995) between these sources, we reconstructed and interpreted the process of
policy analysis. We additionally analysed the views expressed in documents and
interviews, according to a method validated elsewhere (Moret et al., 2007). In
accordance with Grin et al. (1997), we distinguished participants’ interpretive frames
as being comprised of four layers, namely judgement of solutions, problem
definitions, normative and empirical background theories, and normative
preferences. 
Results
Consultation of the field  
In 2001, the PAM staff received indications that the use of selective cox-2 inhibitors
(COXIBs) was less than optimal. COXIBs were, at that time, a new class of analgesics
(non-steroidal anti-inflammatory drugs, NSAIDs) which were claimed to cause less
gastrointestinal side effects than conventional NSAIDs. According to some health care
professionals, however, the added value of COXIBs was rather limited. Despite this, a
rapid increase in the number of prescriptions was observed shortly after the drug was
introduced on the Dutch market.3 Furthermore, in the majority of cases, high
dosages were prescribed, probably because only high dosages were reimbursed.
Another source in the field questioned whether these new drugs actually yield a
therapeutic benefit as compared to the combined use of conventional NSAIDs and
appropriate gastric protectors. The new COXIBs were considerably more expensive
   
4By 2000, rofecoxib had been registered as useful for pain management in patients with osteoarthritis and
celecoxib had been registered as useful for pain management in patients with osteoarthritis and rheumatoid
arthritis.
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than conventional NSAIDs. Additional urges to explore this issue came from a Dutch
publication which revealed that, in the Netherlands, COXIBs were frequently being
prescribed for medical indications other than those for which the drug had been
registered4 (Jabaaij et al., 2001).
Policy analytic process  
In January, 2002, PAM staff conducted an analysis of this issue. The employees
identified three problems, namely off-label use, channelling (use of medicines in
patients at high risk for side effects), and perverse incentives (the reimbursement of
high dosages only). The research questions proposed by PAM staff were:
1. How are COXIBs prescribed in practice and to what degree is this prescription
(in)efficient?
• For which medical indications and patients are these drugs prescribed?
What is the extent of off-label use and what arguments are used to
justify off-label prescriptions?
• Compared to both conventional NSAIDS and other patient groups, how
often is COXIB being prescribed and what are the costs of co-medication
(gastric protectors)? 
• What developments can be observed in patterns of side effects,
especially among high risk patients?
• Which mechanism(s) can explain the financial inefficiency, namely the
reimbursement of high dosages only?
2. How do actors judge the COXIB use in practice? In order to realise an efficient
prescription of new drugs, is control considered useful and necessary?
3. Which policy measures are available or should be developed to limit the
inefficient use of (new) drugs in the Netherlands?
During the working group meeting we attended, we observed that emphasis was
placed on the first question in the document. For PAM staff, however, the policy
related component (third question) was considered most important. Furthermore, we
discussed what level of detail in research questions was most appropriate. We
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suggested replacing the detailed research questions with more general questions while
placing emphasis on the problem definition(s) underlying these questions.
The advisory committee discussed a modified version of this policy document
(January, 2002). According to the committee, the document was ambiguous. They
claimed that the focus was on the COXIBs, while the introduction of the document
which was written by the PAM staff, focused on policy measures for new drugs in
general. The advisory committee argued that more cases should be analysed to allow
for more general conclusions on promoting the efficient use of drugs. They
recommended distinguishing the last question from the preceding questions.
PAM staff preferred, however, to restrict the project to the case of COXIBs as the
inclusion of more cases was likely to make the project impracticable and infeasible.
They considered a detailed analysis of a case essential as it could assess the
motivations that underlie prescribing practice. The final policy document served as
the basis for a European tender for research (April, 2002). 
         
Research proposals  
By June, 2002, the Board had received four research proposals in response to its
tender. These four proposals differed considerably with respect to the problem
definition and proposed research methods. Details of the four proposals are
summarised in Table 6.1.
In proposal A, the researchers proposed reconstructing, through qualitative
research methods, the argumentation that underlies current COXIBs prescriptions
practices. These researchers contended that insight with respect to these arguments
would likely provide an answer to the question of whether COXIBs are being used
(in)efficiently. In their proposal, an explicit distinction was made between off-label
use and inefficient use. These researchers claimed that a drug can be efficient even
when it used for other indications. The researchers considered acquiring support for
the research project from stakeholders to be imperative. 
Proposal B suggested using quantitative research methods to investigate
whether COXIBs decrease the risk of side effects and direct medical costs. This team
did not wish to assume from the onset that policy measures were necessary. In fact,
they doubted whether policy measures were all necessary.
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Table 6.1. Summary of research proposals
Proposal organisation that submitted
proposal
Proposed research methods 
Proposal A non-profit institute for
supporting policy and
decision making
1) survey among physicians, questions about their prescribing practice and
motivations, 
2) group interviews to investigate views on possibility of controlling the use of
COXIBs. 
3) collect and analyze data from available registers on the use of medicines.
Proposal B institute for
pharmaco-epidemiology and
pharmaco-economics
1) Indicators for off-label use to obtain information on the argumentation
behind prescriptions. 
2) Multiple regression methods for comparing ‘off-label prescriptions’ with
‘on-label prescriptions’ using data from databases. 
3) cost-effectiveness analyses to determine the degree of inefficient use.
Proposal C institute for research on
pharmacy
1) Sent questionnaire to patients and physicians to obtain data on
considerations behind prescription (patients’ complaints, previous medication,
indication, etc). 
2) data on previous medication from the pharmacy database. 
3) ask opinion leaders among health insurers, patients, physicians, and
pharmaceutical industry for their judgements on the efficiency of the
prescriptions.
Proposal D research and consultancy
organisation for companies
and government
1) quantitative data on the current use of COXIBs; 
2) interviews with physicians, health care insurers, manufacturers,
associations of physicians, pharmacists, and patients about their judgements
on current prescription practice and the desirability of measures; 
3) organize workshop
In proposal C, researchers offered to perform a prospective cohort study with patients
who have been prescribed COXIB or conventional NSAID. This team recommended
obtaining data on the reasons that underlie these prescriptions. They also suggested
contacting opinion leaders among health insurers, patients, physicians, and the
pharmaceutical industry to acquire insight on the beliefs regarding the efficiency of
these prescriptions. It was argued that these judgements would be critical for drawing
conclusions regarding utilization of COXIBs. 
In proposal D, researchers proposed a project in which quantitative data would be
collected on the current use of COXIBs; in addition, qualitative data would be
collected by interviewing relevant actors about their opinions on current prescription
practices and the need for policy measures. The main objective was to identify policy
measures for preventing inefficient use of new medicines. The COXIB case was
considered by this team to be a case study that could shed light on the more general
issue of (in)efficient use of new drugs.
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Judgement of proposals  
The four proposals were assessed by the PAM staff and the PAM advisory committee.
According to the advisory committee, the efficiency problem had been elaborated
insufficiently in proposal A. An additional problem with this proposal was its strong
reliance on support for the research project from stakeholders. According to PAM
staff, this dependence had the potential to evolve into a non-decisive practice of
policymaking by consensus. The PAM advisory committee further questioned whether
the results would be accepted by the medical profession. Research proposal B seemed
to be strongly affected by an internal research program. The first two questions were
elaborated more comprehensively than had been requested. Furthermore, the
researchers’ perspective seemed to correspond more with medical professionals than
with policy makers. In proposal C, the focus was placed more on clinical practice
than on policy making. A further criticism was that the proposal defined efficiency in
a way which was inconsistent with the tender. The final option, proposal D,
corresponded best with the Board’s intentions. The researchers had paid attention to
creating sufficient support in advance. However, the Board considered the
researchers’ definition of the term efficiency too broad. Furthermore, the Board
considered an investigation of the determinants of prescription critical for defining
intervention target groups; this aspect was not included in proposal D. As a result,
the researchers modified proposal D to include the aspects mentioned by the Board
(October, 2002). Upon completion, the study was commissioned. 
       
Research report  
In May, 2005, the researchers reported their results. Firstly, data on the number of
COXIBs prescriptions were provided. Prescription was defined as efficient if it was
on-label, if use was long-term (meaning that it was not the first NSAID the patient
received) and if the patient was at risk for gastro-intestinal side effects. Less than three
percent of all prescriptions fulfilled all three criteria. The interviews revealed that
physicians considered their prescription practices as rather restrained. The report
indicated that, on average, a physician prescribes COXIBs once or twice a week.
Justifications for prescribing COXIBs included: a) COXIBs are comparable to NSAIDs
(and thus have broad indications for prescription) but cause less side effects; b) the
prescription of one medication only increases therapy adherence; and c) the costs of a
COXIB are considered equal to the costs of combining a conventional NSAID with a
gastric protector. Health insurers considered off-label prescriptions problematic but
lacked the data necessary to distinguish off-label from on-label prescriptions. Neither
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physicians nor health care insurers were defined as 'real problem holders'. However,
the researchers added that, from a societal perspective, inefficient and off-label
prescription is indeed problematic. 
Table 6.2. Interpretive frames of PAM staff and researchers
Actor Proposed solution Problem definition Background theories Normative values
PAM staff Instruments for signalling
and controlling
prescription of new
medicines by health
insurance companies
Inefficient use of new
analgesics (coxibs) 
off-label use
limited evidence on
effectiveness and
safety
Prescription efficient if criteria
for reimbursement are met; if
evidence is available.
New medicines prescribed in
patients in whom no effects
will be found
Policy measures can be used
to realize adequate
prescription from the
beginning.
Health insurance
companies have
important role in
achieving efficient
health care
Proposal A Qualitative research on
motives behind
prescription.
Important role in study
design for supporting
committee of medical
professionals 
HCIB* considers
prescription of coxibs
inefficient, but
physicians may have
good reasons for off
label prescription
Off-label use can result from
unnecessary prescriptions (no
benefit) or a lack of evidence
(at that time).
Trust among participants
needed to reconstruct motives
behind prescription
Supporting power
among professionals
in the field
Proposal B Quantitative research: 
Indicators for off label
use and
cost-effectiveness. 
According to HCIB is
off label prescription
of coxibs problematic
Research question
was complex and not
objective. 
To answer HCIB’s questions
extensive research on a high
level of expertise is needed. 
Theory of HCIB: too much
influence of pharmaceutical
industry 
Pharmaco-epidemiology is
their expertise.
Perform objective
research.
Independence from
government or
pharmaceutical
industry. 
Proposal C Quantitative research:
reasons for prescribing
coxibs 
Judgements of actors on
the efficiency of current
prescribing practice
Coxibs are
frequently used
off-label, but people
can have reasons 
For physicians, prescription
freedom is important.
Indication for prescription
change over time. 
Insight in arguments behind
prescriptions needed for policy
development
Judgement on
efficiency of
prescription should be
left to professionals in
the field
Proposal D Qualitative & quantitative
research. 
Indicators for prescription
actors’ judge-ments of
use and policy
measures.
Inefficient
prescription new
medicines.
HCIB’s problem
definition is narrow:
only off label
Physicians don’t consider
prescribing practice
problematic.
Participation target population
essential in policy
development.
 Prescribing affected by
pharmaceutical industries.
Expertise in policy research
Answer question from
commissioner
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The proposed policy measures were derived from the interviews and a workshop that
was incorporated into the research project. The potential policy measures generated
were placed in one of the following categories: a) formal regulations; b) guidelines; or
c) the provision of information and advice. All potential measures were judged based
on whether the potential measure was: a) orientated to physicians; b) expected to
improve quality; c) feasible; d) suitable for new drugs; e) evidence based; and f)
acceptable in terms of the costs. Two policy measures in the category ‘provision of
information and advice’ were considered most appropriate, namely including a note
(warning sign) in electronic patient records when an off-label prescription is
provided; and academic detailing, which is a process by which a trained health care
professional/educator visits a physician at his/her own office and provides an
educational intervention on a topic. The aim was to provide physicians with objective
information to counterbalance information provided by pharmaceutical industries. 
Although relevant information was provided, the PAM staff considered the
proposed policy measures to be of limited relevance. 
Interpretive frames of PAM staff and researchers  
The main elements of the interpretive frames of PAM staff and research teams who
submitted the various proposals are summarised in Table 6.2. According to PAM staff,
the primary problem was that COXIBs were prescribed excessively and inappropriately
(thus to the wrong patients) shortly after their introduction on the Dutch market.
PAM contended that policy measures that are capable of signalling these excessive
and/or inappropriate prescriptions patterns were necessary. Alternatively, measures,
applied by health insurance companies, were needed to influence prescription
practices in clinical health care practice. This reflected their view that health insurers
should play a role in improving the efficiency of health care. 
The researchers that submitted proposal A emphasised the need for support
from medical professionals. This emphasis was derived from previous negative
experiences with a former research project in which the participants, mostly
physicians, did not sufficiently support the selected approach. The researchers
claimed that creating an atmosphere of trust with respondents is imperative. This was
considered especially important, since asking respondents to convey motivations
underlying off-label prescriptions may be seen as an infringement of professionals.
The researchers that submitted proposal B indicated that they did not share the
problem of the Board. They claimed that “off-label use simply occurs. The Board may
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not like it but this is how things usually go.” They also considered the tender for
proposals biased: “The Board asked for confirmation of their own ideas, namely the
inefficient use of COXIBs.” They emphasised the importance of a more ‘objective’
approach. The researchers who had submitted proposal C also had doubts about the
Board’s problem definition: ‘According to the Board, all prescriptions that deviate from
the registration of indications are inefficient. However, in practice, this issue may be more
complicated.’ They further contended that physicians would consider the freedom to
prescribe in whatever manner they see fit to be important. The researchers from
proposal D challenged, similarly to the others, the problem definition put forth by
the commissioner. Nonetheless, their primary objective was to answer the PAM staff’s
questions.   
Discussion
The researchers appeared to be reluctant to conduct the requested research project.
This reluctance was linked to a) doubt regarding whether the Board's problem
definition would be shared by 'the field'; b) the desire that medical rationality should
override policy objectives; c) the desire to maintain a relationship with medical
professions that is based on respect for the professional autonomy and the expertise of
medical professionals; and d) the conviction that any policy intervention not
supported by medical practitioners will fail. 
Lack of congruence in perspectives 
Candidate researchers expected that 'the field' would contest the proposed policy
measures. This expectation was in fact borne out by the commissioned research
project. The PAM staff considered off label use of these new drugs to be problematic
because of the high costs and also because they were uncertain about the long term
effects and safety of the drugs. Stakeholders in the field (policy's target populations)
did not share the problem definition of inadequate use claimed by the Board. Most
physicians did not consider their own prescription patterns to be problematic. In
addition, they suggested that the proposed solutions conflicted with the normative
values of physicians and could be perceived as an attack on physicians’ professional
autonomy (prescription freedom).
Although most physicians did not consider their COXIB prescribing patterns to be
problematic, the manufacturer of one of the COXIBs had to withdraw the drug from
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the market because of severe side effects in 2004 (Merck, 2004). The fact that the risk
of myocardial infarction had not been indicated earlier was subject to significant
international debate (Hawkey, 2005). Moreover, the role of both the industry and the
FDA in the assessment of the safety of new drugs has also been discussed (Avorn,
2006; Topol, 2004; Waller et al., 2005). 
In retrospect, the Board's concerns with respect to the potential long term
effects and safety of COXIBs may very well have been justified. However, we contend
that the problem is attributable to the way in which the PAM staff defined the
problem. PAM staff emphasised the off label use of the COXIBs. Additionally, the
PAM's pilot study defined not only the problem but also the underlying intentions
and the direction that needed to be taken to solve the problem. Although researchers
were asked to take the target populations' problem definitions into account, as
evidenced by the pilot project, it is apparent that the PAM staff was not particularly
open to alternative perspectives. Finally, the procedures used for the European tender
for research also affected the proceedings. The administrative process complicated
contact between the commissioner and researchers. As a result, a discussion of the
problem definition, the underlying argumentation, and the preferred solutions was
practically impossible. Instead of focussing on off-label use, the focus could have been
on the lack of evidence on the safety of these drugs, especially with respect to off label
use. This kind of problem definition would have resulted in other research questions
that may have been very relevant. In fact, such studies have by now been conducted
(Hippisley-Cox & Coupland, 2005; Lévesque et al., 2005) 
 
Need for interventions that are congruent with perspectives of all actors involved
The results indicated that the perspectives of both the target populations and the PAM
staff were relevant. It is, however, important to note that involving target populations
in policy development does not imply that the target populations control the way in
which the problem is defined, nor which solutions are preferred. Involving target
populations does not mean that consensus on the problem definition and on the
interventions that can provide a solution has to be reached. The primary aim of
involving target populations is to identify solutions that do justice to the perspectives
of all actors involved. 
Seeking congruence between the perspectives of actors demands another approach to
research. Problems and possible solutions should be explored through dialogue and
interaction (Denzin, 1989; Grin et al., 1997). This kind of process can help to: a)
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assess the level of congruence between the perspectives of the actors involved; and b)
stimulate a process of learning. Furthermore, the process can generate procedures by
which differences in interest and power can be taken into account. An analyst can
help to create conditions for mutual trust, which is essential for processes of learning
and reaching agreement (Schön & Rein, 1994). 
Researchers' role 
In this project, researchers were not only asked to provide specific evidence but also
to take the problem definitions of the policy's target populations into account.
Implicitly, it was assumed that researchers should be policy advocates in order to have
a policy impact. Our results suggest that researchers are not necessarily willing to
adopt the role of policy advocate. In fact, researchers often prefer to maintain a
neutral position towards all parties involved in the project. Koch et al. (2003) has also
recognised the reluctance of researchers to take on the role of policy advocate. On the
other hand, Kemp & Weehuizen (2005) have argued that policy analysts and
researchers can play an important role in innovation and policy learning With this in
mind, involving independent policy analysts to assess actors’ perspectives and advise
policy makers may be a worthwhile endeavour. That is, if one follows Jennings’
(1987) distinction, while it may be misguided to treat them as ‘advocates’, they may
play a role as ‘counselor’ to and between the various parties involved.  
Conclusion  
Involving target populations in policy research should not be equated with target
populations being in charge of the problem definition and identification of solutions.
The results of this case study emphasise the importance of seeking solutions that are
congruent with both the perspectives of policy makers and policy’s target
populations. So rather than acting as an advocate, researchers may act as ‘counselors’.
Although it can be difficult to attain congruence between actors involved, an
interactive methodology might provide opportunities to effectively reconcile all
actors’ interests and the power differences that may be present.
99
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Diverging views on relevant policy research: a case
study on improving the efficient use of drugs for
pulmonary hypertension
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A
possible explanation for limited knowledge utilization is a shift in problem
definition during policy research. The process of commissioning policy
research was studied, with special emphasis on the management of shifts in
problem definition. The case study consisted of policy to improve efficiency of the
use of medicines for a particular patient population. We conclude that it is not so
much a shift in problem definition per se that is the main problem. A shift in
problem definition may be an indicator of a social learning process; however, the
participants should be aware of this, and should endorse the validity of shifts in
problem definition, if they occur. 
M Moret-Hartman, R Reuzel, J Grin, GJ van der Wilt. Diverging views on relevant
policy research: a case study on improving the efficient use of drugs for pulmonary
hypertension (submitted)
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M
any theories on knowledge utilization have been described and discussed.
Explanations for use or non-use of knowledge are sought in
communications, in the action of the rational actor, or in the product of
bureaucratic politics (Rich, 1991; Rich & Oh, 2000; Jacobson, 2007). Originally,
knowledge utilization was regarded as a rational process, assuming that a specific
decision can be attributed to the use of specific information. More recently, theories
on knowledge utilization have changed from unidirectional models to interactive
models, from one-time one-direction dissemination towards an ongoing relationship
between producers and users (Jacobson, 2007). Alternative to the viewpoint of
knowledge utilization as a rational process, knowledge utilization may be seen as a
series of events affected by the type of available information and the problem-solving
area (Rich, 1991). Weiss demonstrated that the direct use of evaluation (instrumental
use) in decision rarely takes place (Weiss, 1980; Weiss & Bucuvalas, 1980). More
often, ‘use’ includes processes such as the understanding of programs and gaining of
new ideas and insights (conceptual use). Moreover, many policy actions do not imply
concrete decisions, but involve a set of incremental, uncoordinated steps of decisions.
In the Netherlands, the Health Care Insurance Board (HCIB), an advisory
body to the Ministry of Health, commissions research to obtain knowledge that is
deemed necessary for decision making on the reimbursement or use of drugs. HCIB
found, however, that results of projects that they had commissioned were of limited
relevance to their policy tasks. A possible explanation for this might be that a shift
occurs in problem definition, such that the problem that is addressed by researchers
differs from the problem as originally defined by HCIB. Specifically, the problem may
be redefined in such a way that it becomes amenable to available research techniques,
and fits with the interests of a specific research community (Moret-Hartman et al.,
2007). This suggests that awareness of this phenomenon and management of
problem definition could be a means to improve relevance of policy research. 
       Empirical evidence on explanations for non-use and the effectiveness of
interventions to enhance knowledge utilization is limited. We present the results of a
case study where commissioning procedures had been adjusted to prevent shifts in
problem definition. Research questions were: (1) Did research proposals correspond
with the problems as perceived by both those who commissioned the study and the
stakeholders in the field? (2) Were the research results translated into policy measures
that provide a solution to perceived policy problems?
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Case Description
This research project was commissioned by the HCIB’s Department of Policy Analysis
on Medicines (PAM). The HCIB is an independent organisation between the Ministry
of Health and the actors in the field (physicians, health insurance companies, etc.).
Its task is to coordinate the implementation and funding of health care insurance
provisions. In order to support that contribution, the HCIB performs policy analysis
on optimization problems. The Department of PAM is responsible for identifying
developments that may jeopardise optimal pharmaceutical care, analysing the nature
and size of such threats, and ensuring that further research is conducted that can
provide a basis for policy decisions. An annual plan in which research topics are
prioritised is submitted to the Ministry of Health for approval. The research findings
provide the basis for policy advices to the Ministry of Health. A committee consisting
of experts from the field, mostly in health services research, has been established and
is regularly asked to provide recommendations on PAM’s policy analyses, submitted
research proposals, and reports to the Ministry of Health. 
The Board’s project dealt with two novel, expensive drugs for patients with
pulmonary hypertension. Pulmonary hypertension (PH) is a rare disease of the small
pulmonary arteries that results in an impoverished heart function (Gaine & Rubin,
1998). It can be caused by other diseases (secondary PH) or occur on its own (primary
PH). The main symptom is shortness of breath. The disease presents in relatively
young people (35-45 years old), and the life expectancy after diagnosis is short (one to
two years). In November 1999, the Ministry of Health asked the HCIB for advice on
the reimbursement of a new drug, epoprostenol. Concerns included its high costs
and the possibility that its prescription might extend to non-licensed indications.
Evidence on the drug’s long-term effectiveness or its effectiveness in specific
subgroups of patients was limited. Estimates of the annual costs of epoprostenol
ranged from €225,000 to €450,000 per patient. As arrangements between physicians,
health insurance companies, and the industry were in place, the actual charges were
approximately €50,000 per patient, regardless of the amount needed. The HCIB
advised the Ministry of Health 1) to limit the reimbursement of epoprostenol to PH
patients with moderate to severe disease; 2) that patients should be treated by
physicians specialised in PH treatment; 3) to evaluate the effects of treatment; 4) and
to designate three or four hospitals as PH expert centres. In May 2002, a second drug,
bosentan, was introduced into the market. The advantage of bosentan was that it
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could be administered orally, unlike epoprostenol, which required intravenous
administration. In February 2003, the Ministry of Health decided to restrict the
reimbursement of epoprostenol and bosentan to a) patients with moderate or severe
PH, b) for whom the prescription was provided by a specialist experienced in treating
these PH patients c) after approval by health insurance companies. 
In 2003, PAM staff prepared a policy analysis of current policy on maintaining
the conditions for reimbursement of epoprostenol and bosentan and the effectiveness
of these drugs.
Methods 
We (JG & MM) advised PAM staff during policy analysis, provided feedback on the
policy analysis draft, and analysed the received research proposals. 
Advice on policy analysis was based on lessons from previous case studies and
insights from the theory of the argumentative policy analysis. The argumentative
approach contends that the actions of professionals can be explained by the views
these actors have on a given problem and the argumentation that underlies these
views (Fischer & Forester, 1993). A policy may be more effective if it is congruent
with problem definitions and background theories of actors involved (Grin & van de
Graaf, 1996a). Our results revealed that the problem definition guiding the work
shifted repeatedly throughout the research process (Moret-Hartman et al., 2007). We
contended that the shift in problem definition could be largely explained by
differences in the perspectives of the actors involved, who acted on the basis of a
professional frame that is shaped by education and earlier experiences (Schön 1983,
Schön & Rein, 1994). Researchers redefined the problem based on their expertise and
experiences. As a result, the studies failed to generate the knowledge sought by the
commissioner. Furthermore, problem definitions of researchers and policy makers
failed to correspond with the problems as perceived by the target populations in the
field, the physicians and patients. A policy may only be effective if target populations
consider the proposed policy measure as meaningful (Grin & van de Graaf, 1996a;
Yanow, 2000). This implies that the cooperation of these target populations with
proposed policy depends on the extent to which this policy makes sense in the light
of problems perceived and does not violate normative background theories held.
Thus, it seems advisable to take into account the viewpoint of a policy’s target
populations during the development of new policy measures.
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We recommended that PAM staff a) explicate the board’s problem definition
and argumentation in order to prevent misinterpretations and a subsequent shift in
problem definition; and b) take the problem definitions of the policy’s target
populations into account in order to increase the likelihood of acquiring their
cooperation on policy measures. Confronted with these lessons, the PAM staff 1)
explicated the purpose and the background of their research requests in their
documents; and 2) asked researchers to make an inventory of problems and
judgements of solutions according to the policy’s target populations. 
In providing feedback on the policy analysis draft, we observed that emphasis
had been placed on one solution. We recommended openness to alternative solutions
derived from the problems perceived by the actors involved. We also suggested that
the researchers compile one inventory of problems rather than two separate
inventories among health insurance companies and physicians. We argued that
interaction between these target populations could be advantageous in that it could
stimulate a discussion about problem definitions and widely supported solutions.
We analysed documents (policy analytical documents in different stages and
research proposals) and held semi-structured interviews with the PAM staff and the
researchers who submitted research proposals. All interviews were tape-recorded,
summarized, and coded. We analysed the problem definition and proposed solutions
for each stage of the policy analytical process and the research project that followed.
In the interviews, questions focused on the perceived problems concerning care for
patients with pulmonary hypertension and the underlying argumentation, in
conformity to the methodology of reconstructing interpretive frames (Grin et al.,
1997; Moret et al., 2007). A person’s interpretive frame consists of appreciation of
solutions, problem definitions, background theories, and normative preferences.
Careful analysis of interpretive frames helped distinguish between what was agreed
and what was disagreed. Respondent validation was conducted by sending a
summary of each interview to the respective respondent for correction. 
In January 2006, PAM staff was contacted by telephone to determine how far
the implementation of the proposed policy measures had progressed at that point in
time.  
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Results
Policy analysis 
In 2003, the HCIB’s Department of Pharmaceutical Care (CFH) recommended that
PAM staff evaluate the effectiveness of both epoprostenol and bosentan. PAM staff had
also received indications from health insurance companies who had experienced
problems with respect to appraising reimbursements requests. The health insurance
companies suspected that bosentan was being prescribed to patients who did not
meet the criteria for reimbursement. 
In May 2003, PAM employees prepared a policy analysis on this subject. PAM
staff proposed that research be commissioned to provide the following information:
1) current policy on maintaining the conditions for reimbursement of epoprostenol
and bosentan and the problems encountered by health insurance companies or
physicians; 2) the possible need for adjusting the criteria for reimbursement; and 3)
the therapeutic value and relative position of these drugs, their efficiency, and their
actual use in clinical practice.
Interpretive frame: According to PAM staff, the problem was uncertainty about
the effectiveness of these very expensive drugs (Table 7.1). A normative assumption
held by PAM staff was that use in specific patient-groups is adequate only when
evidence of its effectiveness in these groups is available. The most appropriate
solution was to analyse the effectiveness of these medicines in subgroups of patients.
PAM staff decided to commission two projects simultaneously: Project 1 to obtain
specific information on the effectiveness of the drugs epoprostenol and bosentan;
Project 2 to obtain information about the problems as perceived by physicians and
health insurance companies concerning the reimbursement of these drugs. Both
projects were commissioned using a non-European tender. Projects with expected
costs above certain levels need to be tendered in an open procedure that fits strict
European criteria. The costs of these projects were estimated to be lower, providing
flexibility in the organisation of the tendering process and allowing for meetings
between the commissioner and researchers. In June 2003, three institutes were invited
to submit their proposals. In August 2003, the HCIB received drafts of three research
proposals. One proposal dealt with the evaluation of the effectiveness of the drugs
and two proposals dealt with the inventory of reimbursement problems and possible
solutions. Researchers were invited to present their proposals at the HCIB office. After
these meetings, the researchers adapted and elaborated their proposals.
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Proposal A
The proposal on the evaluation of the drugs’ effectiveness (Proposal A) was submitted
by clinical experts from three hospitals. The authors doubted the appropriateness of
current prescriptions. They proposed to investigate the following: the effectiveness of
the two drugs, the efficiency of the diagnostic and treatment processes, and the effects
of the treatment on patients’ quality of life. To evaluate the effectiveness of
epoprostenol and bosentan, the researchers indicated that they would conduct a
literature review and data analyses based on patients’ records in their respective
hospitals’ databases. The researchers also proposed the inclusion of other novel
medicines in order to assure that the findings were up to date.  
Interpretive frame: According to the researchers, the problem was that the
diagnostic process in other hospitals was frequently inadequate (Table 1). Diagnosis
of PH and its underlying causes is difficult. Prescription of epoprostenol was limited
to a few specialised centres because of complicated, intravenous administration.
Bosentan, however, could be administered orally and was thus more widely
accessible. As a result, more hospitals started to administer the drug themselves
without referring the patient to a clinical expert centre. They claimed that it is known
which subgroups of patients are likely to benefit from the new medicines.
Background theories included that, given the rarity of the disease and the wide range
of mechanisms that can cause it, experience and expertise is needed to diagnose PH
and its underlying causes adequately. The researchers claimed that the best solution
would be to limit the number of clinical centres for diagnosis and prescription of
these drugs. 
Proposal B
The first proposal concerning reimbursement problems (Proposal B) was submitted
by a Dutch knowledge organisation. The researchers proposed an assessment of the
current state of affairs on 1) guideline development by physicians and 2) the
identification of a selected number of hospitals for PH diagnosis and treatment. In
this proposal, both quantitative and qualitative research methods were proposed. The
researchers suggested an analysis of data from registries to determine the current use
of the two drugs. They also suggested conducting interviews to compile an inventory
of a) the current policy according to physicians and health insurance companies; and
b) the problems they perceive. Lastly, they suggested organising a workshop to
discuss problems and possible solutions. 
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Table 7.1. Interpretive frames of PAM staff and researchers
Actor Proposed solution Problem definition Background theories Normative values
PAM staff •Clear criteria for whom
prescription should be
reimbursed
•Research on
effectiveness of
medicines
•Adaptation of criteria
for reimbursement
•Lack of evidence on
effectiveness of the
medicines in subgroups
of patients
•Insurance companies’
difficulties in assessing
reimbursement requests
•No centres for PH care
designated by the
Ministry of Health
•Criteria for assessing the
value of interventions
useful for decision on what
to reimburse
•Use of an intervention is
efficient when there is
evidence of its additional
value (effectiveness and
costs). 
•A limited number of
expertise centres is
sufficient for a small
population.
Efficiency 
Proposal
A
•Research on the
adequacy of diagnosis
and effectiveness of
medicines
•Diagnosis and
treatment in limited
number of hospitals to
increase expertise
•The medicines are
frequently prescribed to
the wrong patients. 
•Diagnosis of subgroup of
PH patients (underlying
cause) in hospitals
frequently inadequate
•Due to rarity of disease
and high variability, many
patients need to be seen
for building up expertise. 
•PH is not one single
disease. 
•Only a minority of PH
patients benefit from the
available medicines.
•An intervention should be
available for patients who
will benefit from it.
Proposal
B 
•Inventory of current
practice & perceived
problems among
actors involved 
•Identify solutions
during workshop 
•Assess whether
current criteria for
reimbursement need to
be adapted
•Problems with decisions
on reimbursement of two
medicines
•No unequivocal criteria
concerning experience of
prescribing physicians
•No centres for PH care
designated by the
Ministry of Health
•Workshops will create
support among actors
involved.
•Reliable and robust
research which answers
commissioner’s  questions
Proposal
C
•Design of solutions
based on suggestions
from actors involved 
•Solution: one clinical
expert centre and a
central committee of
clinical experts who
judge reimbursement
requests 
•Possible inappropriate
use of new PH medicines;
problems of insurance
companies in assessing
the reimbursement
requests
•Self regulation of PH
expert centres by
hospitals unsuccessful
•Policy research to
catalyse policy
implementation
•Adequate orientation of
an intervention in medical
practice
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Interpretive frame: According to the researchers, the reason for the requested
research was that health insurance companies perceived problems indicating that they
lacked the knowledge to assess these reimbursement requests properly. Furthermore,
the HCIB had been informed that bosentan was being prescribed to patients with
problems that were not specifically linked to the therapeutic indications for
epoprostenol and bosentan. Previous recommendations (developing a guideline and
selecting a limited number of hospitals for PH treatment) had not been implemented.
Proposal C
The second proposal for the evaluation of reimbursement problems (Proposal C) was
submitted by a university department. This proposal aimed to provide information
on a) the use of the drugs and the associated costs; b) the current regulation of use
and the perceived problems; and c) possible solutions to these problems. The
researchers proposed to obtain data on the use of the drugs directly from health
insurance companies. Questionnaires would be used to acquire data on the criteria
for use, the characteristics of the clinical centres health insurers work with, and the
perceived problems. Supplementary interviews were also planned. Lastly, the
proposal indicated that meetings would be arranged between representatives of all
actors involved.
Interpretive frame: The researcher defined the problem as a problem of two
expensive drugs being licensed while the evidence on their effectiveness was still
limited (Table 7.1). This researcher claimed that the optimal solution would be to
establish one clinical expert centre and a central committee of clinical experts who
would appraise requests for reimbursement. Preferably, the government should
regulate the prescription of expensive medicines. The researcher considered
self-regulation of such expert centres unlikely. Thus, the requested policy research
might serve as a catalyst for implementing policy measures. 
PAM’s judgement of the research proposals
According to PAM staff, proposal A had not been sufficiently elaborated.
Furthermore, they considered that the researchers had placed too much emphasis on
the adequacy and efficiency of the clinical diagnosis. As a result, PAM staff determined
that the proposal did not fulfil their needs and thus decided not to commission this
project. With respect to the proposals on reimbursement problems, PAM concluded
that the two proposals were very similar. Because the first proposal (Proposal B) was
more detailed than the second (Proposal C), PAM decided to commission Proposal B.
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Research report 
In September 2004, the research report was submitted to the HCIB. The researchers
had evaluated the existing policy on the use of epoprostenol and bosentan.
Self-regulation by means of designating certain hospitals as expert centres had been
unsuccessful. A guideline on PH care had been developed but was not yet
implemented. Health insurance companies had difficulty assessing whether
reimbursement criteria were met, especially with respect to the condition that only
prescriptions provided by specialists be reimbursed. Because of this difficulty, health
insurance companies took this condition to be met when the physician was affiliated
with one of the hospitals specialising in PH treatment. At that time, multidisciplinary
teams for PH care had been established in five hospitals (four university hospitals and
one general hospital). The researchers recommended that these hospitals be
designated as clinical expert centres. They further recommended that this designation
last for a limited period (for example, three years) and that renewal should require an
evaluation. Lastly, the researchers recommended that the condition that drugs should
be reimbursed only if prescribed by a specialist be replaced with the condition that
links reimbursement to the hospital in which the treatment was initiated.
Policy measures 
In November 2004, the HCIB advised the Ministry of Health on policy measures
concerning the reimbursement of epoprostenol and bosentan. Most of the
recommendations provided by the researchers were included. Whereas the researchers
had recommended to limit treatment to a selected number of hospitals with expertise
in PH treatment, PAM staff decided not to adapt the conditions for reimbursement as
such, but rather, to restrict the prescription of these drugs to all teaching hospitals
(n=7) and the one general hospital that had expertise in this field by means of the
Special Medical Procedures Act. Additionally, these clinical expert centres should
participate in a national multidisciplinary working party that would commit them to
treatment according to the protocol and to collecting and analysing prescription data
at a national level. By January 2006, however, regulation by means of the Special
Medical Procedures Act had not been implemented.
Interviews revealed that PAM staff preferred regulation of the prescription of these
medicines by law. Changes in the Dutch health insurance system and in the HCIB’s
function were expected. Since January 2006, maintaining the conditions for
reimbursement had become the task of health insurance companies. The HCIB’s role
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would be limited to decisions concerning the inclusion of medicines in the benefit
package. 
Discussion
In this paper, we reported on a case study in which changes in the commissioning
procedure had been implemented to prevent a shift in problem definition. We found
that a shift in problem definition could not be prevented in all proposals. The
researchers who wrote Proposal A redefined the problem, because they considered
PAM’s problem definition inadequate. The researchers and the PAM staff disagreed on
what kind of information was needed to improve PH care because they held different
background theories. The problem definition did not shift during the tendering of
Project 2. Both proposals resembled the problem as perceived by PAM staff and the
research report of the elected project appeared to answer PAM’s questions. Based on
the findings in the research report, PAM staff advised the Ministry of Health on policy
measures. Concrete policy measures were formulated although the required evidence
on the effectiveness of the drugs (Project 1) had not been obtained. The proposed
policy measure was to restrict reimbursement to a limited number of hospitals. These
measures have, to date, not been implemented, leaving the initial problems unsolved.
Problem shifting not always undesirable 
PAM staff considered the redefinition of the problem in Proposal A to be undesirable.
However, the problem as defined by the researchers corresponded well with the
problems mentioned in Project 2's research report. The researchers who wrote
Proposal A emphasised the relevance of an adequate process of diagnosis above
information on the effectiveness of the drugs in certain subgroups of patients.
Proposal A was focused on the efficiency of diagnosis and selection of patients for
treatment. This was rooted in their background theory, which included that expertise
is needed for adequate and efficient diagnostic process. 
While the rejection of this proposal reflected PAM’s discontent with its focus on
diagnosis rather than the effectiveness of interventions, HCIB thus also missed some
useful insight on the latter. The researchers’ background theory made them aware
that, given the limited number of patients and high variability, it might be desirable
to concentrate PH care in a limited number of clinical centres. As early as 2001, the
HCIB had advised the Ministry of Health to limit the number of hospitals that may
diagnose and treat PH patients. Unlike in the UK, for instance (Evans et al., 2002;
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Peacock, 2003), such centres had not been designated in the Netherlands. The
proposed research on the efficiency of diagnosis could have provided evidence to
support the relevance of limiting the number of PH centres. This finding raises the
question of whether the shift in problem definition should be defined as undesirable. 
Need for learning processes
The greatest barrier in this case study was that neither the commissioner nor the
researchers were open to changing, or even discussing, their divergent viewpoints. In
general, it is difficult to know which problem definitions should be followed. As
Schön and Rein remarked, there are no objective criteria for judging whether
viewpoints are right or wrong (Schön & Rein, 1994). Alternatively, they argued, one
should appeal to a shared perception for reaching agreement on a specific situation. If
congruence in perspectives is lacking, a process of learning should take place (Grin &
van de Graaf, 1996a). The aim is not to reach an agreement on the problem
definition but on interventions that can provide a solution for the perceived
problems. Solutions need to be identified that are congruent with the perspectives of
all actors involved: provide a solution for their problems and do not conflict with
their normative values. Therefore, problems and possible solutions should be
explored through dialogue and interaction. Guba and Lincoln (1989) provided a
methodology for interactive processes and considered the occurrence of learning
within and between actors to be two main criteria for success. One of the conditions
for this kind of learning is the existence of opportunities for actors to exchange ideas
and arguments openly (Grin & van de Graaf, 1996a). 
In the project reported here, the meeting between policy makers and
researchers could have provided an opportunity to come to some sort of agreement
on measures for improving the adequate use of epoprostenol and bosentan. Previous
reports from case studies stressed the need for communication and close cooperation
between researchers and policy makers to improve the policy process (Moynihan,
2004; Milbank, 2001). PAM staff decided to commission two projects simultaneously.
In Project 1, researchers were asked to obtain specific information. In Project 2,
researchers were asked to assess the viewpoints of the policy’s target populations.
Physicians specialised in PH care wrote research Proposal A and thus were members
of the policy’s target population. Because of limited time and expertise, PAM staff
asked researchers to take into account the viewpoints of actors in the field in a
parallel project (Project 2). Ideally, prior to commissioning research, the problems of
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stakeholders in the field should be explicitly incorporated during the process of policy
analysis. Interactive methods for policy analysis can be useful for this purpose. 
Knowledge utilization
HCIB employees considered that facts about the effectiveness of an intervention
would be sufficient for decision making on this subject. However, policy makers have
to deal with a complex decision-making process, which is a challenge for both policy
makers and researchers who provide knowledge to support those decisions.
Researchers need to anticipate different interpretations of research needs. Policy
makers need to anticipate the different perspectives of actors whose cooperation is
needed. As Weiss noted (1993), evaluation takes place within a political environment.
When translating the results into policy measures and implementing these policy
measures, the cooperation of several actors is needed. Results of an evaluation are not
used by changing the judgment of interventions, but utilization mostly involves a
change in the problem definition or background theories. Changes in these deeper
levels of one’s interpretative frame are more difficult to realize (Grin & van de Graaf
1996a). Because information need to compete with experiential knowledge as well as
pathophysiological insights, instrumental use, in terms of the direct application of
new evidence, is unlikely to occur. In this light, knowledge transfer should be
regarded as a process of learning.
Conclusion 
In hindsight, too much emphasis was put on preventing a shift in problem
definition. Assumption was that preventing a shift in problem definition could
enhance the utilization of knowledge from policy research. The main problem was
that neither the commissioner nor the researchers were open to changing, or even
discussing, their divergent viewpoints. For identifying interventions that are
congruent with the perceived problems and normative values of all actors involved,
problems and possible solutions should be explored through dialogue and
interaction. A shift in problem definitions may be necessary for solving problems.
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Interactive problem structuring to develop
meaningful interventions and research questions: a
case study on emergency hospital care for patients
after auto-intoxication
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M
any notable researchers have emphasised the importance of usefulness in
policy research. The quality of an evaluation largely depends on the quality
of the underlying problem definition and the quality of the problem
definition often improves as stakeholder involvement increases. By means of a study
on the management of attempted suicides by drug overdose, we explored whether an
interactive methodology could be adequate for problem structuring. Despite the fact
that a high level of care is often unnecessary, these patients are often admitted to the
internal ward or intensive care unit. To solve the efficiency-problem, some physicians
proposed a pilot study to evaluate the effectiveness of a six-hour observation unit
within the emergency department. Although evaluating such an unit was technically
feasible, we felt uncertain about the appropriateness of this intervention and the way
the underlying problem was structured. Results of the study demonstrated that the
use of interactive problem structuring made the divergent problem definitions and
underlying normative values transparent. Using this model, the information resulting
from our research efforts is expected to be more useful and available to the
stakeholders involved and therefore more effective. Moreover, the study provided us
with a deeper understanding of potential resistance from important stakeholders to
the implementation of such a unit.
M Moret-Hartman, R Reuzel, J Grin, GJ van der Wilt. Interactive problem structuring
to develop meaningful interventions and research questions: a case study on emergency
hospital care for patients after auto-intoxication (submitted)
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S
cholars such as Weiss, Rossi, and Dunn have emphasised usefulness as an
important aspect of policy research. In their view, evaluation research should be
useful for policy making (Dunn, 2004; Rossi et al., 1999; Weiss, 1993).
Following this reasoning, the quality of evaluation largely depends on the quality of
the underlying problem definition and the quality of the problem definition often
improves with the increasing involvement of the stakeholders. William Dunn even
goes so far as to define problem structuring as “a recurring phase of policy inquiry in
which analysts search among the competing problem formulations of different
stakeholders” (Dunn, 2004: 72). Involving stakeholders in problem structuring is
important because:
• Involving stakeholders leads to a more comprehensive view of the problem
situation and therefore diminishes the risk of an error of the third type: solving
the wrong problem.
• It enables the policy analyst to design policy solutions that conform to
stakeholder views and therefore increases the chances of successful
implementation. 
The idea that stakeholder involvement increases successful implementation has been
confirmed by Frank Fischer and others, who argue that a policy is likely to fail if it
does not represent a solution to problems as perceived by stakeholders and if it
violates these stakeholders’ normative preferences (Fischer & Forester, 1993; Fischer,
1999; Grin & van de Graaf, 1996a; Grin & van de Graaf, 1998). The evaluation
driven development and implementation of a policy is shaped by interactions
between all stakeholders, including those who create the policy, those who
implement the policy, and those targeted by the policy (Derthick, 1972; Mazmanian
& Sabatier, 1983; Pressman & Wildavsky, 1973). However, difficulties arise when
stakeholders have different, perhaps even incompatible, views. Moreover, these views
may be misguided, poorly supported by evidence, or otherwise less valid. 
In theory, fourth generation evaluation serves the dual role of involving
stakeholders and eliciting their views, and provides a means to deal with misguided or
incompatible views. As conceived by Guba and Lincoln (1989), its backbone is the
so-called hermeneutic-dialectic circle of interviews. Participants are interviewed
successively. In each interview, the evaluator elicits views and exchanges claims,
concerns, and issues. Having interviewed the last participant, the evaluator then
returns to the first interviewee, presenting them with the other interviewees’ views,
thus moderating a continuous process of ‘vicarious learning’ in which alternative
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views are negotiated, misconceptions are filtered out, and a consensus develops about
problem definitions and solutions.
In this article, we will not address the many intangibles of fourth generation
evaluation such as participant selection, closure, power differences, and so forth.
Rather, we regard fourth generation evaluation as a problem structuring process and,
on the basis of a case study involving the management of attempted suicides by drug
overdose; we will answer the following questions:
1. What problem definition emerges from a fourth generation approach to
problem structuring, as compared to the problem definition as first presented
by the person initiating the problem investigation?
2. What difficulties are encountered that specifically pertain to the fourth
generation approach to problem structuring?
In this article, we will report on the use of an interactive methodology to structure a
problem concerning the clinical treatment of patients who attempted suicide by auto
intoxication. Our aim was to explore, on the basis of this case study, whether an
interactive approach offers an improvement in problem structuring, as compared to
conventional approaches to evaluation in health care that are usually restricted to
assessing an intervention’s effectiveness and efficiency. Initially, we will present the
results of this preliminary study. This will be followed by contrasting our results with
the expected outcomes of a more conventional approach to problem structuring that
does not feature an interactive problem structuring process.
      
Case description
The hospital involved in this study is a university-based teaching hospital. Each year,
approximately 150 persons present themselves at, or are brought to, the emergency
department following an attempted suicide using drugs. Some of the medical
specialists, particularly those in internal medicine, felt that the care provided to these
patients was inefficient. They perceived that while these patients are often admitted
to the internal ward or intensive care unit it is rarely medically necessary. As a result,
these patients occupy hospital beds that other patients may need more urgently, and
thus hospital resources are used inefficiently. Meulendijks et al. (2003), after
analysing the type and amount of drugs used, physiological parameters of the
patients, and the disposition of hospital admissions, confirmed that 60% of auto
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intoxicant patients are admitted to an internal medicine ward or intensive care unit.
Of these patients, only 40% receive treatment. In most cases, this treatment is
initiated within one hour of the patient’s presentation. In the remaining patients,
treatment is started within 4.5 hours after their presentation. Based on retrospective
data, the criteria that predict treatment courses based on the clinical signs were
identified (Brett et al., 1987; Meulendijks et al., 2003).
To solve the efficiency-problem, some physicians suggested that patients be
observed in the emergency department in order to determine whether admission to
the general or intensive care ward is necessary. In the case of an adverse event, the
patient would be transferred to the internal medicine ward or intensive care unit. If
no such events occur within a few hours’ time, the patient would be discharged. 
Our department (Medical Technology Assessment) provides general
methodological support to clinical departments. We were asked to assist in
conducting an assessment of a six-hour observation unit. Although evaluating such
an assessment unit was feasible, we felt uncertain about the appropriateness of the
six-hour observation unit and the way the underlying problem was structured. We
doubted that all stakeholders involved would find the results of such an assessment -
whatever they would be - compelling enough to make them co-operate with whatever
changes the results suggested. 
In order to properly structure the problem regarding the care of patients after
auto intoxication, we suggested that a preliminary study be conducted. This involved
an interactive evaluation where various stakeholders participating in the project
discussed their views. Our aims were: 
1. To reconstruct stakeholders’ views towards hospital care for auto intoxicated
patients, and on this basis establish a shared problem definition,
2. To identify solutions to problems perceived, as well as the conditions under
which these solutions would be met with widespread support; and
3. To identify research questions that appear to fit the problem definition and are
amenable to research.
Methods: Interactive evaluation
We performed an interactive evaluation based on the fourth generation methodology
elaborated by Guba and Lincoln (1989). Interactive methodology involves a multiple
series of open-ended interviews with stakeholders, where the interviewer exchanges
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claims, concerns, and issues between the respondents (Grin et al., 1997). We first
interviewed two actors (an internist and a psychiatrist) who had been involved in the
retrospective study of the treatment of auto-intoxicated patients. At the end of the
interviews, we asked them to suggest the names of other stakeholders, preferably with
opposing views towards the auto-intoxication policy. This ‘snowball’ led us to
interview psychiatrists (n=2), internists (n=2), nurses (n=2), intensive care specialists
(n=3), general practitioners (n=2), a psychiatric critical care worker (n=1), a clinical
psychologist (n=1), an ER physician (in training for internist) (n=1), a pharmacologist
(n=1), the head of the emergency room (n=1), physicians from a general practitioner
centre (medical emergency outside normal working hours) (n=2), a representative of
an organisation for (ex)suicidal patients (n=1), and a patient (n=1). 
During the interviews, which lasted approximately one hour, respondents were
invited to elaborate on the auto-intoxication policy, particularly the problems as they
perceived them, and solutions they considered appropriate. In the second part of the
interview, the interviewer asked them to respond to the viewpoints of other
stakeholders that the interviewer introduced to them anonymously. We sent
interview summaries to the respondents for validation. After the first series of
interviews, an overview of all the interviews was made and circulated among the
respondents. In this summary, we emphasised the criteria for adequate care for
patients after intoxication. During the second series of interviews, we asked
respondents to respond to this summary.
Interviews were transcribed verbatim, and then coded and summarised. We
used the  reconstructing interpretative frames method to analyse the stakeholders’
reasoning (Grin et al. 1997; Moret-Hartman et al., 2007). An interpretative frame is
the interviewer’s reconstruction of a respondent’s view, featuring four ‘layers’ of
problem definitions, proposed solutions, empirical and normative background
theories, and normative preferences (Grin & van de Graaf, 1996b; Schön, 1983). This
method is a suitable tool for analysis, particularly in cases where it is important to
associate a respondent’s problem definitions and solutions with his or her
background theories and preferences. Interpretative frames helped us to assess
whether proposed solutions matched problems as perceived by stakeholders and did
not violate these stakeholders’ normative preferences. In this way, we merged
Fischer’s theory of argumentative policy analysis with the fourth generation
evaluation paradigm. 
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Furthermore, we scrutinised the responses provided by the interviewees against the
literature available on the subject. Using this data and research, we wrote a draft of
the final report that we also circulated among the respondents for comments. 
Results: Interactive evaluation
We approached 25 stakeholders for interviews. Two persons declined the invitation
and three persons could not be reached to make an appointment. Twenty
stakeholders participated in this study. Thirteen of them were interviewed twice. Of
those who were interviewed once, three respondents replied to the overall summary
by mail or telephone. Two respondents indicated that they felt less involved with the
situation being addressed. Two respondents could not be reached for a second
interview. A summary of the respondents’ interpretative frames is presented in Table
8.1. Below, we present a summary of the discussions between the most important
respondents. 
Internist  
According to an internist, the main problem was that many intoxicated patients were
being admitted to a general ward or intensive care unit, while, in retrospect,
admission often appeared unwarranted. These hospital beds are scarce and expensive.
Unnecessary admissions might result from the unreliability of patients’ anamneses. It
is often unclear what patients have ingested, how much, and how long ago. Patients
are sometimes somnolent when they arrive at the hospital, or under- or overestimate
the amount of drugs ingested, sometimes deliberately. As a result, it is difficult to
assess the risk of complications. However, most auto-intoxications are considered
non-life-threatening. Furthermore, most drugs reach peak blood levels within a few
hours. On the basis of this, the internist argued that the solution to the efficiency
problem is to monitor the patient for a few hours in the emergency department. 
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Table 8.1. Stakeholders’ judgement towards a 6-hour observational unit, their problem definitions and underlying argumentatio
Actor Judgement of 
solution
Problem definition Background theories Normative values
Internist  + Patients’ risk is uncertain
Admission of intoxicated
patients is not always
necessary
Current hospitalisation policy
is inefficient.
Current policy on admission is too
defensive. 
Usually no severe complications
after intoxication.
Complications can be predicted
using clinical signs
Hospitalisation at somatic unit
adequate if physical complications
can be expected
Internist should
assess physical
risk and initiate
needed therapy
Risk assessment
based on actual
data
Physician
at ED**
 +
if central
monitoring is
available
Anamnesis is unreliable.
Patients risk uncertain
Observation in general ward
difficult at night: few nurses
and no technical apparatus
to monitor patients.
Suicidal act is often a cry for
attention 
Many patients have psychiatric
disorder
Some patients deliberately over- or
underestimate ingested amount. 
Patient with psychosocial problems
not at internal ward.
assess physical
risk and initiate
needed therapy
Intensive
care
specialist
at
teaching
hospital
 +
also other
interventions
needed
Sometimes admission to
intensive care unit
unnecessary.
Risk estimated by relatively
inexperienced physicians
Intoxicated patients not seen
by senior physicians.
Physicians in ER are in training for
internist 
Intensive care specialist is
specialised in care for critically ill
patients 
Lists of possible complications from
national expertise centre too
theoretical; might not occur in
practice. 
Use available
expertise.
Only patients
whose vital signs
are threatened
need to be
admitted at IC. 
Risk assessment
based on
experiences in
clinical practice.
Intensive
care
specialist
at general
hospital
+/-
medium care
unit available
Uncertainty about risks; both
somatically and in terms of
repetition of a suicidal act.
No problems perceived in
current situation (patients at
medium care unit)
Patient can over- or underestimate
amount of ingested medicines
For assessing risk of complications,
patients should be strictly
monitored
Safety
Exclude risks as
much as possible
Nurse at
ED
±
if separated and
have desinated
team of nurses
Patients can be aggressive
or agitated.
Care for these patients is
laborious; patients cannot be
left unattended. 
In an observational unit,
more routine patient care
tasks need to be done.
Suicidal act can be a cry for
attention.
Speaking with patients about
problems not considered as nursing
task.
Working in
specialised care
and high turnover. 
Head
nurses
ED
± 
if at separated
unit
Patient flow at ED is
suboptimal.
Physicians at ED have little
experience.
High turn over of patients at ER.
Usually, intoxications are of
comparatively short duration.
Sometimes observation can avoid
hospitalisation.
Efficiency and
adequate patient
flow. 
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Pharmaco
logist
±
measurements
of ingested
drugs more
adequate
Anamnesis is unreliable;
uncertain what was ingested
Hospital has no clear
structure for the disposition
of intoxicated patients.
For assessing the risk for
complications one should know
what and how much has been
ingested
Knowledge available on toxicity and
complications for specific medicines
Use available
expertise. 
Risk assessment
based on evidence
of the toxicity of
drugs.
Psychiatri
st at
teaching
hospital
 + If patients are hospitalized
they are seen the next
morning; patient less willing
to talk about the event and
family and friends usually not
present
Hospitalisation not optimal for
patients’ social situation.
Offer patients the
care they need. 
Aim of
consultation: to
understand what
happened
Psychiatri
st at
general
hospital 
-
no opportunity
for psychiatric
consultation at
convenient
moment
Patients not only have
somatic problem but also
may have psychosocial
crisis.
Patients will not remember
things discussed shortly after
event.
Psychosocial or psychiatric
care not well arranged.
After intoxication amnesia can
occur.
Consultation also a means to
arrange aftercare.
A suicidal event provides the
opportunity to evaluate patient
situation and therapy.
Patients have limited problem
solving ability
Prevent repetition
of suicide attempt 
Aim of
consultation:
arrange adequate
mental care
Clinical
psycholog
ist
- 
Other
interventions
needed:
Introduction of a
casemanager 
First
appointment
aftercare inside
the hospital.
Active outreach. 
There is little attention given
to patients who attempt
suicide.
Connection between acute
care in the hospital and
aftercare is suboptimal.
Continuity in care and care giver
can prevent repetition of suicide
attempt. 
Active approach from hospital and
care givers needed in preventing
repetition
Patients who attempt suicide have
increased vulnerability 
Discussing suicidal tendency can
be difficult and threatening for care
givers.
Prevent repetition
of suicide attempt.
Continuity of
health care
General
practitione
r
- 
Other
interventions
needed:Initiation
of care in
co-operation
with general
practitioner
Co-ordination of mental
after-care is suboptimal
Psychiatrists don’t have an
adequate overview of care patients
are receiving.
Insufficient communication between
primary health care and hospital
care
General
practitioner is
central dossier
holder.
Continuity of
health care
Employee
from
organisati
on
supportin
g
(ex)suicid
al patients
- 
Other
interventions
needed:
Central triage on
acute
(psycho)social
problems
Insufficient attention towards
patient problems.
Accessibility of psychosocial
care in acute situations is
limited.
Suicidal act results not only from
psychiatric disorder but also often
due to psychosocial problems. 
If problems are not solved,
repetition of suicidal attempt.
Patients more likely to talk about
problems with fellow sufferers 
Psychiatrist not most adequate
caregiver to talk to these patients. 
Provide solutions
to patients’
problems.
Give patients the
ability to speak
about their
problems.
* ‘+’ supporting a 6-hour observational unit; ‘±’ supporting if conditions are met; ‘-‘ opponent
** ED = emergency department
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ER physician 
The ER physician agreed that an observational unit could be useful, not only for
patients suffering from auto-intoxication, but also for other classes of patients, such
as those with head traumas. In fact, she argued that the general ward is an inadequate
location for monitoring a patient’s physical state due to the lack of apparatus to
measure blood pressure, heart rate, and respiration. Moreover, most auto-intoxicant
patients arrive during the evening or at night when only a few nurses are present in
the general ward. However, the ER physician pointed out another aspect
surrounding the care of suicidal patients. Some patients become aggressive, and do
not remain in their beds. Furthermore, the ER physician claimed that many patients
who intoxicate themselves have psychiatric disorders. Therefore, she argued, patients
who are somatically safe should be admitted to a psychiatric ward. An observational
unit for this class of patients requires additional measures to ensure the safety of both
patients and medical personnel.
Intensive care specialist 
An intensive care specialist agreed that the existing hospitalisation policy concerning
auto intoxication was inefficient. Due to the uncertainty with respect to drug intake
and risk, patients might be admitted to an intensive care unit too readily. However,
an observation unit in the ER does not necessarily solve this problem. In the ER,
patients are commonly seen by newly graduated physicians who have limited
expertise and experience. Therefore, the intensive care specialist emphasised that,
besides the introduction of an observational ward, persons involved in the
development of hospital policies should develop a clinical protocol concerning
diagnostic interventions to be performed, and experts to be consulted. 
Emergency department nurse 
ER nurses rejected the implementation of observation unit, should this unit be
located in the ER. They acknowledged the existing efficiency problem, but raised
several objections against the proposed solution. First, they argued that some patients
who have intoxicated themselves behave aggressively or become agitated, thus
disturbing the care of other patients. Secondly, most ER nurses are specially trained
to work in a dynamic, acute care environment. They prefer not to perform routine
nursing activities such as washing and feeding patients. For these reasons, an
observational ward should be located in a separate ward and a separate team of nurses
should be established to care for these patients. 
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Clinical pharmacist 
Thus far, all respondents agreed that the existing care for auto intoxicated patients
was inefficient, framing the problem similarly, but rather arguing that an
observational unit could be appropriate only under certain conditions. The first
interviewee to frame the problem differently was a clinical pharmacist. According to
him, the problem was that patients’ anamneses were unreliable and that referring
physicians lack the knowledge to adequately assess a patient’s prognosis. A better
solution would be to measure the type or amount of drug ingested by the patient in
the patient’s blood or urine. Using this information, a clinical pharmacist could
estimate the risk of complications. As well, the clinical pharmacist emphasised that
additional modifications were also needed to improve the care for intoxicated
patients. First and foremost, a multidisciplinary team should be established to deal
with these patients. Furthermore, physician knowledge regarding the diagnosis, and
treatment of auto intoxicants should be enhanced through education. 
Psychiatrist 
A psychiatrist also considered the implementation of an observational ward useful,
but like the pharmacist, he departed from another problem definition. If patients
have been hospitalised, the psychiatrist is called in for an evaluation the following
morning. The psychiatrist prefers to visit the patient as soon as possible after the
event, because he considers the patient more willing to speak about the situation
shortly after the event. Secondly, family members or friends are more likely to be
present in the evening, when most auto intoxications occur. Family or friends often
have useful information regarding the patient. The aim of the consultation is to assess
the suicidal risk and to understand what happened. According to the psychiatrist, an
observational unit would provide an opportunity to talk to the patient soon after the
intoxication. 
However, a psychiatrist from a general hospital considered it useless to have a
psychiatric consultation shortly after the event. Patients can be somnolent upon
arrival and later will not remember what has been discussed during the consultation.
Many patients have ingested benzodiazepines which may cause amnesia. According
to this psychiatrist, the aim of a psychiatric consultation is to assess the suicidal risk
and arrange adequate care. In his view, it is best to admit patients to a medium care
ward, where they are visited by a psychiatrist the next morning. He agreed that the
general ward was unsuitable, because patients could not be monitored adequately.
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The patients’ physical state may deteriorate and there is a risk of repetition of the
suicidal act. 
Clinical psychologist
According to a clinical psychologist, many caregivers have little affinity with these
patients and get irritated with them. Caregivers do not always understand when
relatively small problems result in suicidal acts. A negative attitude exhibited by a
caregiver affects the patient’s willingness to talk about his or her problems with a
psychiatrist. Another problem that the psychologist raised was that the connection
between hospital care and after-care for these patients is inadequate. Some patients
will not show up at outpatient consultations or community mental care clinics,
which is problematic as continuous care is considered necessary to prevent a
repetition of the suicidal act. In order to improve the continuity between acute
hospital care and after-care, active outreach measures should be used to encourage
patients to keep appointments and caregivers could come to the hospital to meet the
patients. 
General practitioner 
The general practitioner also perceived problems concerning the co-ordination of
after-care. Often, the psychiatrist arranges a new therapy, which sometimes interferes
with therapy a patient is already receiving. Furthermore, the psychiatrist is not always
adequately informed about previous, often unsuccessful, interventions. Mental
after-care should be arranged in co-ordination with other caregivers, including the
patient’s general practitioner, who keeps the general patient file.
Patient 
An employee from an organisation providing support to (post)suicide attempt
patients agreed that not all patients receive adequate care. Many patients do not want
to talk with a psychiatrist about their problems. They do not want to be labelled as a
psychiatric patient, or have grown disillusioned with psychiatric care. Although some
patients have a psychiatric disorder, the suicidal act usually results from psychological
and social problems. 
A patient who has been admitted to a psychiatric ward after treatment in the
emergency department does not remember anything from the emergency
department. The psychiatric ward provides him with a feeling of safety and security.
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At this ward, patients have the opportunity to talk about problems with some
fellow-sufferers, who empathise with the patients’ situation. 
Conclusions 
Based on the interviews, we drew the following conclusions:
1. The introduction of a six-hour observation unit was well supported within the
university hospital, under the condition that it is located in a separate unit and
equipped with its own, well-trained staff.
2. In order to improve patient care, arrangements should be made between
departments in the hospital and between hospital and primary (mental) health
care. These arrangements should be documented in (local) guidelines.
3. Currently, the psychiatric consultation targets different goals: acute care and
non-acute care. An observational unit might cause problems with non-acute
care, such as the arrangement of after-care. Possibly, the psychiatric
consultation could be split up with a consultation shortly after the attempted
suicide, and a later consultation, perhaps on the next day. A disadvantage of
this is that it is time consuming to see patients twice. Furthermore, it is
uncertain whether a patient will show up for the second consultation once
discharged. 
4. Relevant research questions were determined that concerned the efficiency of
an observational unit, as well as several issues concerning psychiatric care.
Would the implementation of an observational unit decrease the number of
unnecessary hospitalisations? Would the implementation of an observational
ward decrease the number of patients who are consulted by a psychiatrist?
Would patients remember or keep appointments that are made at the
observational ward? Would the implementation of an observational ward
decrease the number of patients who repeat a suicide attempt? 
Outcome: Interactive evaluation versus conventional approach
To assess whether our interactive problem structuring process had been useful, we
needed to compare our results with the results we would have obtained, had we used
a conventional approach. While the actual results resulting from a conventional
approach are based on conjecture, according to the internist who first presented the
problem to us, it is safe to assume that the problem would have been framed in terms
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of efficiency and unnecessary hospitalisations. Research would have focussed on the
efficiency of a six-hour observation at the ER. Already, we believe that we may point
out a few important differences.
Efficiency research improved 
Despite the fact that efficiency remains an important issue, and efficiency research
remains relevant, the interactive process led us to understand how to improve the
validity and usefulness of the outcomes. Efficiency research, especially when it is
comparative, rests on the assumption that both comparators are optimised and stable,
i.e. that they are no longer ‘moving targets’. As the interviews have clearly shown, in
our instance, this was not the case. Therefore, efficiency research is as yet premature.
The interactive problem structuring process yielded a broader insight into the
conditions under which a six-hour observation unit could be successful. In particular,
the arrangements between the departments involved, and the role of the psychiatrist
likely contribute to optimised care. The discussion on these issues has led to research
questions that, at this stage, appear to be more relevant than the question of
efficiency.
The first question raised through our research concerned the uncertainty
surrounding the patients’ anamneses and the associated risks. To ameliorate this
problem, two possible strategies were proposed: a) the introduction of an observation
unit; and/or b) a laboratory analysis and titre of patient blood and urine to determine
the kind and amounts of the drugs ingested. Few studies have been performed that
have followed a group of consecutive auto-intoxicant patients post emergency
treatment to calculate the risk for complications (Hollander et al., 1999; Meulendijks
et al., 2003). A six-hour period for monitoring patients is often mentioned in articles
or books on clinical toxicology based on pharmacological data. Most patients have
ingested benzodiazepines that are relatively non-life threatening when taken alone
(Meulendijks et al., 2003). In intoxicated patients, complications occurred within a
few hours after ingestion. (Arranto et al., 2003; Liebelt et al., 1997). In other medical
fields, observational units resulted in a reduction in the number of hospitalisations
(Martinez et al., 2001). Information from blood and urine drug screening can also
affect the decision regarding hospitalisation of patients after intoxication (Fabbri et
al., 2003). Identification of intoxicants, drug levels and patient observation are
considered to be complementary approaches (Kellerman et al., 1988; Perrone et al.,
2001). In only a few cases, however, did drug measurements result in a change in
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clinical practice (Kellerman et al., 1987). Apparently, in most cases, observation of
patients will suffice. Nevertheless, some drugs or combinations of drugs are associated
with a high risk of complications (tricyclic antidepressants), or have complications
that might occur long after ingestion (acetaminophen) (Neeleman & Wessely, 1997).
It is important to ascertain whether these medicines have been ingested.
The second question dealt with the most effective time for a psychiatric
consultation to take place. Previous studies have demonstrated lower immediate and
delayed recall in patients or healthy volunteers who had ingested benzodiazepines
(Verwey et al., 2000; Verwey et al., 2005). These data suggest that after 12 hours, and
even after 24 hours, patients remember little (Verwey et al., 2000). Should patients
be seen shortly after arrival (a few hours after ingestion) or the next day (less than 12
hours after ingestion)? Are the recall tests used in the above-mentioned studies
comparable to the information discussed during a psychiatric consultation, and are
the results transferable to the situation in our hospital? However, even patients who
have used different methods for their suicide attempts have had problems recalling
what they have discussed with their psychiatrist (Kerkhof, 1985). 
Different framing and resistance from stakeholders 
Another significant finding from our research is that a six-hour observation in the ER
would meet with resistance from the ER nurses. This is a critically important insight,
as the nurses’ resistance would have most likely led to poorer quality care.
Acknowledging this factor and adjusting the plans for a six-hour observation unit
before an efficiency research project is conducted will not only ensure a better quality
of patient care, but ensure the validity and usefulness of the research.
Our study supported the theory of argumentative policy analysis in that
different stakeholders frame the situation with respect to auto-intoxicated patients
differently. Importantly, the interactive process not only revealed differing problem
definitions and perceived solutions, but has also enabled us to uncover and describe
deeper levels of the respondents’ interpretative frames, i.e. normative and empirical
background theories, and preferences. Understanding why a stakeholder frames a
problem the way he or she does is important for determining if these stakeholders
will cooperate with implementing particular solutions. For example, factors such as
the lack of affinity with the patients felt by some stakeholders, or the normative
assumption that the hospital should assume full responsibility for the care of suicidal
patients (not only for the treatment of their physical intoxication), determined the
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view of stakeholders toward appropriate and acceptable changes in current practice. It
is difficult to imagine how failing to acknowledge these factors would not lead to
conflict, as the theory predicts, and how research that inevitably conforms to only
one particular view could be useful in such a context.
Auto intoxication in broader perspective 
The interactive process has lead us to recognise that in our study there was a marked
difference between the hospital and patient perspectives regarding the care for
patients after auto intoxication. The patient perspective dealt with offering integrated
care to optimise the pathway of care. These perspectives do not necessarily contradict
each other, but the patient perspective does lead to different research questions such
as those concerning psychiatric consultations and aftercare, aside from the question
of efficiency. Interviews revealed that in addition to the uncertainty surrounding the
ingested drugs and the risk of complications, other problems might threaten patient
care. Besides the treatment of the somatic problem, consideration should be paid to
the psychosocial or psychiatric problems underlying the suicide attempt. Many
studies on the management of these patients deal with either somatic (Jones, 1999) or
psychosocial care (Kapur et al., 2004; Kerkhof, 1985). Although these problems can
be discussed separately, our study demonstrated that the solutions to these problems
may interfere with each other. Some respondents emphasised the need for measures
to improve the continuity between acute care in the hospital and (mental) after-care.
Others discussed the possible consequences of a six-hour observation unit on the
usefulness of the psychiatric consultation. 
Discussion
The theory of argumentative policy analysis explains that a policy fails when it does
not match stakeholder views. We have embedded this theory in fourth generation
methodology, using the reconstruction of interpretative frames as our chief analytical
tool, to develop an interactive problem structuring process. We have used this process
to re-structure the problem of managing patients after auto intoxication, which we
assumed to be an ill-structured problem. That is, we assumed that the actors
disagreed on what information was needed and what norms were at stake. In such
cases, the analyst has an important role in defining the problem (Dunn, 1994;
Hisschemöller, 1993).
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The interactive methodology was useful in that it effectively made the divergent
problem definitions and underlying normative values transparent. Compared to the
traditional approach (evaluation in health care mostly assumes that the problem
concerns efficiency), problem structuring resulted in the identification of alternative
interventions and research questions. Even though efficiency remained an important
issue, the interactive process demonstrated that efficiency research was premature.
Questions that appeared to be more relevant were linked to the assumptions actors
had about the proposed intervention.
Only a few studies were found where the outcomes of interactive methods
were compared to the results of conventional methods. One problem with such
comparison is that the methodologies are based on different paradigms, each having
its own criteria for quality. Although it might be difficult to define which outcomes
are best, the relevance of the outcomes may differ. An interactive methodology has
been used in the evaluation of cochlear implants (Reuzel, 2004). This interactive
evaluation resulted in concrete policy recommendations supported by a wide range of
stakeholders. A previous study assessing the efficiency of cochlear implants did not
provide all the relevant information needed for policy decisions on this subject and
was strongly contested. As well,  it is difficult to compare the outcomes of studies
done in different situations. Grin and Hoppe (2000), compared the structuring of car
mobility problems in three technology assessment projects. They concluded that not
only the methodology used (interactive methods or not) affected the outcome, but
also institutional characteristics and context.
      
Validity of the interactive approach 
With regard to the validity of our approach, we would like to address the following
issues.
First, although we believe that the problem concerning auto intoxication is
now better structured than it was, we cannot tell with certainty whether the process
has been exhaustive and the problem structure may be further enhanced, perhaps by
involving still more participants.
Secondly, the role of the interviewer\moderator is critically important. Without the
interviewer’s creative role, the process probably would not have had enough impetus
to lead to a desired problem definition. However, in order to play this role, the
interviewer assumes the power to influence the process. As the responses to our report
are fairly favourable, we feel that the role of the evaluator has not been problematic in
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this case. However, the issue deserves more attention. This has been addressed it in
greater detail elsewhere (Reuzel et al., 2007).
Thirdly, it was difficult to bring the process to a closure, that is, to define the
boundaries of the problem. For example, was it valid to leave issues such as the
aftercare for patients and arrangements between caregivers inside and outside the
hospital out of the problem definition? We feel that it was. However, this is far from
self-evident, especially if the establishment of an observation unit has consequences
for the issues mentioned, as some participants argued.
Fourthly, the process has been too short to leave sufficient room for ‘vicarious
learning’ (Guba & Lincoln, 1989).  Moreover, learning processes were difficult to
trace, as during the first series of interviews some respondents anticipated the
viewpoints of other stakeholders, which were partially known to them. Usually,
participants in an interactive process learn, and on this basis adjust their views at all
levels of their interpretative frames. Guba and Lincoln trust that vicarious learning
eventually leads to congruence between the views of participants, or even consensus.
Regarding this subject, it is important to note the disagreement between the two
psychiatrists on when best to consult with the patient. We have tried to settle this
issue using the evidence available in the literature, but it remains uncertain whether
both psychiatrists could have lived with the outcome, should they both have worked
in our hospital. In this instance, the time allotted for the study has been too short to
reach congruence or consensus. Therefore, we have marked the issue as a further
research question and a relevant part of the problem. We considered this lack of
congruence valuable as it allowed us to identify this research question and
demonstrate the usefulness of our approach. We have not used the interactive process
to reach agreement about solutions for the care of auto intoxicated patients, but for
problem structuring. 
 
Conclusion 
Despite questions of validity, we believe that the interactive problem structuring
process has been a valuable project. It has significantly broadened and improved our
insight into the subject under investigation. As a result, our research efforts will be
better geared to information needs from persons involved and therefore more useful.
Moreover, we have gained a deeper understanding of potential resistance from
important stakeholders and now have the opportunity to acknowledge their
reasoning.
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C
urrently, the means by which the limited usability of Health Technology
Assessments (HTA) in policy making and clinical practice can be improved is
sought in strategies that advocate the active implementation of research
findings. In this thesis, an alternative hypothesis for improving the limited usability
of HTA was proposed. A possible explanation for the limited impact of HTAs is that
they do not sufficiently answer the questions deemed important by their potential
users, namely policy makers and health care professionals. This hypothesis, based on
the theory of argumentative policy analysis, contended that policy makers and
professionals often have different perspectives on the situation and therefore assess
interventions differently. If an evaluation of an intervention is to be relevant for
policy making, it should not be limited to the mere assessment of the intervention’s
outcome. Rather, it must also explore and discuss possible differences in the relevant
actors’ problem definitions, their underlying assumptions, and their normative values
(Fischer, 1999). In this thesis, a number of case studies have been analysed in an effort
to explore whether the insights put forth by the argumentative approach to policy
analysis can provide an explanation for the successes and failures of not only the
proceedings that are part and parcel to HTA but also the policy making that follows
an HTA.
The research questions included:
1. In cases where HTA research or the implementation of subsequent policy
measures failed, were the research findings or policy measures congruent with
the views of all actors involved? 
2. How does involving the policy’s target population’s influence the design of
policy research? Does their participation result in research findings or
subsequent policy measures that are congruent with the views of all actors
involved? 
3. What are the outcomes of an interactive process of problem structuring in
policy research, whereby the problem definitions, underlying assumptions, and
norms are analyzed and discussed? How does this impact the interventions
themselves, the criteria for success, and the research questions considered
relevant?
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Analyses of the Case Studies
Ill Structured Problems
Analyses of the case studies indicated that the actors involved, namely policy makers,
researchers, and policy’s target populations, did not agree on the kind of information
that was needed nor did they agree on which intervention was most appropriate.
They defined the problems for which solutions were sought differently and therefore
used different criteria to assess the intervention in question. These differences in
problem definition were the result of differences in the theoretical assumptions
(background theories) and normative values held by each actor. In accordance with
Hisschemöller (1993) and Dunn (2004), we contend that this resulted from the fact
that the problems were ill structured. There was no agreement with respect to what
kind of information was necessary and the actors held divergent normative values. 
In the case study on the use of mebeverine for the treatment of irritable bowel
syndrome (Chapter 3), policy makers requested information on the effects of the drug
and on the effects of a diet. Attempts to exclude the drug from the benefit package
failed due to discussions on the evidence relating to the drug’s effectiveness. A new
trial was expected to generate the knowledge that was lacking. A normative value of
the policy makers was that costs should be carried by the community only when the
drugs that had proven to be effective. For physicians, however, new evidence would
not change their prescribing patterns. They considered the frequent visits of
unsatisfied patients to be their greatest problem. They claimed that, mebeverine is
safe and effective in some patients and could therefore be prescribed, even if the
effects were a placebo effect. According to the physicians, prescribing a medicine was
important as it could help to maintain a good and cooperative relationship with the
patient.
In the case study investigating the use of epoprostenol and bosentan for the
treatment of pulmonary hypertension (Chapter 7), policy makers commissioned
research to generate the necessary information on the effectiveness of these two drugs.
A normative value in this case was that the use of medicines in specific patients
groups is only adequate if evidence on its effectiveness in those groups is available.
Assumption was that criteria related to the characteristics of an intervention, such as
efficacy, effectiveness, therapeutic value, and efficiency, are useful criteria for
determining whether or not an intervention should be reimbursed. However,
according to the researchers (in this case, the researchers were physicians), the
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problem was that the medicines were frequently prescribed to the wrong patients.
They claimed that the diagnosis was inadequate due to lack of experience and
expertise. Background theories that emerged were the condition pulmonary
hypertension is rare and the condition is often the result of other underlying
pathology. The researchers thus claimed that experience is needed to make an
adequate diagnosis. The researchers considered an adequate selection of patients
necessary to yield adequate prescription practices of the drugs. 
In the case study on intoxication (Chapter 8), it became evident that two
psychiatrists valued the observational unit differently. The psychiatrists had different
perspectives with respect to what defines an optimal situation and what the aim of
the psychiatric consultation should be. According to one psychiatrist, an
observational unit for intoxicated patients can create an opportunity to talk to the
patients shortly after the event. This psychiatrist also claimed that the psychiatric
consultation should be used to, firstly, assess if, and to what extent, the patient is
suicidal and, secondly, understand what happened. His colleague in another hospital
considered short admission at an observational unit impractical. He claimed that the
patient would not remember the agreements that had been made. Additionally, he
indicated that relevant caregivers from outside the hospital can rarely be contacted
when an intoxication incident takes place as this most often occurs outside of regular
work hours. The psychiatrist emphasised that, although a suicide assessment is
important, arranging adequate post-incident care for the patient must also be made a
priority. In the same case study, internists and clinical pharmacists agreed that the
uncertain anamnesis of intoxicated patients is a problem. However, their preferences
with respect to solutions varied. The clinical pharmacists claimed that measuring the
type and amount of ingested drugs is the only way to determine the risk of
complications while the internist claimed that observing the patient’s symptoms and
physical state is an adequate method of predicting the actual risk of complications. 
Answering the Wrong Question  
The fact that the health care problems were ill-structured was insufficiently
acknowledged in the case studies presented in this dissertation. As a result, the
problem definitions shifted during the research project and the implementation of
subsequent policy measures failed. Although research provided an answer to a
research question relevant from one point of view, this question was irrelevant to
either the commissioner of the study or the actors who need to cooperate on the
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subsequent policy measures. In essence, the research conducted answered the wrong
question. This is called a type III error (Dunn, 2004; Hisschemöller, 1993) and,
evidently, due to the type III error, the subsequent policy measures endeavoured to
solve the wrong problem.
Due to a shift in problem definition, the research results generated by a
preliminary study in the mebeverine case (Chapter 3) were not considered useful by
the commissioner. As a result, the intended clinical trial was not commissioned. In
the case study on the use of epoprostenol and bosentan for the treatment of
pulmonary hypertension (Chapter 7), the researchers redefined the problem because
they considered the initial definition inadequate. Once again, this redefinition was
not considered useful by the commissioner and the study was not commissioned. In
our case study on Cox-2-selective inhibitors (Chapter 6), the problem shifted in three
out of the four research proposals after a European tender for research proposals was
presented. This case study showed that the researchers were strongly oriented towards
standard medical rationality and practice and, at the same time, were inspired by the
methodologies they were used to apply.
In some other case studies, the focus was placed on why the implementation of
some policy measures based on the research results failed. It became evident that
policy failed because the target population defined the problem in such a way that
the applied interventions could not be considered a solution to the problem.
Alternatively, the interventions conflicted with the target populations’ normative
values. In the study on interferon-beta (Chapter 5), the actors agreed that
interventions could be useful. However, they did not agree that the implementation
of policy measures was needed to optimise patient care. Neither the Ministry of
Health nor the policy's target populations, namely the physicians and health care
insurance companies, considered the situation to still be problematic at the time the
policy was proposed. In the mebeverine case study (Chapter 3), the failure to
withdraw mebeverine was the immediate impetus for the research project. However,
whether the selected means, namely providing new evidence, could have prevented a
second policy failure remains questionable. It is unlikely that new evidence would
have provided a solution to the problems perceived by the target populations. In the
case study on lamotrigine (Chapter 4), a protocol on the use of lamotrigine had not
been successfully implemented. The protocol did not correspond with the normative
values of the neurologists in specialised centres on searching for adequate and new
therapies. 
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In many cases, the evaluation was limited to the level of what Fischer (1999) terms
verification. These evaluations focused only on measuring whether the intervention
met a set of defined criteria. In practice, however, we observed that actors disagreed
not only on what criteria or outcome measures were relevant but also on which
problem needed to be solved. 
       
Diversity
Variability in problem definitions was related to: a) differences in interpretive frames;
b) differences with respect to the context in which actors worked; and c) the
characteristics of the topic being investigated. In all case studies, differences in
interpretive frames were found between actors from the various disciplines. Relevant
actors included policy makers, physicians, and researchers. Differences were not only
found between actors from various disciplines, they were also found within a given
discipline. In the case study on care for intoxicated patients (Chapter 8), the
psychiatrists had different views with respect to the aim of the psychiatric
consultation and the relationship between the physician and the patient. These
differences in problem definitions were shaped by differences in theoretical
assumptions and normative values. 
Differences with respect to the context in which actors worked were also
found. In the case study on the use of Lamotrigine for the treatment of epilepsy
(Chapter 4), neurologists working in a general hospital and neurologists working in a
tertiary level epileptic centre treated different spectrums of the epilepsy patient
population and also held different treatment goals. The neurologists that worked in
the general hospital were restrictive in their prescription practices when it came to
prescribing the relatively new drug Lamotrigine. Most epilepsy patients receiving
treatment in the general hospital could be effectively treated using conventional
drugs. The neurologists therefore decided that the patients should not be exposed to
new drugs that may have unknown effects. In contrast, the neurologists at the
epileptic expertise centre treated patients with complex epilepsy and their views thus
differed from those of the neurologists working in the general hospital. Additionally,
in the case study on intoxication (Chapter 8), the available equipment differed. In the
general hospital a medium care unit was available. This affected the proposed
interventions to arrange adequate care for intoxicated patients. Furthermore, the
cases demonstrated that changes within the work environment affected the actors’
ideas regarding their responsibilities and their appraisals of the interventions. In both
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the case study on Interferon-beta to treat multiple sclerosis (Chapter 5) and the case
study on the new drugs for pulmonary hypertension (Chapter 7), the interventions
that had been proposed earlier were no longer considered meaningful by the actors’
after reorganisation because the proposed measures no longer belong to their task.
Lastly, many of the case studies dealt with topics that were difficult to define
for one or more of the following reasons: a) the projects dealt with indistinct diseases
whereby multiple theories about the underlying mechanism of the disease exist (i.e.
irritable bowel syndrome and multiple sclerosis); b) the diagnostic process for the
disease was complex (i.e. pulmonary hypertension and the risk assessment for
intoxicated patients); c) finding the optimal treatment for an individual patient was
difficult (i.e. irritable bowel syndrome, epilepsy, adequate care for patients who have
attempted suicide by intoxication); d) the disorders demanded multidisciplinary care
(i.e. in the case on intoxication, the patient required both somatic and psychiatric or
psychosocial care), or e) patients’ complaints could be attributed to multiple causes or
diseases (i.e. new analgesics, pulmonary hypertension, the underlying reasons for the
suicide attempt). These difficulties related to the topic in need of investigation are
frequently dealt with as uncertainties. In many cases, research was commissioned in
an effort to decrease the uncertainty. However, disagreement among experts will
remain existent, because they are arguing from different premises (Schwartz &
Thompson, 1990).
Problem Structuring
In order to avoid answering the wrong question, it is imperative that we engage in a
more explicit and extensive process of problem structuring whereby the different
perspectives are taken into account. As suggested by Fischer (1999), a full evaluation
should include an assessment of actors’ problem definitions and their underlying
argumentation. In the case studies presented in Chapters 5, 6, 7, and 8, the target
populations had been involved so that their perspectives would be taken into
account. However, the results of these studies suggest that participation of
stakeholders is insufficient for estimating the likelihood of successful policy
implementation (interferon-beta, chapter 5). Compiling an inventory of the target
populations’ problem definitions parallel to commissioning specific research was also
insufficient. In the studies presented in Chapter 6 and Chapter 7, the target
populations were consulted in a part of the study. However, they were not given the
opportunity to influence the problem definition nor were they able to impact the
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direction in which solutions would be sought. Although the fact that the actors may
define the problem differently was acknowledged, our findings indicated that the
PAM staff’s definition of the problem had the most influence on the kind of
knowledge sought through research.
In Chapter 8, we found that an interactive methodology based on the model
for fourth generation evaluation (Guba & Lincoln, 1989) was useful in that it
effectively made the divergent problem definitions and underlying normative values
transparent. In the study reported in Chapter 8, the interactive process of problem
structuring yielded a much broader insight on the conditions under which an
intervention, a six hour observation unit, could be successful. In comparison to the
traditional approach, problem structuring resulted in the identification of alternative
interventions and research questions. Even though efficiency remained an important
issue, the interactive process demonstrated that efficiency research was premature.
Questions that appeared to be more relevant were linked to the assumptions actors
had about the proposed intervention with respect to the uncertainty surrounding
patients' anamneses and associated risks and/or the most adequate moment for
psychiatric consultation.
If an interactive approach had been applied in the other case studies, the
proceedings of the studies could have been quite different. In the case study on the
use of Epoprostenol and Bosentan for the treatment of pulmonary hypertension
(Chapter 7), an interactive approach could have made it possible to obtain evidence
that was relevant to both perspectives. For example, both the effectiveness in certain
groups of patients and the efficiency of the whole process of diagnosis and treatment
could have been evaluated. With respect to the health care problem concerning
treatment for patients with the irritable bowel syndrome (Chapter 3), acknowledging
the differences between patient subgroups and understanding the potential
mechanisms underlying the complaints could have been highly advantageous. In the
absence of convincing evidence on specific therapies for identifiable subgroups of
patients, identifying the best treatment for an individual patient in a standardised
way, for example by means of N-of-1 trials, may be necessary. These suggestions
correspond with the problems as defined by the physicians and could have potentially
led to prescription practices whereby patients who are likely to benefit from
Mebeverine are given the prescription and patients who are unlikely to benefit are
not given the prescription.
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For a full evaluation, an analyst should aim to identify the various problem
definitions and make the underlying assumptions and normative values transparent.
If actors' interpretive frames are insufficiently congruent, the underlying assumptions
should be discussed. It is even worthwhile to make the nature of this incongruence
the topic of research. The methodology of reconstructing interpretive frames (Grin et
al.,  1997) is adequate in not only elucidating the viewpoints of individuals but also
assessing the degree of congruence in perspectives (Chapter 2). Additionally, the
classification of problems according to Hisschemöller (1993) can help to determine
what kind of research is needed. If a problem is well structured, current HTA methods
can provide evidence that the actors can agree upon. In these cases, researchers assess
whether or not the defined criteria are met by the intervention (verification). When a
problem is ill structured, problem definitions and underlying argumentation should
be discussed (as will be further discussed below). This corresponds with the levels of
validation and vindication (Fischer, 1999). In other words, assessing the degree to
which a problem is structured can enable effective decision-making and helps to
decide at which level of Fischer's model the evaluation should take place. In this
alternative approach to evaluation, it is not the specific intervention that is the main
objective. Rather, it is the problem for which a solution is sought. By applying an
interactive methodology, we make it possible to pay attention to diversity in
perspectives and situations. In many schemes on evaluation or policy research,
assessing whether a programme meets criteria is only a part of the whole process or
approach. In the context of policy analysis, Dunn (2004) has placed significant
emphasis on the problem structuring phase. Conventional HTA methods are limited
to one of the phases of policy research (methods used during the ‘recommendation’
phase). In conducting a problem oriented HTA, we can learn from the examples of
argumentative (also called interpretive) methods put forth by Grin & van de Graaf
(1996b), Grin et al., (1997), Yanow (2000) and Reuzel (2001). The elaboration of this
problem oriented approach to HTA is provided in paragraph ‘recommendation’
following a short reflection on the case studies and a brief discussion of some relevant
aspects characteristic to this argumentative approach.
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Reflections
Limitations of this Study
The aim of this study was to explore whether the theory of argumentative policy
analysis could provide an explanation for the limited applicability of HTA results. In
order to explore the hypotheses in different contexts, the case studies were chosen so
that they would differ on several variables. The case studies dealt with either failed
policy research, failed implementation of policy measures, or cases in which lessons
learned were incorporated to prevent failure. The cases also included different forms
of medical expertise such as primary care, hospital care or both. Additionally, the
cases involved problems arranged within a regional context (i.e. one hospital) or at a
national level. 
Unfortunately, no case studies in which policy research resulted in the
successful implementation of policy measures were included. In two prospective case
studies (new analgesics in Chapter 6 and the drugs Epoprostenol and Bosentan in
Chapter 7), some of the lessons learned from previous studies were incorporated.
However, the time frame of these studies was too short to thoroughly assess the
consequences of the implemented changes. Furthermore, some comments can be
made on the approach taken in these cases (see above, paragraph ‘problem
structuring’). Additionally, in the case on care for intoxicated patients, the proposed
observational unit has, to date, not yet been implemented. At the time of the
evaluation, it was already clear that the implementation of an observational ward
would not be implemented prior to the realisation of a new hospital building. As a
result, clear evidence on the surplus value of the argumentative approach in terms of
the successful implementation of policy measures cannot yet be determined.
Nevertheless, this study did provide us with several insights that suggest that the
argumentative approach is a promising means of improving the link between an HTA
and its users. As discussed above, an interactive process of problem structuring was
successful in assessing the degree of congruency. It also generated outcomes other
than those yielded by a more conventional approach (Chapter 8). Some lessons can
be learnt but further research is needed so that the limitations and difficulties of this
approach can be dealt with effectively. 
        
Reflections on the Theory of Argumentative Policy Analysis 
Although the theory provided an adequate framework for explaining both the
proceedings of research projects and the subsequent policy measures, we identified
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some difficulties that manifest when an argumentative approach to policy
development is applied. 
Firstly, we observed that changes in the policy context negatively affected the
project on Interferon Beta (Chapter 5) and the project on drugs for pulmonary
hypertension (Chapter 7). Shifts in the Health Care Insurance Boards responsibilities
created a situation in which the proposed policy measures were no longer considered
relevant. As a result, the projects ended without solving the problem. In these
research projects, it appeared difficult to anticipate these political changes. Possibly, if
the approach to the problem had been broader, it may have been possible to deal
with the changes in the political context. However, time and resources are all too
often limited thereby making it difficult to redefine the problem when some steps
have already been taken, as was the case in the study on pulmonary hypertension
(Chapter 7). In both case studies, the actors’ reactions to the changes in context were
dependent on the actors’ interpretive frames. Each actor assessed the consequences of
the actual changes and took action according to this assessment. Obviously,
predicting the way in which changes within the context will affect the proceedings of
policy development is difficult. It is thus imperative that the analyst learn how to
handle these changes effectively. 
Secondly, we noticed that some difficulties presented when changes in the
process of commissioning research were implemented (Chapter 6 & 7). The main
assumption of the argumentative approach is that policy making is a process of co-
production. The adoption of an argumentative approach strongly depends on the
willingness of the actors to learn from one another and the various perspectives put
forth by other actors. The results indicated that policy makers were not always open
to the suggestions and perspectives of the target populations. When policy makers
noticed that target populations or the researcher had not "understood" what they
wanted, they often decided not to commission the project or they discontinued the
research project (Chapter 3 on Mebeverine, Chapter 6 on new analgesics, and
Chapter 7 on pulmonary hypertension). In the case study on the use of new
analgesics (Chapter 6), researchers questioned the acceptability of the research
project’s outcome. While the staff members of the Health Care Insurance Board
requested that the researchers analyse target groups problem definitions, they also
requested that the researchers generate the knowledge they considered most relevant.
Evidently, these two requests conflicted. Apparently, it is not obvious to apply a
problem oriented approach. This is partly due to the fact that actors are often
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suspicious of the perspectives of others. Schön and Rein (1994) referred to Habermas
who stressed that discussion can only take place when actors have freedom, openness
and equality in dialogue. Clearly, domination of any one perspective inhibits
dialogue. Unfortunately, having freedom, openness and equality in dialogue is an
ideal situation that is very difficult to create in practice. For example, we observed
strategic behaviour among stakeholders in the project on policy measures for
Interferon Beta use (Chapter 5). Eliminating strategic behaviour is practically
impossible. A procedure is needed that makes it possible to deal with this strategic
behaviour in a sound way. 
Evidently, the difficulties relating to the application of an argumentative
approach, namely changes in the context, limited willingness to learn from one
another and strategic behaviour, demand that conditions be placed upon the
procedure and the role of the analyst. This is discussed further below (paragraph ‘The
role of the researcher’)
        
The Need for Interaction and Learning
Although the reconstruction of interpretive frames through one interview can assess
the degree of congruence in perspectives (Chapter 2), it cannot predict the actions of
the actors. When congruence in the perspectives (problem definitions, underlying
assumptions and norms) is insufficient, a process of learning needs to take place. This
learning may include considering another solution, redefining an actor’s problem
definition, or adapting an actor’s background theories. Learning between actors that
hold divergent interpretive frames aims to construct congruent meanings.
Congruence is necessary for the identification of interventions that are broadly
supported. It is also necessary for the elicitation of cooperation from all actors
involved. The results of the case studies have demonstrated that involving actors and
target populations without discussing their problem definitions and underlying
assumptions prior to the selection of interventions is insufficient (Chapter 5, 6, and
7). Reaching for consensus by creating shared problem definitions or shared values is
not necessary (Grin & van de Graaf, 1996a). Grin and van de Graaf (1996a) have
provided some conditions for learning between actors. They distinguished between
first-order learning (learning related to assessments of solutions and problem
definitions) and second-order learning (learning related to assumptions and
background theories). Discussing problem definitions and underlying assumptions
during interaction (frame reflection) can result in a redefinition of problem
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definitions and their underlying assumptions (reframing) (Schön & Rein, 1994).
According to Guba and Lincoln (1989), the occurrence of learning within or between
participants during an interactive process is one of the main criteria for its success.
Learning does not only imply a change in perspectives, but also the
acknowledgement of each others point of view (Reuzel 2001). Learning can take place
between respondents in an interactive process. Alternatively, measures can be
implemented to in an effort to attain learning in certain (target) populations (Grin &
van de Graaf, 1998). 
Interaction between stakeholders enables us to judge the validity of the claims
that play an important role in the interactive process. When actors disagree, deciding
which perspective should be changed is difficult. Many questions arise: Should policy
makers change their perspective when interviews reveal that the target population
holds different views towards the situation? What must be done when the target
population does not perceive problems for which changes are needed? Should target
populations then change their perspective? In the case study on the use of
Epoprostenol and Bosentan for the treatment of pulmonary hypertension (Chapter
7), policy makers asked if there was enough evidence on the effectiveness of the
medicines while physicians believed that an adequate diagnosis was also needed. In
the case study on the use of new analgesics (Chapter 6), policy makers defined the
problem in a one sided fashion and this resulted in dismissive reactions from the
field. Physicians did not consider their prescription practices of the new analgesics to
be problematic. Nevertheless, at a national level, many off label prescriptions were
observed and the drugs appeared to be less innocent than previously thought thereby
leading to the withdrawal of the drugs from the market. Schön and Rein (1994)
remarked that there are no independent criteria that can be used to judge whether
frames are right or wrong. Judging an actor’s assumptions is limited to assessing its
coherence and verifying the theoretical assumptions. Alternatively, we can endeavour
to reach a shared perception and agreement on a specific situation. Attempting to
understand the perspectives of others by translating one frame to another is one
potential method by which this can be done. Actors themselves can seek mutual
understanding and thereby create shared frames (Schön & Rein, 1994). One should
be able to place the perspective of another on a given situation in one’s own frames.
This idea corresponds with Habermas’ concept of  'communicative action', which is
an act of speech that is oriented towards mutual understanding (Outhwaite, 1996, p.
160) The goal of communicative action is to enable one or more persons to reach an
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understanding. However, frame reflection does not always lead to a reframing of the
problem and reframing does not always lead to a resolution of the problem (Schön &
Rein, 1994). Sometimes controversies can be resolved at a practical level.
Interventions that provide a solution for quite different problems and different norms
can be identified. In the case study on intoxication (Chapter 8), the six hour
observational unit was considered useful for numerous problems relating to various
normative values. For internists, the unit was seen as an opportunity to monitor
patients and therefore a means by which the risk of complications could be decreased.
For psychiatrists, the unit provided an opportunity to talk to the patient shortly after
the event. 
Lastly, it is important to note that sometimes external factors can help to
define the scope of the analysis. In general, the level of freedom with which the
commissioner can act strongly affects how the analysis is defined. For example, in the
projects initiated by the Health Care Insurance Board, its mission determined the
range in which the definition of problems and the identification of solutions could be
discussed
       
The Role of the Researcher
A problem oriented approach impacts the role of HTA researchers. This approach
requires the analyst to take an active part in defining the nature of the problem
(Dunn, 2004). HTA researchers should enlighten and inform policy by helping
surface the diversity of socioethical issues that may affect individuals and society
(Lehoux et al., 2007). It is the researchers’ task to analyse the problem and the degree
to which actors agree. If actors disagree, the analysts must structure the problem in
such way that it is manageable. To do this, researchers should reconstruct arguments
and moderate the discussion. As a mediator, the analyst can create a climate in which
actors with different perspectives are stimulated to rethink their interests (Schön &
Rein, 1994). The researchers can then verify the arguments put forth by either
consulting other sources, such as the literature, or confronting the actors with each
other’s arguments. As demonstrated in Chapter 6, this role is often difficult.
Additionally, many researchers are incline to resist this role as they often hold strong
views on how they should relate to other actors. Consequently, applying an open,
problem oriented approach can be difficult. In the project on intoxication, one
specific intervention, namely the six hour observational unit, received significant
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attention right from the start. The underlying assumptions were made transparent
but these assumptions could have been discussed more explicitly.
Alternatively, policy makers can play a role in problem structuring. This,
however, can be problematic as policy makers are often stakeholders with vested
interests. In the case studies on the use of COXIBs and Epoprostenol, the
commissioned research was strongly affected by the HCIB’s preferences with respect to
the intervention. Unfortunately, HCIB’s preferences led to dismissive reactions from
both researchers and health professionals. 
Recently, many authors emphasise a dialogue between researchers and users to
improve research utilisation (Millbank, 2000; Moynihan, 2004; Hivon et al., 2005;
Elliot & Popay, 2000; McGregor & Brophy, 2005; Levin et al., 2007). Schön and
Rein (1994) have argued that collaboration between academics, (policy) designers,
and practitioners is imperative. They proposed consultative policy research in which
the researcher helps practitioners to generate usable knowledge. The researcher can
help practitioners in two ways. Firstly, the researcher can aid the process of frame
reflection by reconstructing the interpretive frames. Secondly, he or she can help
practitioners to create conditions for mutual trust, which is essential for processes of
learning and reaching agreement.
Several difficulties that the analyst must deal with during the interactive
process have been mentioned (paragraph ‘reflections on the theory of argumentative
policy analysis’). Nonetheless, the interactive research methodology does provide
opportunities to deal with power differences and strong identities. Criteria for a
sound interactive process have been presented by Guba and Lincoln (1989) and
elaborated upon for interactive Technology Assessment by Reuzel (2001). Important
elements of an interactive analysis include: individual interviewing, discussing
respondents’ utterances anonymously, and engaging the analyst as a moderator
between all participants. Clearly, the analyst can play an active role in redressing
power differences (Reuzel et al., 2007). In order to increase the rigor of the analysis,
the analyst's role should be made transparent and ownership should be left to the
participants of the interactive process.
       
The Role of Scientific Evidence
Evaluation should not be limited to the assessment of the intervention’s outcomes
but should also discuss the differences in problem definitions and underlying
assumptions. The kind of information needed and how that information will be used
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depends largely on the degree of problem structuring and the kind of changes that are
needed. Sometimes it is more appropriate to assess the assumptions behind certain
interventions or problem definitions. Although, in the context of the project on
intoxication (Chapter 8), prior research was concerned with the evidence relating to
the cost effectiveness of a six hour observation, the interactive analysis indicated that
evidence on the effects of drugs for amnesia was equally important for implementing
the unit. Empirical research is thus not restricted to measuring the outcome of
interventions in terms of defined criteria. The theoretical assumptions on how an
intervention can provide a solution to a problem and how the intervention can
contribute to the final goal must also be considered. The outcome of evaluations
should be used more frequently for interpreting the relationship between the
intervention, the mechanisms that make an intervention work, and its context
(realistic evaluation; Pawson & Tilly, 1997). 
Another consequence of applying an problem oriented approach is that
scientific evidence is no longer the only source of knowledge that governs the
direction of evaluation and subsequent policy measures. Current ideas on the use of
research results promote the direct application of specific outcomes to a specific
intervention, change or implementation. However, Weiss demonstrated that the
direct use of evaluation (instrumental use) in decision rarely takes place (Weiss, 1980;
Weiss & Bucuvalas, 1980). More often ‘use’ includes processes such as the
understanding of programs and gaining new ideas and insights (conceptual use).
Moreover, many policy actions do not imply concrete decisions, but involve a set of
small uncoordinated steps of decisions. It is more likely that new evidence from
research is used conceptually by redefining problem definitions or assumptions that
are part of an actor’s background theories. Because information competes with
experiential and epidemiological knowledge as well as pathophysiological insights, the
direct application of new evidence is unlikely to occur.
Recommendation: More Emphasis on Problem Analysis in HTAs
Conventional HTA methods need to be embedded in a more problem based
approach, whereby an extensive process of problem analysis must take place prior to
the design of research projects. The aim of an HTA would then be to assess the level
of problem structuring and the type of research needed to deal with this problem.
When problems are well structured, conventional HTA methods are adequate for
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providing the necessary knowledge. When problems are ill structured, interactive
research methods are needed to structure the problem and identify broadly supported
interventions and changes. Thus, by taking into account the problem definitions of
actors involved and their underlying arguments, assumptions and values, the
approach becomes problem based. This kind of approach results in an evaluation that
takes contextual considerations and the heterogeneity of the situation and
perspectives into account. 
However, there may be a gap between the theoretical ideal of the
argumentative approach and the practical possibilities in HTA research. A number of
factors do affect the actual potential of using HTA in a problem based manner. These
factors include the amount of time available to conduct the study, the expertise
needed, and the willingness of actors involved to have an open attitude to alternative
problem definitions and solutions. Furthermore, the current structure for funding
HTA studies may also serve as a limitation. Attaining funding for a problem analysis
prior to conventional research is difficult. Furthermore, a problem based approach
may result in uncertainty regarding the results of the study. Therefore, the following
practical method for preventing type III errors (solving the wrong problem) is
recommended: The process of HTA research should be divided into three phases,
namely 'problem analysis', 'problem structuring' and a 'knowledge provision'.
Following this, all researchers should assess the level of structuring needed to improve
the usability of their study results. This approach is comparable to the 'usable
knowledge' approach posited by Hoppe & Grin (2000). 
The question remains whether a process of problem analysis is sufficient to
reconstruct the perspectives (problem definitions, underlying assumptions, and
values) of the actors involved. In order to reconstruct a problem definition and the
assumptions that underlie that definition, interaction between actors may be
necessary. The concept of "reconstructing" suggests that an actor’s problem
definition is not a given fact that can easily be measured. Sometimes people will give
the issue additional consideration when confronted with another perspective.
Alternatively, an actor may redefine his or her perspective when confronted with
alternative views. As discussed above, an important goal of interactive research is
changing perspectives. This too needs to be explored further. In conclusion, despite
the possible limitations of the approach, I contend that an explicit process of problem
analysis that takes the perspectives of relevant actors into account prior to actual
research is imperative. 
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Argumentative Problem Analysis
Prior to conventional HTA research, one should identify which actors are involved,
who needs to cooperate on possible interventions and who is likely to experience the
consequences of the intervention. The following step is the assessment of how these
actors define the problem and judge the interventions. Based on this information, an
estimate of the level of problem structuring (ill, moderately, or well structured
problems) should be made. The level of problem structuring will then determine the
kind of research or intervention needed to solve the problem(s). When the problem is
well structured, conventional HTA methods can be used to generate the requested
information. When problems are ill structured, the problem should be structured
actively so that agreement can be reached on the criteria for success and the kind of
interventions that should be implemented. For this purpose, the interactive HTA
method is appropriate. This method should be performed by analysts with sufficient
experience in using these methods so that the results generated are valid. The
question is, how can we, with minimal effort, get a good impression of the level of
structuring? The case studies in this thesis revealed a number of variables that can
effectively serve as an indicator for ill structured problems. Factors that were
associated with diversity included (mentioned above) the involvement of actors from
various disciplines, the existence of different perspectives and theories on the
underlying causes of the disease being subject to evaluation, and differences in the
contexts in which actors work. 
Yanow (2000, p.22) has provided the following steps for interpretive analysis:
a) identify artefacts that are carriers of meaning for a given policy issue; b) identify
communities of meaning/practices that are relevant; c) identify the (discourses(; d)
identify the points of conflict and their conceptual sources; e) develop interventions,
such as showing the implications of different meanings or mediating and intervening
to bridge the differences. Grin et al. (1997) have developed a handbook in which
steps for an interactive Technology Assessment are presented. Using these models as a
basis, the steps to be followed in a problem based, argumentative approach in HTA
are identified and presented in Table 9.1.
Recommendations for Practice and Future Research
Although a number of aspects require further exploration, some recommendations
can be made. All HTA researchers should be able to perform an extensive process of
problem analysis. Problem analysis should involve the identification of potentially
divergent definitions of the problem for which a solution is sought. In HTA
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education, courses on how people frame problems and on how this can lead to
different perspectives should be provided. Furthermore, the methodology of
reconstructing interpretive frames should be taught as a tool for problem analysis and
assessing the degree of congruence in perspectives.
Expertise on interactive methodology is needed for adequate problem
structuring when problems are ill structured. So, in addition to including experts on
economics or quality of life, multidisciplinary groups in HTA departments should also
include experts on interactive methodology. Alternatively, multidisciplinary working
groups can be formed around research projects in which experts in interactive
methodology are also included. 
Commissioners, policy makers, and funding institutes should demand a solid
problem analysis in research which should then be extensively described in research
reports. In order to generate adequate reports, the criteria for policy issue papers
developed by Dunn (2004) could be applied. Possibly, one could organise a limited
number of pilot projects.
Based on the discussion above concerning the distinction between policy
analysis and problem structuring, some questions remain unanswered. A comparison
between the outcome of an ‘argumentative problem analysis’ and ‘interactive
problem structuring’ using the methodology described by Guba & Lincoln (1989)
should be made. Relevant questions could include: a) is it possible to reconstruct
actors underlying background theories and normative values to an acceptable level
during problem analysis?; b) when a problem analysis is conducted with a limited
number of respondents, what are the chances that some relevant perspectives will be
missed?; c) will this complicate implementation?; d) is it possible to assess the level of
structuring during a problem analysis in which only a limited number of stakeholders
participate without interaction and discussions regarding the underlying arguments?
Another important research question is whether HTA projects in which argumentative
problem analysis have been performed actually result in the successful
implementation of policy measures that indeed solve the perceived problem(s).
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1. Identify stakeholders:
a. actors who's co-operation is needed
b. actors who might experience consequences 
2. Identify their definitions of the problem
a. Include a limited number of stakeholders that might have different
perspective (based on expertise or context in which they work)
b. Identify which criteria are considered as relevant
c. Identify what should be changed in current practice
3. Identify underlying assumptions, arguments and values
a. Assumptions on mechanism behind disease and intervention
b. Arguments concerning own task and aim of treatment
4. Assess the degree of structuring
a. is the problem well-structured, moderately structured or ill-structured
5. Action:
a. Show implications of different interpretations
b. Identify the type of research that is needed
i. well-structured problem: identify solution and possible
research questions (conventional methods, such as cost-
effectiveness analysis; RCT)
ii. ill-structured problems: reach for agreement on problem
definition and interventions (interactive methods, interactive
Technology Assessment)
c. Apply or commission requested empirical or interactive research
Table 9.1. Steps in problem oriented HTA
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CI Cochlear Implant
COXIBs Cox-2 selective inhibitors 
ER Emergency room
HCIB Health Care Insurance Board (Dutch: College voor Zorgverzekeringen,
CVZ)
HTA Health Technology Assessment
IBS Irritable bowel syndrome
IFNß Interferon-beta
MS Multiple Sclerosis
NSAIDs Non-steroidal anti-inflammatory drugs 
PH Pulmonary hypertension
PAM (department of) Policy Analysis of Medicines (Dutch: Beleidsonderzoek
geneesmiddelen, BOG)
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Summary
Improving the usefulness of Health Technology Assessment
This thesis addresses the problem of the limited impact of Health Technology
Assessment (HTA) research on health policy and clinical practice and investigates the
ways by which we can improve the usability of research for health policy and clinical
practices. HTA is a type of policy research that aims to provide information
concerning medical technologies in order to support health care decision making.
Although, in many cases, HTAs appear to affect health care decisions, their actual
contribution has been frequently debated. Currently, two solutions that seek to
increase the applicability of research are being instituted, namely the standardisation
of research methods and the active implementation of research findings in clinical
practice. An alternative explanation for the limited impact of HTAs is that they do not
sufficiently answer the questions deemed important by their potential users, namely
policy makers and health care professionals. This alternative explanation is based on
insights from the theory of argumentative policy analysis. This theory provides a
possible explanation for the failed implementation of policy measures. The
development and implementation of a policy is shaped by the interactions between
all actors involved. The basic idea of the argumentative approach is that actors'
behaviours can be explained by different views on a problem and the argumentation
behind these views. The way in which a problem is defined depends on the
assumptions the actors have about the situation and their beliefs regarding what is
considered good practice (normative values). The implementation of policy measures
may only be effective if implementers and target populations consider the proposed
policy measure to be meaningful. The latter implies that the proposed policy 1) must
make sense in light of their perception of the problem and 2) does not violate their
normative values. 
Evaluation is usually restricted to assessing whether a specific programme or
intervention has, or has not, fulfilled the programme objectives. According to Frank
Fischer, the main problem is that such evaluations fail to take into account the
underlying assumptions and normative values which influence the evaluation of
specific interventions. The outcome of an evaluation depends heavily on the criteria
used to evaluate it. Which outcome measures are relevant depends on how the
problem is defined and the purpose of the improvement. Fischer presented a
framework for including empirical and normative concerns in evaluation. A full
evaluation should not only include an assessment of the effectiveness of an
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intervention but also an assessment of the more general assumptions and normative
values.
HTA might not adequately take into account the possible difficulties that result
from divergent problem definitions resulting from differing assumptions and values.
Current HTA methods are adequate for solving well-structured problems, when actors
agree on what information is required and which norms are at stake. When actors
disagree on the nature of the problem, what information is required, and which
normative values are at stake, the problem is ill-structured. If the problem is ill-
structured, conventional research methods might lead to the over-simplification of
the problem.
In this thesis, I will explore the hypothesis that it is imperative to consider the
stakeholders’ perspectives, even when dealing with technologies that initially appear
to be less controversial. The main questions to be answered are:
1. In cases where HTA research or the implementation of subsequent policy
measures failed, were the research findings or policy measures congruent with
the views of all actors involved? 
2. How does involving the policy’s target population’s influence the design of
policy research? Does their participation result in research findings or
subsequent policy measures that are congruent with the views of all actors
involved? 
3. What are the outcomes of an interactive process of problem structuring in
policy research, whereby the problem definitions, underlying assumptions, and
norms are analyzed and discussed? How does this impact the interventions
themselves, the criteria for success, and the research questions considered
relevant?
Methodology: reconstructing interpretive frames
A central method in this approach is the reconstruction of someone’s interpretive
frame: someone’s judgement about an intervention, problem definition, underlying
background theories, and normative values. This model aims to explain people’s
acting and assess the likelihood of people’s cooperation prior to the implementation
of interventions. In chapter 2, the concepts of validity and reliability in relation to
this method for analysis are discussed. We presented data concerning the inter-
observer agreement of this method for analysis. Reconstructing interpretive frames
from verbatim transcribed interviews seems reliable to assess the cooperation of
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respondents on proposed solutions. Thus, the method is useful for identifying widely
endorsed policy interventions. The method is less reliable when it comes to
identifying relevant issues raised by the respondents and the most important problem
definitions, at least with analysts not involved in data collection. 
Retrospective analysis of research projects
In the next three chapters, case studies are presented in which policy research or
subsequent policy measures had failed. The case studies consisted of research projects
that were commissioned by the Department of Policy Analysis of Medicines (PAM) of
the Dutch Health Care Insurance Board (HCIB), an advisory board for the Ministry
of Health. Based on document analysis and interviews, the interpretive frames of
actors involved were reconstructed. Aim was to assess whether research results or
policy measures were congruent with the problems as perceived by actors involved
and their (normative) background theories.
The first case dealt with a project on the drug mebeverine for patients with the
irritable bowel syndrome (Chapter 3). Prior to this project, measures to exclude the
drug from the health package had failed. Stakeholders disagreed whether the drug
fulfilled the criteria to qualify for reimbursement. Research was expected to provide
the lacking knowledge. Due to differences in interpretive frames, however, the
problem definition shifted during a preceding project on the design of the requested
trial. The proposed trial did not fit the problems of the commissioners of the study.
However, even if a shift in problem definition could have been prevented, it is
questionable whether the requested trial could have prevented failed policy decision a
second time. The proposed research did not correspond with the problems perceived
by physicians and patients. The funding and usage problems relating to mebeverine
were ill-structured. Actors disagreed on the information needed and the norms at
stake. Unfortunately, researchers and policy makers did not acknowledge that the
problem was ill-structured. As a result, the problem definition shifted during the
research project and the subsequent studies endeavoured to answer the wrong
question. 
The second case dealt with a guideline on the use of lamotrigine set up by the
HCIB (Chapter 4). A survey had shown that only a minority of neurologists were
familiar with the guideline, and even fewer applied it in practice. The proposed
guideline was based on the expected improper use of lamotrigine and aimed to
restrict use to patients with refractory epilepsy. The guideline was based on the
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available evidence from clinical trials at that time. The results from this study indicate
that the problem definitions of policy maker and practising neurologists differed
widely, and that the policy measure was conflicting with certain professional beliefs.
The guideline might have seemed a solution for the problems of policy makers: to
keep the prescription of lamotrigine low to control costs of anti-epileptic drugs.
However, target populations did not cooperate and thereby policy failed.
Alternatively to guideline development, the HCIB might consider ways of assisting or
encouraging the professional community, e.g. by co-funding naturalistic trials that
are unlikely to be funded by manufacturers. Policy makers failed to acknowledge how
the target population defined problems or what argumentation gave direction to their
prescription practices. This case study supports the idea that it is important to
establish how target populations of policy measures experience problems and which
solutions appear sensible to them at an early stage of policy development.
Based on the findings in these two case studies, one could draw the lesson that
more attention should be paid to perspectives of stakeholders. In a project on
interferon-beta for patients with multiple sclerosis (Chapter 5), workshops were held
in which stakeholders participated. All participants seemed to agree on the
desirability of specific policy measures. However, policy measures had never been
implemented. Retrospective analysis of this case study revealed that no problems were
perceived for which the proposed policy measures could provide a solution. At the
Ministry of Health and the HCIB, the subject of IFNß was no longer a high priority.
Policy makers considered the policy measures useful for actors in the field.
Neurologists, however, did not perceive major problems for which a solution was
needed. This study has shown that the organisation of workshops in which target
populations participate does not qualify as an appropriate process of interactive
policy development. From the beginning, emphasis had been put on a limited
number of interventions aimed to control the expected increase in treatment costs.
Although target populations participated in policy development, perceived problems
and which interventions could provide a solution had been discussed insufficiently. 
Implementing lessons from the case studies
Based on the findings in the case on mebeverine, the HCIB made a few changes in
their process of commissioning research (Chapter 6 & 7). Besides providing specific
evidence, researchers were asked to analyse the problems as they are perceived by the
policy's target populations. 
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In chapter 6, a case study concerning policy measures for prescription of the selective
cox-2 inhibitors (COXIBs)is presented. The problem behind the requested study was
its frequent off label prescription and high costs. Off label was considered
problematic because the uncertainty on the effect of these medicines at long term.
Researchers were asked to analyse the problems as perceived by the policy's target
populations. Simultaneously, researchers were asked to produce knowledge that was
considered relevant to the PAM staff. Interviews showed that researchers seemed to be
reluctant to conduct the requested research. Researchers doubted whether PAM's
problem definition would be shared by 'the field'. At the time of finishing the study,
however, one of the COXIBs was withdrawn from the market because of serious side
effects. The results of this case study emphasize that involving target populations in
policy research should not imply that target populations control the problem
definition and identification of solutions. What went wrong was the way in which
PAM staff defined the problem. The PAM's prestudy defined not only the problem,
but also the underlying intentions and the direction that needed to be taken to solve
the problem.
In chapter 7, a research project concerning the regulation of drugs for patients
with pulmonary hypertension is presented. In this project, changes in the
commissioning procedure had been implemented to prevent a shift in problem
definition. Assumption was that preventing a shift in problem definition could
enhance the utilization of knowledge from policy research. As part of the tendering
process, the commissioner and the researchers met in an effort to reach an agreement
on the research questions. Nevertheless, the participants only concluded they had
different views on the situation. Researchers, who were also physicians with expertise
in the subject of investigation, redefined the problem based on their experiences and
assumptions. As a result, the PAM staff determined that the proposal did not fulfil
their needs and thus decided not the commission this project. In hindsight, we can
contend that too much emphasis was placed on preventing a shift in the problem
definition. A shift in problem definitions may be necessary for solving problems.
What went wrong in both case studies in chapter 6 & 7, is that neither the
commissioner, nor the researchers were open to discuss their viewpoints. Although
parallel research was commissioned to identify the problems perceived by target
populations, the request for evidence on the effectiveness was strongly affected by a
specific solution preferred by PAM. For identifying interventions that are congruent
with the perceived problems and normative values of all actors involved, problems
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and possible solutions should be explored through dialogue and interaction.
Preferably, the target populations of policies should be involved in the process of
problem structuring to achieve agreement on the most feasible solutions to the
perceived problems and the kind of knowledge that research should generate. 
Interactive problem structuring
In the eighth chapter, an interactive methodology was used for problem structuring.
This project was set up to identify problems and possible solutions concerning the
care of patients with auto-intoxication seen at the emergency department. Despite
the fact that a high level of care is often unnecessary, these patients are often admitted
to the internal ward or intensive care unit. To solve the efficiency-problem, some
physicians proposed a pilot study to evaluate the effectiveness of a six-hour
observation unit within the emergency department. Twenty respondents from several
disciplines had been interviewed, most of them twice. This case study showed that it
is possible to perform an interactive process of problem structuring to assess the
degree of congruence in perspectives of actors involved. Based on this information
broadly supported solutions and relevant research questions were identified. The
results of this process differed from a traditional approach in several ways. We
concluded that the inefficiency around hospitalization was only one of the possible
problem definitions. According to others, equally important was the insufficient use
of existing expertise of attention paid towards underlying problems. Other
interventions can be considered relevant in order to improve care. Criteria for
assessing the success implementation are identified. Finally, relevant research
question did not only include the evaluation of proposed interventions (solutions)
but questions related to the underlying background theories supporting or
contradicting the proposed interventions appeared equally important. Efficiency
research rest on the assumption that both comparators are optimized and stable.
Interviews revealed that this was not the case in the case study on care for intoxicated
patients. Therefore, efficiency research is as yet premature.
Discussion
In chapter 9, the findings from the abovementioned case studies are discussed. In
many case studies, interventions were valued differently due to differences in problem
definitions. Actors disagreed on what the problem was and which information was
needed. These differences in problem definitions resulted from differences in
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underlying background theories and normative values. The problems were ill-
structured: there was no agreement on which information was needed and actors held
different normative values. It was insufficiently acknowledged that problems were
ill-structured, as a result, research provided an answer to the wrong question.
Consequences were that results were irrelevant to its commissioners or policy’s target
populations did not co-operate on proposed policy measures. Thus, another
approach is needed in HTA, entailing a more extensively process of problem analysis.
Interactive problem structuring appeared feasible and lead also to different
outcomes (in terms of relevant interventions and research questions) as compared to a
more traditional approach. However, we also observed some difficulties when
applying a problem based approach. Firstly, the adoption of an argumentative
approach strongly depends on the willingness to learn from other perspectives. It is
important to realise that the choice for a problem based approach is funded on
normative view towards adequate policy making and the desired relation between
policy research and policy making. Main assumption behind the argumentative
approach is policy is seen as a process of co-production; i.e the assumption that for
successful policy making the co-operation of policy’s target populations is needed.
Secondly, it asks for another role of research and the researchers. Aim of HTA should
not be to provide just evidence, but to provide evidence that is relevant for solving
problems. It is the researchers task to analyse the problem to assess to what degree
actors agree, if they disagree an attempt should to structure the problem in such way
that it is manageable. Thus, the researcher should adequately analyse the problem to
identify which question needs to be answered. In case of insufficient congruence in
perspectives, some kind of learning should take place to make perspectives more
congruent.
Recommendation: Argumentative problem analysis in HTA
Conventional HTA methods need to be embedded in a more problem based
approach, whereby an extensive process of problem analysis must take place prior to
the design of research projects. The research process should be split up in a “problem
analysis phase”, “problem structuring phase” and a “knowledge providing phase”. All
researchers should assess the degree of structuring in order to improve the relevance
of their research: argumentative problem analysis. Firstly, the researcher assess which
actors are involved, who need to cooperate on possible interventions or are likely to
experience its consequences. Next step is to assess how they define the problem, judge
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interventions and the normative values they held. Based on this information an
estimate should be made on the degree of congruence in perspectives. In case of well
structure problems, conventional HTA methods can be used to provide the requested
information. In case of ill-structured problems, the problem should structured in
order to reach more congruence to be able to identify broadly supported
interventions. Methods for interactive Technology Assessment can be used for this
purpose.
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Samenvatting
Verbeteren van de bruikbaarheid van Health Technology Assessment 
In hoofdstuk 1 wordt een inleiding gegeven op het onderwerp van dit proefschrift: de
bruikbaarheid van Health Technology Assessment (HTA) en de noodzaak tot een
goede probleemstructurering. Er is discussie over de beperkte impact van HTA op
besluitvorming in de klinische praktijk of op nationaal niveau. Diverse artikelen zijn
geschreven waarin is ingegaan op de vraag hoe het gebruik van onderzoeksresultaten
te verbeteren. In het algemeen kunnen hierbij twee strategieën worden
onderscheiden: het standaardiseren van onderzoeksmethoden of het onderzoeken van
strategieën voor het verbeteren van de implementatie van resultaten in de praktijk.
Aanvullend op deze gangbare strategieën, wil ik een andere oplossing introduceren,
gebaseerd op inzichten vanuit de theorie van de argumentatieve beleidsanalyse. Een
alternatieve verklaring voor de beperkte impact van HTA is dat de resultaten
onvoldoende aansluiten bij de problemen zoals die worden ervaren door beoogde
gebruikers. De argumentatieve beleidsanalyse is één van de theorieën die een
verklaring wil bieden voor problemen met de implementatie van beleidsmaatregelen.
De ontwikkeling en implementatie van beleid wordt gevormd door interacties tussen
betrokken actoren. De kern van deze theorie is dat het handelen van actoren
verklaard kan worden op basis van de wijze waarop iemand een probleem definieert
en de onderliggende argumentatie. 
In veel gevallen is een evaluatie beperkt tot het meten van uitkomsten. Volgens
Frank Fischer is het probleem dat dergelijke evaluaties de onderliggende
veronderstellingen en normatieve waarden onvoldoende in beschouwing nemen. De
uitkomsten van een evaluatie zijn sterk afhankelijk van de gehanteerde criteria. Welke
uitkomstmaten van belang zijn hangt af van de wijze waarop het probleem
gedefinieerd is en wat het doel is van de verandering. Fischer presenteerde een
raamwerk voor een volledige evaluatie. Een volledige evaluatie omvat zowel een
beoordeling van de effectiviteit van interventies als de meer algemene
veronderstellingen en normatieve waarden.
In HTA wordt onvoldoende rekening gehouden met het feit dat problemen
verschillend gedefinieerd kunnen worden door betrokkenen. Huidige kwantitatieve
onderzoeksmethoden zijn vooral geschikt voor zogenaamde goed gestructureerde
problemen: situaties waarbij betrokkenen het eens zijn over welk informatie gewenst
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is om een probleem op te kunnen lossen en welke normen daarbij in het geding zijn.
Indien betrokken het niet eens zijn over welke informatie er nodig is en er tevens
verschillende normatieve waarden in het geding zijn is er sprake van een
ongestructureerd probleem. Indien er sprake is van een ongestructureerd probleem,
zal de conventionele benadering leiden tot een vereenvoudiging van het probleem,
waardoor het probleem slechts gedeeltelijk of het verkeerde probleem wordt opgelost.
In dit proefschrift behandel ik de hypothese dat het wenselijk is in HTA
rekening te houden met de verschillende perspectieven van betrokken actoren, ook
indien men te maken heeft met onderwerpen die op het eerste gezicht niet zo
controversieel zijn. Onderzoeksvragen zijn:
1. In gevallen waarin HTA onderzoek of de implementatie van daarop gebaseerde
beleidsmaatregelen is gefaald, in hoeverre waren de onderzoeksresultaten of de
beleidsmaatregelen congruent met de perspectieven van betrokken actoren
(aanluitend bij de wijze waarop het probleem werd gedefinieerd en niet strijdig
met normatieve veronderstellingen)?
2. Wat zijn de resultaten van onderzoek en daaropvolgende beleidsmaatregelen
indien beoogde doelgroepen van het beleid participeren in beleidsonderzoek?
Leidt participatie tot onderzoeksresultaten en beleidsmaatregelen die
congruent zijn met de perspectieven van betrokken actoren? 
3. Wat zijn de uitkomsten van een interactief proces van probleemstructurering,
waarbij probleemdefinities, onderliggende veronderstellingen en normatieve
voorkeuren worden geanalyseerd en bediscussieerd? Is het van invloed op de
selectie van interventies om een oplossing te bieden voor de problemen, de
criteria om de interventies te evalueren en de onderzoeksvragen die als relevant
worden ervaren?
Methodologie: reconstructie van handelingstheorieën
Een belangrijke analysemethode bij deze benadering is de reconstructie van
handelingstheorieën: de combinaties van iemands oordeel over een interventie, de
wijze waarop het probleem is gedefinieerd, onderliggende (normatieve)
achtergrondtheorieën, en iemands diepere voorkeuren. Dit model beoogt het
handelen van actoren te verklaren en de medewerking van actoren aan bepaalde
interventies vooraf in te schatten. In hoofdstuk 2 worden de concepten van validiteit
en betrouwbaarheid in relatie tot deze analysemethode bediscussieerd. De resultaten
van een analyse van de inter-beoordelaarsvariatie bij het reconstrueren van
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handelingstheorieën zijn gepresenteerd. Het reconstrueren van handelingstheorieën
op basis van uitgetypte interviews is betrouwbaar als het gaat om het inschatten van
iemands medewerking aan bepaalde interventies. Daarmee is de methode geschikt om
interventies te identificeren die waarschijnlijk op brede steun kunnen rekenen. De
betrouwbaarheid van het identificeren van de belangrijkste problemen voor een actor
was echter matig.
Retrospectieve analyse van case studies m.b.v. argumentatieve beleidsanalyse
In hoofdstuk 3, 4 en 5 worden drie case studies gepresenteerd waarin
beleidsonderzoek of de implementatie van de daaropvolgende beleidsmaatregelen was
gefaald. De case studies hebben betrekking op onderzoek uitgezet door de afdeling
Beleidsonderzoek Geneesmiddelen (BOG) van het College voor Zorgverzekeringen.
Aan de hand van documentanalyse en interviews zijn de handelingstheorieën van
betrokken actoren gereconstrueerd. Met behulp hiervan is nagegaan in hoeverre de
onderzoeksresultaten of voorgestelde beleidsmaatregelen aansloten bij de problemen
van betrokken actoren en niet strijdig waren met hun normatieve
achtergrondtheorieën.
In hoofdstuk 3 wordt de casus over het geneesmiddel mebeverine voor
patiënten met prikkelbaar darmsyndroom gepresenteerd. Voorafgaande aan het
onderzoeksproject was door het ministerie geprobeerd het middel uit het
verstrekkingenpakket te halen. Deze maatregel mislukte echter. Betrokken actoren
waren het niet eens over de vraag of het geneesmiddel aan alle criteria voor
vergoeding voldeed. Onderzoek naar de effectiviteit van het middel werd uitgezet en
de verwachting was dat de resultaten hiervan bruikbaar waren om alsnog succesvol
beleid uit te voeren. Gedurende het onderzoekstraject trad er een verschuiving in de
probleemdefiniëring op. Het uiteindelijke voorstel voor een onderzoek sloot
onvoldoende aan bij de probleemdefiniëring volgens de opdrachtgevers. Echter, ook
indien een verschuiving in de definiëring van het probleem kon worden voorkomen,
is het niet waarschijnlijk dat het gevraagde onderzoek de problemen zou hebben
opgelost. Het onderzoek sloot onvoldoende aan bij de problemen zoals die werden
ervaren door potentiele doelgroepen van het beleid. Het probleem rondom de
middelen voor het prikkelbare darmsyndroom was ongestructureerd. Dit werd
onvoldoende erkend, waardoor tijdens het project een verschuiving in de definiëring
van het probleem optrad en de uiteindelijke studie een antwoord op de verkeerde
vraag zou geven.
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In hoofdstuk 4 is een casus beschreven over een richtlijn opgesteld door het College
voor Zorgverzekeringen over het voorschrijven van het anti-epilepticum lamotrigine.
De aanbevelingen in de richtlijn zijn gebaseerd op de beschikbare kennis uit
wetenschappelijke studies op dat moment. De kern van de richtlijn was dat het
voorschrijven van lamotrigine beperkt moest worden tot patiënten met moeilijk
behandelbare epilepsie. De reden voor het opstellen van de richtlijn was de
verwachting dat het middel inadequaat zou worden voorgeschreven. Een recente
enquête toonde dat de richtlijn in de praktijk nauwelijks gebruikt werd. Interviews
lieten zien dat beleidsmakers en neurologen het probleem verschillende definieerden.
De beleidsmaatregel leek een oplossing voor de problemen zoals gedefinieerd door
beleidsmakers: het beperken van het voorschrijven van lamotrigine om de kosten laag
te houden. De doelgroepen van het beleid werkten echter niet meer, waardoor het
beleid faalde. Een mogelijk alternatieve maatregel om het adequaat voorschrijven van
dit middel te bevorderen, is het ondersteunen van de medische professionals,
bijvoorbeeld door het financieren van gewenste studies (in natuurlijke setting) die
door fabrikanten nooit zouden worden gefinancierd. Deze studie laat zien dat het
wenselijk is om bij beleidsontwikkeling de doelgroepen van het beleid in een
vroegtijdig stadium te betrekken.
Op basis van deze twee studies kan de conclusie worden getrokken dat het
wenselijk is om de perspectieven van doelgroepen van beleid mee te nemen in
beleidsondersteunend onderzoek. In een project over beleidsmaatregelen voor het
geneesmiddel interferon-beta voor patiënten met Multipele Sclerose (hoofdstuk 5)
zijn deze doelgroepen gevraagd te participeren in workshops. Tijdens de workshops
leken alle betrokkenen het eens te zijn over de wenselijkheid van een aantal concrete
beleidsmaatregelen. Echter, deze maatregelen zijn uiteindelijk nooit geïmplementeerd
in de praktijk. Een mogelijke verklaring is dat er door de betrokkenen geen
problemen werden ervaren waarvoor deze maatregelen een oplossing konden bieden.
Bij het ministerie en het College voor Zorgverzekeringen had het onderwerp geen
hoge prioriteit meer. Zij gaven aan dat de maatregelen vooral voor de beroepsgroep
meerwaarde konden hebben. De neurologen echter ervaarden geen problemen
waarvoor deze maatregelen een oplossing zouden bieden. Deze studie laat zien dat het
organiseren van workshops waaraan doelgroepen van beleid deelnemen niet gelijk is
aan interactieve beleidsontwikkeling. Een mogelijke verklaring voor het verloop van
het project is dat in het project veel nadruk lag op een beperkt aantal
beleidsmaatregelen en niet zozeer de problemen waarvoor oplossingen nodig waren.
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Tevens werden onderliggende veronderstellingen en achtergrondtheorieën
onvoldoende bediscussieerd.
Implementeren van lessen uit retrospectieve analyse van case studies
Naar aanleiding van de bevindingen in de cases over mebeverine heeft het BOG een
aantal wijzigingen doorgevoerd in hun aanbestedingsprocedures. Twee projecten
waarin de vernieuwde aanpak is toegepast zijn beschreven in hoofdstuk 6 en 7. In
deze projecten werd aan de onderzoekers gevraagd om niet alleen bepaalde kennis aan
te leveren maar ook de probleemdefinities volgens betrokken actoren te achterhalen
en mee te nemen in het project. 
In hoofdstuk 6 wordt een casus beschreven over beleidsmaatregelen rond de
selectieve cox-2 remmers. Het probleem was dat deze nieuwe medicijnen op grote
schaal off-label werden voorgeschreven. Achtergrond was dat er onvoldoende kennis
was over de effecten van deze middelen op langere termijn. Onderzoekers werd
gevraagd om na te gaan hoe de doelgroepen van beleid problemen rondom de inzet
van deze middelen ervaren. Tegelijkertijd dienden zij bepaalde informatie te leveren
die relevant was volgens het College voor Zorgverzekeringen. Uit interviews met de
onderzoekers die een voorstel hadden ingediend bleek dat zij kritisch waren ten
aanzien het gevraagde onderzoek. Volgens de onderzoekers werd de wijze waarop het
probleem was gedefinieerd niet gedeeld door artsen, waardoor er weinig draagvlak
zou zijn voor maatregelen. Tijdens de afronding van het onderzoeksproject werd één
van de middelen van de markt gehaald in verband met ernstige bijwerkingen. Het
betrekken van doelgroepen bij onderzoek en beleidsontwikkeling wil dus niet zeggen
dat deze doelgroepen volledige zeggenschap moeten krijgen over de wijze waarop het
probleem gedefinieerd is. Echter, in de beleidsanalyse werd niet alleen het probleem
op een bepaalde wijze gedefinieerd waar doelgroepen kritiek op hadden, maar hierin
werd ook een duidelijke oplossingsrichting aangegeven.
In hoofdstuk 7 wordt een casus beschreven over beleid rond twee nieuwe, dure
geneesmiddelen (epoprostenol en bosentan) voor patiënten met pulmonale
hypertensie. In dit project werden maatregelen genomen om de kans op een
verschuiving in de probleemdefiniëring te verkleinen. De veronderstelling was dat het
voorkomen van een verschuiving in de probleemdefiniëring de bruikbaarheid van
uiteindelijke resultaten zou verbeteren.. Tijdens de aanbesteding van het onderzoek
werd een bijeenkomst georganiseerd waarbij overleg tussen de onderzoekers en
opdrachtgever mogelijk was. Desondanks trad er probleemtransformatie op in één
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van de deelprojecten. De onderzoekers, medisch specialisten, herdefinieerden het
probleem bewust op basis van hun eigen inzichten en ervaringen. BOG medewerkers
besloten dit onderdeel niet aan te besteden. Achteraf gezien werd er teveel nadruk
gelegd op het voorkomen van probleemtransformatie, terwijl een herdefiniëring van
het probleem soms noodzakelijk kan zijn om problemen op te lossen. 
Het probleem was dat in beide projecten betrokkenen (opdrachtgever en de
onderzoekers) niet echt open stonden om hun perspectieven op de situatie te
bediscussiëren. Ondanks het feit dat onderzoek was uitgezet om de
probleemdefinities volgens doelgroepen van het beleid te identificeren, werd parallel
onderzoek uitgezet dat als doel had specifieke informatie te leveren die relevant was
volgens het perspectief van de opdrachtgever. Idealiter, zouden doelgroepen
betrokken moeten worden bij de probleemanalyse om vervolgens na te gaan welke
interventies een oplossing kunnen bieden en welk onderzoek wenselijk is. 
Interactieve probleem structurering
In hoofdstuk 8 zijn de resultaten van een interactieve procedure voor
probleemstructurering gepresenteerd. Het project had betrekking op het identificeren
van ervaren problemen en gewenste oplossingen rondom de acute opvang van
patiënten in een ziekenhuis na intoxicatie met een overdosis (genees)middelen.
Aanleiding voor het onderzoek was de ervaring dat veel patiënten werden opgenomen
op een intensive care, terwijl - achteraf gezien - dit vaak niet nodig was. Een van de
betrokkenen stelde voor de doelmatigheid te onderzoeken van een 6-uurs observatie
van deze patiënten op de spoedeisende hulp van het ziekenhuis. Twintig actoren
werden geïnterviewd, waarvan het merendeel tweemaal, en gevraagd naar ervaren
problemen en onderliggende veronderstellingen en argumenten. Met behulp van deze
interactieve methode was het mogelijk de mate van congruentie in perspectieven vast
te stellen. Vervolgens konden interventies worden geïdentificeerd die op breed
draagvlak zouden kunnen rekenen onder de betrokkenen en vervolgens relevante
onderzoeksvragen. De uitkomsten van deze interactieve analyse verschillenden van de
traditionele benadering op een aantal punten. Allereerst bleek de ondoelmatigheid
rond het opnamebeleid slechts één van de probleemdefinities. Volgens anderen waren
problemen rond het onvoldoende gebruik maken van aanwezige expertise in het
ziekenhuis even belangrijk. Andere interventies werden genoemd om de zorg voor
deze patiëntenpopulatie te verbeteren. Ook konden criteria voor goede zorg worden
vastgesteld. Tot slot waren niet alleen onderzoeksvragen met betrekking op het
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evalueren van effecten van interventies relevant, maar ook vragen naar onderliggende
achtergrondtheorieën die bepaalde interventies ondersteunden of tegenspraken. Een
belangrijke veronderstelling achter huidig doelmatigheidsonderzoek is dat de
interventie die onderwerp van onderzoek volledig is uit-ontwikkeld en
geoptimaliseerd. De interviews toonden aan dat het niet het geval was bij dit
onderwerp. Doelmatigheidsonderzoek was daarmee nog voorbarig.
Discussie
In het slothoofdstuk worden de bevindingen uit de case studies bediscussieerd. In de
meeste case studies werden interventies verschillend beoordeeld door betrokken
actoren door verschillen in de probleemdefinities. Actoren waren het niet eens over
wat het probleem was en welke informatie nodig was. De verschillen in
probleemdefinities kunnen grotendeels worden toegeschreven aan verschillen in
achtergrondtheorieën en diepere voorkeuren. De problemen waren ongestructureerd:
er was geen overeenstemming over welke kennis nodig was en de actoren hielden
verschillende normatieve voorkeuren. Tijdens de projecten werd er onvoldoende
rekening mee gehouden dat de problemen ongestructureerd waren. Onderzoek gaf
vaak een antwoord op de verkeerde vraag. Als gevolg daarvan waren de resultaten niet
bruikbaar voor de opdrachtgever of was er geen medewerking van doelgroepen aan
voorgestelde beleidsmaatregelen. Kortom, meer aandacht is nodig voor uitgebreide
probleemanalyse in HTA. 
Een interactieve probleemanalyse bleek uitvoerbaar en leidt mogelijk ook tot
andere uitkomsten in vergelijking met de traditionele benadering in HTA. Echter, bij
de uitvoering van een dergelijke benadering werden ook enkele moeilijkheden
ervaren. Allereerst is de adoptie van de argumentatieve benadering sterk afhankelijk
van de bereidheid om van andere perspectieven te leren. Het is van belang te
realiseren dat een probleemgerichte benadering een normatieve keuze omvat ten
aanzien van adequate beleidsontwikkeling en de gewenste relatie tussen
beleidsonderzoek en beleidsontwikkeling. Een belangrijk uitgangspunt is dat beleid
wordt gezien als een proces van co-productie wat veronderstelt dat de medewering
van doelgroepen van het beleid nodig is om het beleid succesvol te laten zijn. Ten
tweede vergt deze benadering een andere rol voor HTA onderzoek en onderzoekers.
Het doel van HTA is niet zozeer het leveren van kennis, maar het leveren van kennis
dat relevant is om bepaalde problemen op te lossen. Het is de taak van de
onderzoeker om problemen te analyseren en de mate van structurering van het
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probleem vast te stellen. Indien betrokken actoren het niet eens zijn, dient de
onderzoeker het probleem te structureren op zodanige wijze dat het hanteerbaar is.
Indien er onvoldoende congruentie in perspectieven is moet er een proces van leren
optreden om meer congruentie te bewerkstelligen. Dit is nodig om oplossingen te
kunnen identificeren die op een breed draagvlak kunnen rekenen bij de
implementatie.
Aanbeveling: interactieve probleem analyse in HTA
Huidige methoden voor HTA onderzoek zouden moeten worden ingebed in een meer
probleem gerichte benadering, waarbij het onderzoek moet worden voorafgegaan
door een uitgebreide probleemanalyse. Bij het HTA onderzoek moet onderscheid
worden gemaakt tussen een “fase van probleem analyse”, een “fase van probleem
structurering” en een “kennis producerende fase”. Alle onderzoekers moeten de mate
van structurering vaststellen voorafgaande aan het onderzoek om de relevantie van
het onderzoek te verhogen door middel van interpretatieve probleem analyse. In de
eerste plaats moet de onderzoeker nagaan welke actoren bij het onderwerp van studie
betrokken zijn, actoren wiens medewerking nodig is bij het uitvoeren van interventies
of actoren die mogelijk consequenties hiervan ervaren. In de tweede plaats moet
worden nagegaan hoe deze actoren het probleem definiëren, interventies beoordelen
en welke normatieve voorkeuren daaraan ten grondslag liggen. Ten derde, op basis
van deze informatie dient te worden nagegaan in welke mate het probleem
gestructureerd is. Indien het probleem goed gestructureerd is, kunnen conventionele
methoden voor onderzoek (kwantitatief onderzoek; bijvoorbeeld kosten-
effectiviteitsstudies) worden toegepast om de gewenste informatie te leveren. Indien
het probleem slecht gestructureerd is, is verdere structurering van het probleem nodig
om meer congruentie in perspectieven te bewerkstelligen. Interactieve
onderzoeksmethoden kunnen hiervoor worden toegepast. 
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spannend tot het eind. Binnenkort sta jij hier. 
Joris en Steven, ik vind het leuk dat jullie als paranimfen naast mij staan. Jullie
steun is zeer waardevol.
Een speciaal woord van dank aan mijn ouders. Van jullie heb ik geleerd om
iets aan te pakken en gewoon bij het begin te beginnen. Of het nu gaat om het
opknappen van een oud huis of het schrijven van een proefschrift. Dank voor alle
hulp en steun. En ma, met het gummetje dat je mij bij mijn afstuderen gaf, wordt de
‘s’ nu weggepoetst.
Tot slot, lieve Gerben, mijn maatje en veel meer dan dat. De afgelopen
periode heb ik gemerkt hoe bijzonder onze band is. Na een periode vol spannende
ontwikkelingen gaan we nu lekker genieten ... samen met Bram.
